Newsletter 2012

92
2012 NEWSLETTER TRANSPLANT COUNCIL OF EUROPE CONSEIL DE L’EUROPE Vol. 17 • Nº 1 • SEPTEMBER • 2012 INTERNATIONAL FIGURES ON DONATION AND TRANSPLANTATION - 2011

description

Newsletter Europe 2012

Transcript of Newsletter 2012

Page 1: Newsletter 2012

2012

NEWSLETTERTRANSPLANT

COUNCILOF EUROPE

CONSEILDE L’EUROPE

Vol

. 17

• N

º 1

• SE

PT

EM

BE

R •

201

2

INTERNATIONAL FIGURES ONDONATION AND TRANSPLANTATION - 2011

Page 2: Newsletter 2012

Editor: Rafael Matesanz

AULA MÉDICA EDICIONES. Paseo Pintor Rosales, 26 - 28008 Madrid (España)Tel. 91 357 66 09. Fax 91 357 65 21. Depósito legal: M-9.990-1996. ISSN: 2171-4118.

NATIONAL DATA PROVIDED BY:

Organización Nacional de Trasplantes (ONT) – SpainRafael MatesanzBeatriz MahilloMarina AlvarezMar Carmona

AUSTRIAJacqueline Smits (ET)BELGIUMJacqueline Smits (ET)BULGARIAVioletta MarinkovaCYPRUSPanayiotis HadjicostasChrystalla DespotiMaurizio Di Fresco (MTN)CZECH REPUBLICLucie BaudyšováDENMARKFrank Pedersen (SKT)ESTONIAPeeter DmitrievFINLANDFrank Pedersen (SKT)FRANCECristelle CantrelleMarie ThuongGERMANYBrigitte OssadnikJacqueline Smits (ET)GREECEAnastasios HatzisGeorgia MenoudakouMaurizio Di Fresco (MTN)HUNGARYSz cs AnikóIRELANDMaeve RaesideITALYAndrea RicciPaola Di CiaccioLATVIASergey TrushkovLITHUANIAVita AnulytèLUXEMBURGJacqueline Smits (ET)MALTACarmel AbelaMaurizio Di Fresco (MTN)NETHERLANDSRik van LeidenJacqueline Smits (ET)POLANDPiotr MalanowskiPORTUGALCatarina BolotinhaROMANIADan Adrian LuscalovSLOVAKIALudovit LacaSLOVENIABarbara UštarJacqueline Smits (ET)

SPAINElisabeth CollCarmen MartínDavid UruñuelaSilvia MartínSWEDENFrank Pedersen (SKT)UNITED KINGDOMMark Jones

(ET) EUROTRANSPLANTAustria, Belgium, Croatia,Germany, Luxemburg,Netherlands and Slovenia

(SKT) SCANDIATRANSPLANTDenmark, Finland, Norway,Sweden and Iceland

ALGERIAFarid HaddoumMaurizio Di Fresco (MTN)AUSTRALIALee ExcellKylie HurstBELARUSAleh RumoCANADAPatrick BedfordLiz Anne Gillham-EisenCROATIAJacqueline Smits (ET)EGYPTAhmed GhaliMaurizio Di Fresco (MTN)GEORGIAGia TomadzeICELANDFrank Pedersen (SKT)ISRAELTamar AshkenaziLIBYAMunir AbudherAsem BukrahMaurizio Di Fresco (MTN)LEBANONAntoine EstephanMaurizio Di Fresco (MTN)MACEDONIAGoce SpasovskiMOLDOVAIgor CodreanuTatiana TimbalariNEW ZEALANDLee ExcellKylie HurstNORWAYFrank Pedersen (SKT)

PALESTINEMohammed AyyoubMaurizio Di Fresco (MTN)RUSSIAYan MoysyukSWITZERLANDFranziska BeyelerDagmar VernetSYRIABassam SaeedMaurizio Di Fresco (MTN)TUNISIAHafed MestiriBen Abdallah TaiebMaurizio Di Fresco (MTN)TURKEYTürkay SeyhanBahri KemaglouMaurizio Di Fresco (MTN)USAJohn Rosendale

(MTN) MEDITERRANEANTRANSPLANT NETWORKAlgeria, Cyprus, Egypt, France,Greece, Israel, Italy, Lebanon,Lybia, Malta, Morocco,Palestine, Spain, Syria, Tunisiaand Turkey

ARGENTINACarlos SorattiMartín Alejandro TorresRicardo Rubén Ibarwww.grupopuntacana.orgBOLIVIAOlker Calla Rivadeneirawww.grupopuntacana.orgBRASILHeder Murari Borbawww.grupopuntacana.orgCHILEJose Luis Rojaswww.grupopuntacana.orgCOLOMBIAJuan Gonzalo López CasasDiana Carolina Plazas Sierrawww.grupopuntacana.orgCOSTA RICAMarvin Agüero ChinchillaCésar A. Gamboa Peñarandawww.grupopuntacana.orgCUBAAngela Olga Hidalgo Sánchezwww.grupopuntacana.orgDOMINICANAFernando Morales Billiniwww.grupopuntacana.org

ECUADORDiana Almeidawww.grupopuntacana.orgEL SALVADORMauricio Venturawww.grupopuntacana.orgGUATEMALARudolf García-Gallontwww.grupopuntacana.orgHONDURASMEXICOLuis Antonio Meixueiro DazaOmar Sánchez Ramírezwww.grupopuntacana.orgNICARAGUATulio René Mendieta Alonsowww.grupopuntacana.orgPANAMACesar Cuero Zambranowww.grupopuntacana.orgPARAGUAYHugo A. Espinoza C.www.grupopuntacana.orgPERUJuan A. Almeyda Alcántarawww.grupopuntacana.orgURUGUAYInés AlvarezRaul José Mizrajiwww.grupopuntacana.orgVENEZUELACarmen Luisa Lattuf de MilanésZoraida Pacheco Graterolwww.grupopuntacana.org

GRUPO PUNTA CANAArgentina, Bolivia, Brasil, Chile,Colombia, Costa Rica, Cuba,Dominicana, Ecuador, ElSalvador, España, Guatemala,Honduras, México, Nicaragua,Panamá, Paraguay, Perú,Portugal, Puerto Rico, Uruguayy Venezuelawww.grupopuntacana.org

Page 3: Newsletter 2012

NEWSLETTERTRANSPLANT 2012

CONTENTS• International Figures on Organ Donation and Transplantation Activity.

Year 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

• International Data on Organ Donation and Transplantation Activity,Waiting List, Family Refusals and Transplantation of VascularisedComposite Allografts. Year 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33

• International Data on Tissues and Hematopoietic Stem Cell Donationand Transplantation Activity. Year 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

• Good Practice Guidelines in the Process of Organ Donation . . . . . . . . . . . . . 65

• Co-operation between countries of the Black Sea Area (BSA Project):Development of the activities related to donation and transplantation . . . . . 79

• Transplantation of Non-Nationals and Non-Residents in the Countriesof the Council Of Europe: Results of a Survey Conducted in theContext of the Initiatives of the European Committee on OrganTransplantation (CD-P-TO) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83

Page 4: Newsletter 2012

FOR THE PURPOSES OF THIS NEWSLETTER THE FOLLOWING DEFINITIONS WERE USED:

Actual deceased organ donorAn actual deceased organ donor is a person from whom at least one organ has been recovered for the purpose oftransplantation, in contrast to a utilised donor, who is an actual donor from whom at least one organ has beentransplanted. The number of utilised donors is therefore lower or equal than the number of actual donors.

Donor after brain deathA donor after brain death (DBD) is a deceased organ donor in whom death has been determined by neurologiccriteria.

Donor after circulatory deathA donor after circulatory death (DCD) is a deceased organ donor in whom death has been determined by circulatoryand respiratory criteria.

Multiorgan donorA multiorgan donor is an actual donor from whom at least two different types of organs have been recovered forthe purpose of transplantation.

Total TX. (all combinations included)Includes the transplantation of the corresponding organ with or without the simultaneous transplant of a differenttype of organ (s).

Double-kidney TX.One double-kidney TX. is counted as 1 TX.

TX. from living donorsA living donor is a living human being from whom organs have been recovered for the purpose of transplantation.A Living Donor has one of the following three possible relationships with the recipient:

A/ Related:A1/ Genetically Related:

1st Degree Genetic Relative: Parent, Sibling, Offspring2nd Degree genetic relative, e.g. grandparent, grandchild, aunt, uncle, niece, nephew,Other than 1st or 2nd degree genetically related, for example cousin

A2/ Emotionally Related: Spouse (if not genetically related); in-laws; Adopted; FriendB/ Unrelated = Non Related: Not Genetically or Emotionally Related

Heart-lung TX. One heart-lung TX. is counted as 1 lung TX., 1 heart TX. and 1 heart-lung TX.

Double-lung TX. One double-lung TX. is counted as 1 TX.

Total number of patients transplantedFor more than one organ transplanted into the same recipient: kidney-liver-heart TX. = counted as one recipient.

Absolute numberIncludes all figures corresponding to all donors/ patients adults and children.

PaediatricIncludes only paediatric activity (patients aged < 15 years).

Waiting List Example: At 1/1/2011 there were 200 patients active on the WL. Along the year, 100 patients are newly includedon the WL (first row). In total, 300 patients have been ever active on the WL during the year (second row). Alongthe year, 200 patients were transplanted (number recorded in a different questionnaire), 50 patients remain activeat the end of the year (third row), 25 patients died (fourth row) and 25 patients were excluded (number not to bereported, but derived from previous figures).

Patients included on the WL for the first time in the course of 2011 100

Total number of patients ever active on the WL during 2011 300

Patients awaiting for a transplant (only active candidates) on 31/12/2011 50

Patients who died while on the WL during 2011 25

(*The United Nations Fund report (UNFPA: http://www.unfpa.org/public/) is used as the data source for estimates ofpopulation size, unless a more up-to-date figure is available from an official source).

Page 5: Newsletter 2012

COUNCIL OF EUROPE

CONSEIL DE L’EUROPE3

International Figures on Organ Donation

and Transplantation Activity. Year 2011

Page 6: Newsletter 2012

6.7

24.5

15.5

17.2 16

.9 18.2

14.4

14.7

13.0

12.5

13.1

17.6

24.4

15.5

33.6

3.6 0.

5

6.9

4.2

21.8

35.3

25.0

12.5

20.7

17.0

13.6

30.1

18.0

28.1

11.8

10.0

3.3

5.5

2.3

4

10.8

30.0

0.6

AC

TU

AL

DE

CE

ASE

D O

RG

AN

DO

NO

RS

–bot

h D

BD

an

d D

CD

incl

ud

ed- A

nn

ual

Rat

e p.

m.p

. 201

1

Page 7: Newsletter 2012

36.7

60.4

46.3

32.8 33

.8 35.0

6.8

28.1

34.8

42.0

23.5

25.1

34.3

49.4

23.0

53.9

10.2

0.3

2.9

2.3

16.2

39.4

28.8

52.9

45.7

35.3

43.1

44.2

51.5

46.7

49.5

22.7

18.2

KID

NE

Y T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

4.0

5

28.2

18.6

31.8

11.717

.5

10.2

3.4

45.0

0.8

17.2

Page 8: Newsletter 2012

45.8

26.7

30.4 30

.8 33.6

27.0

25.1

24.1

21.1

20.4

30.5

42.9

23.0 51

.8

6.7

1.0

1.1

12.2

7.0

3.5

25.3

46.3

41.1

22.6

36.7

27.7

25.1

43.1

45.1

21.8

KID

NE

Y T

X. F

RO

MD

EC

EA

SED

DO

NO

RS

An

nu

al R

ate

p.m

.p. 2

011

10.9

6

30.0

16.2

17.6

5.6

Page 9: Newsletter 2012

36.7

14.6

19.6

2.4 3.

1 1.4

1.0

9.7

17.9

2.4

4.7

3.8

6.5 2.

0

3.5

2.9

1.2

4.0

32.4

3.5

6.6

4.6

12.6

6.0

16.5

26.3

3.6

4.4

0.9

KID

NE

Y T

X.

FRO

M L

IVIN

G D

ON

OR

S A

nn

ual

Rat

e p.

m.p

. 201

1

17.3

4.0

9.2

3.4

7

15.0

0.8

17.2

15.7

15.1

11.7

17.5

2.4

0.6

1.3

0.3

Page 10: Newsletter 2012

LIV

ER

TR

AN

SPLA

NT

-in

clu

ded

all

th

e co

mb

inat

ion

s-A

nn

ual

Rat

e p.

m.p

. 201

0

8

17.8

16.6

10.4 6.

2 0.5

1.4

7.8

14.7

9.1

4.5

4.4

8.4

15.2

10.0

28.2

3.0

0.5

0.8

3.7

12.1

17.0

24.1

17.9

13.6

13.6

12.2

8.1

27.2

20.5

3.6

4.5

0.2

9.9

0.2

5.5

LIV

ER

TR

AN

SPLA

NT

-all

com

bin

atio

ns

incl

ud

ed-

An

nu

al R

ate

p.m

.p. 2

011

Page 11: Newsletter 2012

HE

AR

T T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

9

6.0

5.5

3.3

1.4

0.7

2.1

4.5

5.2

3.5

1.4

6.5 6.1 7.0

8.6

0.3 0.

3

0.5

1.2

4.6

5.0

6.3

4.5

1.3

2.4

2.6

6.9

4.3

1.5

2.2

1.4

3.0

0.1

2.5

Page 12: Newsletter 2012

LUN

G T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

10

5.6

6.4

4.3 2.

3

0.1

0.4

4.1

5.4

1.7

14.3

0.1

2.0

4.9

5.0

6.8

1.8

3.1

4.1

10.1

1.7

0.3

7.8

Page 13: Newsletter 2012

PAN

CR

EA

S T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

11

4.0

3.7

0.2

0.1

0.9

2.1

1.0

3.0 1.9 0.5

2.7

0.1

0.3

1.0

2.4

1.1

3.5

1.8

3.8

1.8

1.3

2.3

0.9

0.2

1.6

Page 14: Newsletter 2012

SMA

LL B

OW

EL

TR

AN

SPLA

NT

-all

com

bin

atio

ns

incl

ud

ed-

An

nu

al R

ate

p.m

.p. 2

011

12

0.2

0.1

0.1

0.2

0.2

0.1

0.3

0.1

0.0

Page 15: Newsletter 2012

TO

TAL

NU

MB

ER

OF

PAT

IEN

TS

TR

AN

SPLA

NT

ED

An

nu

al R

ate

p.m

.p. 2

011

13

36.7

91.4

75.6

50.9 42

.3 36.8

9.0

38.2

61.4

30.4

49.6 40

.0

0.3

2.9

3.4

20.4

52.6

52.1

86.4

73.0

61.5

42.7

62.6

67.2

75.9

28.2

25.1

4.0

20.2

16.4

11.7

17.5

10.3

3.6

47.5

0.8

22.6

Page 16: Newsletter 2012

14

EU

RO

PEA

N U

NIO

N D

ATA

96

04

AC

TU

AL D

EC

EA

SED

OR

GA

N D

ON

OR

S (

both

DB

D a

nd

DC

D in

clu

ded

)

Kid

ney

Tran

sp

lan

ts

Liv

er

Tran

sp

lan

ts

Heart

Tran

sp

lan

ts

Lu

ng

Tran

sp

lan

ts

Pan

creas

Tran

sp

lan

ts

Sm

all

Bo

wel

Tran

sp

lan

ts

18

71

2

(2

0,6

% L

D)

70

06

(3

,5%

LD

)1

98

01

67

78

59

56

*2

01

1 d

ata

N=

27

CO

UN

TR

IE

S (

50

4,2

mil

lio

n i

nh

ab

itan

ts)

Page 17: Newsletter 2012

15

CA

NA

DA

US

A

AU

ST

RA

LIA

NEW

ZEA

LAN

D

Pop

ula

tion

(m

illi

on i

nh

abit

ants

):34

.5A

ctu

al d

ecea

sed

orga

n d

onor

s -b

oth

DB

Dan

d D

CD

incl

ude

d-(p

mp)

531

(15.

4)K

idn

ey T

X. f

rom

dec

ease

d do

nor

s (p

mp)

803

(23.

3)K

idn

ey T

X. f

rom

liv

ing

don

ors

(pm

p)43

3(1

2.6)

Live

r To

tal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)48

7(1

4.1)

Hea

rt T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)15

7(4

.6)

Hea

rt-L

un

g To

tal

TX

. (pm

p)1

(0.0

)Lu

ng

Tota

l T

X. -

all

com

bin

atio

ns

incl

ude

d-(p

mp)

181

(5.2

)Pa

ncr

eas

Tota

l T

X. -

all

com

bin

atio

ns

incl

ude

d-(p

mp)

108

(3.1

)Sm

all

Bow

el T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)2

(0.1

)To

tal

nu

mbe

r of

pat

ien

ts t

ran

spla

nte

d (p

mp)

Pop

ula

tion

(m

illi

on i

nh

abit

ants

):31

3.1

Act

ual

dec

ease

d or

gan

don

ors

-bot

h D

BD

and

DC

Din

clu

ded-

(pm

p)81

26(2

6.0)

Kid

ney

TX

. fro

m d

ecea

sed

don

ors

(pm

p)11

838

(37.

8)K

idn

ey T

X. f

rom

liv

ing

don

ors

(pm

p)57

72(1

8.4)

Live

r To

tal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)63

42(2

0.3)

Hea

rt T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)23

49(7

.5)

Hea

rt-L

un

g To

tal

TX

. (pm

p)27

(0.1

)Lu

ng

Tota

l T

X. -

all

com

bin

atio

ns

incl

ude

d-(p

mp)

1849

(5.9

)Pa

ncr

eas

Tota

l T

X. -

all

com

bin

atio

ns

incl

ude

d-(p

mp)

1082

(3.5

)Sm

all

Bow

el T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)12

9(0

.4)

Tota

l n

um

ber

of p

atie

nts

tra

nsp

lan

ted

(pm

p)28

539

(91.

1)

Pop

ula

tion

(m

illi

on i

nh

abit

ants

):22

.6A

ctu

al d

ecea

sed

orga

n d

onor

s -b

oth

DB

Dan

d D

CD

incl

ude

d-(p

mp)

337

(14.

9)K

idn

ey T

X. f

rom

dec

ease

d do

nor

s (p

mp)

570

(25.

2)K

idn

ey T

X. f

rom

liv

ing

don

ors

(pm

p)25

5(1

1.3)

Live

r To

tal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)21

5(9

.5)

Hea

rt T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)66

(2.9

)H

eart

-Lu

ng

Tota

l T

X. (

pmp)

2(0

.1)

Lun

g To

tal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)15

9(7

.0)

Pan

crea

s To

tal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)26

(1.2

)Sm

all

Bow

el T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)–

Tota

l n

um

ber

of p

atie

nts

tra

nsp

lan

ted

(pm

p)12

26(5

6.0)

Pop

ula

tion

(m

illi

on i

nh

abit

ants

):4.

4A

ctu

al d

ecea

sed

orga

n d

onor

s -b

oth

DB

Dan

d D

CD

incl

ude

d-(p

mp)

35(8

.0)

Kid

ney

TX

. fro

m d

ecea

sed

don

ors

(pm

p)61

(13.

9)K

idn

ey T

X. f

rom

liv

ing

don

ors

(pm

p)57

(13.

0)Li

ver

Tota

l T

X. -

all

com

bin

atio

ns

incl

ude

d-(p

mp)

30(6

.8)

Hea

rt T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)12

(2.7

)H

eart

-Lu

ng

Tota

l T

X. (

pmp)

–Lu

ng

Tota

l T

X. -

all

com

bin

atio

ns

incl

ude

d-(p

mp)

13(3

.0)

Pan

crea

s To

tal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)3

(0.7

)Sm

all

Bow

el T

otal

TX

. -al

l co

mbi

nat

ion

s in

clu

ded-

(pm

p)–

Tota

l n

um

ber

of p

atie

nts

tra

nsp

lan

ted

(pm

p)11

5(2

6.1)

Page 18: Newsletter 2012

16

AC

TU

AL

DE

CE

ASE

DO

RG

AN

DO

NO

RS

-bot

h D

BD

an

d D

CD

in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

3.1

1.7

7.1

8.4

14.9

11.2

3.8

4.3

1.0

0.5

11.3

2.2

6.5

20.0

5.1

Page 19: Newsletter 2012

17

KID

NE

Y T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

21.5

4.5

18.8

17.0

27.0

2.1

25.2

10.1

7.2

7.4

31.5

6.9

12.9

5.6

13.8

38.8

7.1

Page 20: Newsletter 2012

18

KID

NE

Y T

X. F

RO

MD

EC

EA

SED

DO

NO

RS

An

nu

al R

ate

p.m

.p. 2

011

5.0

2.2

14.1

15.5

20.9

16.8

7.0

6.1

1.9

1.1

12.7

3.5

11.3

37.6

6.2

Page 21: Newsletter 2012

19

KID

NE

Y T

X.

FRO

M L

IVIN

G D

ON

OR

SA

nn

ual

Rat

e p.

m.p

. 201

1

16.5

2.3

4.7

1.5

6.1

2.1

8.4

3.2

1.1

5.5

7.1

5.8

0.2

2.0

2.5

1.2

25.3

Page 22: Newsletter 2012

20

LIV

ER

TR

AN

SPLA

NT

-all

com

bin

atio

ns

incl

ud

ed-

An

nu

al R

ate

p.m

.p. 2

011

0.9

0.9

1.8

4.1

9.0

7.6

0.3

1.3

3.0

1.9

1.0

5.2

7.1

Page 23: Newsletter 2012

21

HE

AR

T T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

0.2

1.7

2.6

0.8

0.3

1.3

0.2

0.1

1.8

2.4

Page 24: Newsletter 2012

22

LUN

G T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

0.1

0.6

0.2

0.1

1.6

0.3

Page 25: Newsletter 2012

23

PAN

CR

EA

S T

RA

NSP

LAN

T-a

ll c

omb

inat

ion

s in

clu

ded

-A

nn

ual

Rat

e p.

m.p

. 201

1

0.1

1.8

0.9

0.1

1.5

Page 26: Newsletter 2012

SMA

LL B

OW

EL

TR

AN

SPLA

NT

-all

com

bin

atio

ns

incl

ud

ed -

An

nu

al R

ate

p.m

.p. 2

011

24

0.1

0.0

0.1

Page 27: Newsletter 2012

TO

TAL

NU

MB

ER

OF

PAT

IEN

TS

TR

AN

SPLA

NT

ED

An

nu

al R

ate

p.m

.p. 2

011

25

5.3

23.1

33.9

2.1

34.8

10.4

8.9

7.1

24.4

22.5

49.4

35.7

6.9

Page 28: Newsletter 2012

422

1 A

CTU

AL D

EC

EA

SED

OR

GA

N D

ON

OR

S (

both

DB

D a

nd

DC

D in

clu

ded

)

Kid

ney

Tran

sp

lan

tsLiv

er

Tran

sp

lan

tsH

eart

Tran

sp

lan

tsLu

ng

Tran

sp

lan

tsP

an

creas

Tran

sp

lan

ts

Sm

all

Bo

wel

Tran

sp

lan

ts

10

92

2

(4

0,4

% L

D)

23

77

(7

,5%

LD

)4

25

11

02

719

*2

01

1 d

ata

N=

18

CO

UN

TR

IE

S (

56

6,3

mil

lio

n i

nh

ab

itan

ts)

LA

TIN

AM

ER

IC

AN

CO

UN

TR

IES

26

271

4221

Page 29: Newsletter 2012

10

68

79

SO

LID

OR

GA

NS

TR

AN

SP

LA

NTED

EA

CH

YEA

R

Kid

ney

Tran

sp

lan

tsLiv

er

Tran

sp

lan

tsH

eart

Tran

sp

lan

tsLu

ng

Tran

sp

lan

tsP

an

creas

Tran

sp

lan

ts

Sm

all

Bo

wel

Tran

sp

lan

ts

73

17

92

16

02

55

82

39

27

23

62

22

7

- 9

5 M

em

ber S

tate

s r

ep

orte

d h

avin

g a

ny a

cti

vit

y o

n t

ran

sp

lan

tati

on

to

th

e G

OD

T.

- In

form

ati

on

of

org

an

tran

sp

lan

tati

on

acti

vit

ies i

s i

nclu

ded

in

th

e G

OD

T:

89

fro

m2

01

0,

7 f

ro

m 2

00

9 a

nd

6 c

ou

ntr

ies f

ro

m 2

00

8.

GLO

BA

L A

CTIV

ITY

IN

OR

GA

N T

RA

NS

PLA

NTA

TIO

N2

01

0 ES

TIM

ATES

27

Page 30: Newsletter 2012

28

Page 31: Newsletter 2012

29

Page 32: Newsletter 2012

30

Page 33: Newsletter 2012

31

Page 34: Newsletter 2012
Page 35: Newsletter 2012

International Data on Organ Donation andTransplantation Activity, Waiting List, FamilyRefusals and Transplantation of Vascularised

Composite Allografts. Year 2011

Page 36: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

EUR

OP

EAN

UN

ION

CO

UN

TRIE

SC

OU

NTR

IES

AU

STR

IAB

ELG

IUM

BU

LGA

RIA

CY

PR

US

CZE

CH

. R.

DEN

MA

RK

ESTO

NIA

FIN

LAN

DFR

AN

CE

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

8.4

11.0

7.4

1.1

10.5

5.6

1.3

5.4

65.1

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)20

5 (2

4.4)

331

(30.

1)4

(0.5

)6

(5.5

)18

5 (1

7.6)

73 (1

3.0)

22 (1

6.9)

93 (1

7.2)

1630

(25.

0)A

ctua

l don

ors

afte

r ci

rcul

ator

y de

ath

–DC

D-

(pm

p)6

(0.7

)64

(5.8

)0

NA

1 (0

.1)

00

058

(0.9

)M

ultio

rgan

don

ors

149

256

26

105

5013

6114

58

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)41

5 (4

9.4)

514

(46.

7)17

(2.3

)31

(28.

2)36

0 (3

4.3)

235

(42.

0)44

(33.

8)17

7 (3

2.8)

2976

(45.

7)%

(TX.

fro

m li

ving

d. /

TX.

fro

m d

ecea

sed

d.)

13.3

7.8

52.9

61.3

11.1

42.6

9.1

7.3

10.1

Pae

diat

ric <

15 y

ears

1114

00

04

28

59TX

. fro

m d

ecea

sed

dono

rs (p

mp)

360

(42.

9)47

4 (4

3.1)

8 (1

.1)

12 (1

0.9)

320

(30.

5)13

5 (2

4.1)

40 (3

0.8)

164

(30.

4)26

74 (4

1.1)

Sin

gle

TX. (

pmp)

358

(42.

6)46

7 (4

2.5)

8 (1

.1)

12 (1

0.9)

318

(30.

3)13

4 (2

3.9)

37 (2

8.5)

164

(30.

4)26

18 (4

0.2)

Dou

ble

TX. (

pmp)

2 (0

.2)

7 (0

.6)

00

2 (0

.2)

1 (0

.2)

3 (2

.3)

056

(0.9

)TX

. fro

m li

ving

don

ors

(pm

p)55

(6.5

)40

(3.6

)9

(1.2

)19

(17.

3)40

(3.8

)10

0 (1

7.9)

4 (3

.1)

13 (2

.4)

302

(4.6

)TX

. fro

m R

elat

ed li

ving

don

ors

(pm

p)-

-9

(1.2

)19

(17.

3)36

(3.4

)99

(17.

7)4

(3.1

)13

(2.4

)30

2 (4

.6)

TX. f

rom

Unr

elat

ed li

ving

don

ors

(pm

p)-

-0

04

(0.4

)1

(0.2

)0

0N

ATX

. fro

m D

CD

(pm

p)16

(1.9

)91

(8.3

)0

NA

2 (0

.2)

NA

0N

A65

(1.0

)

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)12

8 (1

5.2)

299

(27.

2)6

(0.8

)N

A88

(8.4

)51

(9.1

)8

(6.2

)56

(10.

4)11

64 (1

7.9)

Pae

diat

ric <

15 y

ears

736

0N

A1

71

778

Spl

it TX

. (pm

p)2

(0.2

)7

(0.6

)3

(0.4

)N

A0

-0

-90

(1.4

)D

omin

o TX

. (pm

p)0

2 (0

.2)

-N

A0

00

019

(0.3

)TX

. fro

m li

ving

don

ors

(pm

p)2

(0.2

)35

(3.2

)3

(0.4

)N

A0

00

014

(0.2

)TX

. fro

m D

CD

(pm

p)2

(0.2

)45

(4.1

)0

NA

0N

A0

NA

5 (0

.1)

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)51

(6.1

)76

(6.9

)2

(0.3

)N

A68

(6.5

)29

(5.2

)-

18 (3

.3)

410

(6.3

)P

aedi

atric

<15

yea

rs5

40

NA

01

-1

27

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)1

(0.1

)3

(0.3

)0

NA

00

00

12 (0

.2)

Pae

diat

ric <

15 y

ears

--

0N

A0

00

01

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)12

0 (1

4.3)

111

(10.

1)0

NA

18 (1

.7)

30 (5

.4)

3 (2

.3)

23 (4

.3)

324

(5.0

)P

aedi

atric

<15

yea

rs4

-0

NA

00

00

3S

ingl

e TX

. (pm

p)7

(0.8

)13

(1.2

)0

NA

5 (0

.5)

6 (1

.1)

1 (0

.8)

1 (0

.2)

82

(1.3

)D

oubl

e TX

. (he

art-

lung

TX.

in

clud

ed) (

pmp)

113

(13.

5)98

(8.9

)0

NA

13 (1

.2)

24 (4

.3)

2 (1

.5)

22 (4

.1)

242

(3.7

)TX

. fro

m li

ving

don

ors

(pm

p)-

-0

NA

0N

A0

NA

0TX

. fro

m D

CD

(dou

ble

+ si

ngle

)(pm

p)-

17 (1

.5)

0N

A0

NA

0N

A0

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)16

(1.9

)14

(1.3

)0

NA

32 (3

.0)

--

1 (0

.2)

73 (1

.1)

Pae

diat

ric <

15 y

ears

--

0N

A0

--

-0

Kid

ney

- P

ancr

eas

TX. (

pmp)

16 (1

.9)

11 (1

.0)

0N

A28

(2.7

)-

-1

(0.2

)67

(1.0

)P

ancr

eas

TX. A

lone

(pm

p)-

3 (0

.3)

0N

A4

(0.4

)-

-0

6 (0

.1)

TX. f

rom

DC

D (p

mp)

--

0N

A0

-N

A-

-

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

--

0N

A0

--

-10

(0.2

)P

aedi

atric

<15

yea

rs-

-0

NA

0-

--

8Li

ver

+ S

mal

l bow

el (p

mp)

--

0N

A0

--

-3

(0.1

)S

mal

l bow

el T

X. A

lone

(pm

p)-

-0

NA

0-

--

5 (0

.1)

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

--

25 (3

.4)

NA

521

(49.

6)34

4 (6

1.4)

55 (4

2.3)

275

(50.

9)47

55 (7

3.0)

Pae

diat

ric <

15 y

ears

--

0N

A14

-3

-16

3P

atie

nts

tran

spla

nted

fro

m li

ving

don

ors

(pm

p)57

(6.8

)75

(6.8

)12

(1.6

)19

(17.

3)40

(3.8

)10

0 (1

7.9)

4 (3

.1)

13 (2

.4)

316

(4.9

)

`NA

´: N

ot a

pplic

able

34

Page 37: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

EUR

OP

EAN

UN

ION

CO

UN

TRIE

SC

OU

NTR

IES

GER

MA

NY

GR

EEC

EH

UN

GA

RY

IREL

AN

DIT

ALY

LATV

IALI

THU

AN

IALU

XEM

BO

UR

GM

ALT

AP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/81

.811

.410

.04.

560

.82.

23.

30.

50.

4

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)12

00 (1

4.7)

79 (6

.9)

131(

13.1

)93

(20.

7)13

25 (2

1.8)

40 (1

8.2)

39 (1

1.8)

9 (1

8.0)

12 (3

0.0)

Act

ual d

onor

s af

ter

circ

ulat

ory

deat

h –D

CD

- (p

mp)

0-

01

(0.2

)6

(0.1

)13

(5.9

)N

A-

0M

ultio

rgan

don

ors

1041

5154

8692

54

168

8

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)28

50 (3

4.8)

185

(16.

2)25

1 (2

5.1)

192

(43.

1)17

51 (2

8.8)

77 (3

5.0)

75 (2

2.7)

018

(45.

0)%

(TX.

fro

m li

ving

d. /

TX.

fro

m d

ecea

sed

d.)

27.9

24.9

18.7

14.1

12.1

14.

00

33.3

Pae

diat

ric <

15 y

ears

-5

77

653.

90

00

TX. f

rom

dec

ease

d do

nors

(pm

p)20

55 (2

5.1)

139

(12.

2)20

4 (2

0.4)

165

(36.

7)15

40 (2

5.3)

74 (3

3.6)

72 (2

1.8)

012

(30.

0)S

ingl

e TX

. (pm

p)20

20 (2

4.7)

137

(12.

0)20

4 (2

0.4)

162

(36.

0)14

32 (2

3.6)

74 (3

3.6)

72 (2

1.8)

012

(30.

0)D

oubl

e TX

. (pm

p)35

(0.4

)2

(0.2

)0

3 (0

.7)

108

(1.8

)0

00

0TX

. fro

m li

ving

don

ors

(pm

p)79

5 (9

.7)

46 (4

.0)

47 (4

.7)

27 (6

.0)

211

(3.5

)3

(1.4

)3

(0.9

)0

6 (1

5.0)

TX. f

rom

Rel

ated

livi

ng d

onor

s (p

mp)

-46

(4.0

)47

(4.7

)27

(6.0

)13

4 (2

.2)

3 (1

.4)

3 (0

.9)

05

(12.

5)TX

. fro

m U

nrel

ated

livi

ng d

onor

s (p

mp)

--

00

77 (1

.3)

0N

A0

1 (2

.5)

TX. f

rom

DC

D (p

mp)

0-

01

(0.2

)2

(0.0

)26

(11.

8)N

A0

NA

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)11

99 (1

4.7)

42 (3

.7)

41 (4

.4)

61 (1

3.6)

1034

(17.

0)1

(0.5

)12

(3.6

)0

NA

Pae

diat

ric <

15 y

ears

740

20

660

00

NA

Spl

it TX

. (pm

p)75

(0.9

)-

1 (0

.1)

068

(1.1

)0

NA

0N

AD

omin

o TX

. (pm

p)12

(0.1

)-

00

00

NA

0N

ATX

. fro

m li

ving

don

ors

(pm

p)71

(0.9

)-

00

15 (0

.2)

00

0N

ATX

. fro

m D

CD

(pm

p)0

-0

00

0N

A0

NA

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)36

6 (4

.5)

6 (0

.5)

14 (1

.4)

6 (1

.3)

278

(4.6

)3

(1.4

)5

(1.5

)-

1 (2

.5)

Pae

diat

ric <

15 y

ears

190

10

260

0-

0

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)10

(0.1

)-

08

(1.8

)1

(0.0

)0

0-

NA

Pae

diat

ric <

15 y

ears

0-

00

10

0-

NA

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)33

7 (4

.1)

-N

A8

(1.8

)12

0 (2

.0)

01

(0.3

)-

NA

Pae

diat

ric <

15 y

ears

5-

NA

06

00

-N

AS

ingl

e TX

. (pm

p)57

(0.7

)-

NA

7 (1

.6)

32 (0

.5)

00

-N

AD

oubl

e TX

. (he

art-

lung

TX.

in

clud

ed) (

pmp)

280

(3.4

)-

NA

1 (0

.2)

88 (1

.4)

01

(0.3

)-

NA

TX. f

rom

livi

ng d

onor

s (p

mp)

--

NA

00

0N

A-

NA

TX. f

rom

DC

D (d

oubl

e +

sing

le)(

pmp)

0-

NA

00

0N

A-

NA

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)17

1 (2

.1)

1 (0

.1)

10 (1

.0)

8 (1

.8)

58 (1

.0)

03

(0.9

)-

NA

Pae

diat

ric <

15 y

ears

0-

00

10

0-

NA

Kid

ney

- P

ancr

eas

TX. (

pmp)

154

(1.9

)1

(0.1

)10

(1.0

)7

(1.6

)41

(0.7

)0

3 (0

.9)

-N

AP

ancr

eas

TX. A

lone

(pm

p)14

(0.2

)-

01

(0.2

)14

(0.2

)0

NA

-N

ATX

. fro

m D

CD

(pm

p)0

-0

00

0N

A-

NA

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

9 (0

.1)

-N

AN

A4

(0.1

)0

NA

-N

AP

aedi

atric

<15

yea

rs0

-N

AN

A2

0N

A-

NA

Live

r +

Sm

all b

owel

(pm

p)4

(0.0

)-

NA

NA

2 (0

.0)

0N

A-

NA

Sm

all b

owel

TX.

Alo

ne (p

mp)

5 (0

.1)

-N

AN

A2

(0.0

)0

NA

-N

A

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

-23

2 (2

0.4)

304

(30.

4)19

2 (4

2.7)

3167

(52.

1)81

(36.

8)93

(28.

2)-

19 (4

7.5)

Pae

diat

ric <

15 y

ears

-5

134

161

30

-0

Pat

ient

s tr

ansp

lant

ed f

rom

livi

ng d

onor

s (p

mp)

866

(10.

6)46

(4.0

)47

(4.7

)27

(6.0

)22

6 (3

.7)

3 (1

.4)

3 (0

.9)

-6

(15.

0)

`NA

´: N

ot a

pplic

able

35

Page 38: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

EUR

OP

EAN

UN

ION

CO

UN

TRIE

SC

OU

NTR

IES

NET

HER

LAN

DS

PO

LAN

DP

OR

TUG

AL

RO

MA

NIA

SLO

VAK

IASL

OVE

NIA

SPA

INSW

EDEN

U. K

.P

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/16

.738

.310

.721

.45.

52.

047

.29.

462

.3

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)22

7 (1

3.6)

553

(14.

4)30

1 (2

8.1)

77 (3

.6)

69 (1

2.5)

31 (1

5.5)

1667

(35.

3)14

6 (1

5.5)

1056

(17.

0)A

ctua

l don

ors

afte

r ci

rcul

ator

y de

ath

–DC

D-

(pm

p)11

7 (7

.0)

00

3 (0

.1)

00

117

(2.5

)0

405

(6.5

)M

ultio

rgan

don

ors

178

323

223

5840

24-

123

749

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)86

0 (5

1.5)

1075

(28.

1)53

0 (4

9.5)

219

(10.

2)12

9 (2

3.5)

46 (2

3.0)

2498

(52.

9)43

5 (4

6.3)

2752

(44.

2)%

(TX.

fro

m li

ving

d. /

TX.

fro

m d

ecea

sed

d.)

51.2

3.7

8.9

34.2

10.1

012

.542

.337

.3P

aedi

atric

<15

yea

rs13

5010

92

063

1594

TX. f

rom

dec

ease

d do

nors

(pm

p)42

0 (2

5.1)

1035

(27.

0)48

3 (4

5.1)

144

(6.7

)11

6 (2

1.1)

46 (2

3.0)

2186

(46.

3)25

1 (2

6.7)

1726

(27.

7)S

ingl

e TX

. (pm

p)41

9 (2

5.1)

-45

5 (4

2.5)

141

(6.6

)11

5 (2

1.0)

46 (2

3.0)

2167

(45.

9)25

0 (2

6.6)

-D

oubl

e TX

. (pm

p)1

(0.0

)-

28 (2

.6)

3 (0

.1)

1 (0

.2)

019

(0.4

)1

(0.1

)-

TX. f

rom

livi

ng d

onor

s (p

mp)

440

(26.

3)40

(1.0

)47

(4.4

)75

(3.5

)13

(2.4

)0

312

(6.6

)18

4 (1

9.6)

1026

(16.

5)TX

. fro

m R

elat

ed li

ving

don

ors

(pm

p)21

7 (1

3.0)

40 (1

.0)

31 (2

.9)

-10

(2.0

)0

304

(6.4

)18

3 (1

9.5)

934

(15.

0)TX

. fro

m U

nrel

ated

livi

ng d

onor

s (p

mp)

223

(13.

4)0

16 (1

.5)

-3

(0.5

)0

8 (0

.2)

1 (0

.1)

92 (1

.5)

TX. f

rom

DC

D (p

mp)

207

(12.

4)0

06

(0.3

)0

014

0 (3

.0)

-62

2 (1

0.0)

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)13

5 (8

.1)

300

(7.8

)21

9 (2

0.5)

65 (3

.0)

25 (4

.5)

20 (1

0.0)

1137

(24.

1)15

6 (1

6.6)

759

(12.

2)P

aedi

atric

<15

yea

rs21

305

20

068

1410

1S

plit

TX. (

pmp)

1 (0

.1)

00

4 (0

.2)

01

(0.5

)4

(0.1

)-

124

(2.0

)D

omin

o TX

. (pm

p)2

(0.1

)0

26 (2

.4)

00

06

(0.1

)3

(0.3

)4

(0.1

)TX

. fro

m li

ving

don

ors

(pm

p)8

(0.5

)18

(0.5

)0

8 (0

.4)

00

28 (0

.6)

7 (0

.7)

37 (0

.6)

TX. f

rom

DC

D (p

mp)

37 (2

.2)

00

3 (0

.1)

00

8 (0

.2)

-12

4 (2

.0)

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)44

(2.6

)80

(2.1

)46

(4.3

)7

(0.3

)19

(3.5

)14

(7.0

)23

7 (5

.0)

52 (5

.5)

148

(2.4

)P

aedi

atric

<15

yea

rs4

43

00

117

336

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)0

00

00

04

(0.1

)1

(0.1

)4

(0.1

)P

aedi

atric

<15

yea

rs0

00

00

00

00

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)68

(4.1

)15

(0.4

)18

(1.7

)0

00

230

(4.9

)60

(6.4

)19

1 (3

.1)

Pae

diat

ric <

15 y

ears

10

00

00

60

2S

ingl

e TX

. (pm

p)13

(0.8

)10

(0.3

)10

(0.9

)0

00

100

(2.1

)15

(1.6

)35

(0.6

)D

oubl

e TX

. (he

art-

lung

TX.

in

clud

ed) (

pmp)

55 (3

.3)

5 (0

.1)

8 (0

.7)

00

013

0 (2

.8)

45 (4

.8)

156

(2.5

)TX

. fro

m li

ving

don

ors

(pm

p)0

00

00

0N

A-

0TX

. fro

m D

CD

(dou

ble

+ si

ngle

)(pm

p)27

(1.6

)0

00

00

8 (0

.2)

-19

(0.3

)

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)30

(1.8

)34

(0.9

)25

(2.3

)0

01

(0.5

)11

1 (2

.4)

35 (3

.7)

236

(3.8

)P

aedi

atric

<15

yea

rs0

00

00

05

-2

Kid

ney

- P

ancr

eas

TX. (

pmp)

20 (1

.2)

33 (0

.9)

25 (2

.3)

00

1 (0

.5)

92 (1

.9)

26 (2

.8)

163

(2.6

)P

ancr

eas

TX. A

lone

(pm

p)2

(0.1

)1

(0.0

)0

00

014

(0.3

)9

(1.0

)35

(0.6

)TX

. fro

m D

CD

(pm

p)4

(0.2

)0

00

00

0-

40 (0

.6)

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

1 (0

.1)

00

00

09

(0.2

)2

(0.2

)21

(0.3

)P

aedi

atric

<15

yea

rs0

00

00

07

-8

Live

r +

Sm

all b

owel

(pm

p)0

00

00

00

-9

(0.1

)S

mal

l bow

el T

X. A

lone

(pm

p)1

(0.1

)0

00

00

4 (0

.1)

-12

(0.2

)

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

1122

(67.

2)14

64 (3

8.2)

812

(75.

9)-

-80

(40.

0)40

79 (8

6.4)

711

(75.

6)39

02 (6

2.6)

Pae

diat

ric <

15 y

ears

3984

18-

-1

154

-33

5P

atie

nts

tran

spla

nted

fro

m li

ving

don

ors

(pm

p)44

8 (2

6.8)

58 (1

.5)

47 (4

.4)

83 (3

.9)

13 (2

.4)

034

0 (7

.2)

191

(24.

4)10

63 (1

7.1)

`NA

´: N

ot a

pplic

able

36

Page 39: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

OTH

ER C

OU

NTR

IES

CO

UN

TRIE

SA

LGER

IAA

UST

RA

LIA

BEL

AR

US

CA

NA

DA

CR

OA

CIA

EGY

PT

GEO

RG

IAIC

ELA

ND

ISR

AEL

LEB

AN

ON

LIB

YAP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/36

.022

.69.

634

.54.

482

.54.

30.

37.

64.

36.

4

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)N

A33

7 (1

4.9)

96 (1

0.0)

531

(15.

4)14

8 (3

3.6)

NA

02

(6.7

)82

(10.

8)10

(2.3

)N

AA

ctua

l don

ors

afte

r ci

rcul

ator

y de

ath

–DC

D-

(pm

p)N

A86

(3.8

)0

65 (1

.9)

-N

A0

0-

22 (5

.1)

NA

Mul

tiorg

an d

onor

s N

A24

056

-13

0N

A0

262

8N

A

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)12

4 (3

.4)

825

(36.

5)17

5 (1

8.2)

1236

(35.

8)23

7 (5

3.9)

1417

(17.

2)17

(4.0

)11

(36.

7)24

2 (3

1.8)

80 (1

8.6)

5 (0

.8)

% (T

X. f

rom

livi

ng d

. / T

X. f

rom

dec

ease

d d.

)10

030

.93.

435

.03.

810

010

010

049

.281

.310

0P

aedi

atric

<15

yea

rs12

2321

-4

--

-9

-0

TX. f

rom

dec

ease

d do

nors

(pm

p)0

570

(25.

2)16

9 (1

7.6)

803

(23.

3)22

8 (5

1.8)

NA

0-

123

(16.

2)15

(3.5

)N

AS

ingl

e TX

. (pm

p)0

554

(24.

5)16

9 (1

7.6)

786

(22.

8)22

5 (5

1.1)

NA

0-

-15

(3.5

)N

AD

oubl

e TX

. (pm

p)0

16 (0

.7)

017

(0.5

)3

(0.7

)N

A0

--

0N

ATX

. fro

m li

ving

don

ors

(pm

p)12

4 (3

.4)

255

(11.

3)6

(0.6

)43

3 (1

2.6)

9 (2

.0)

1417

(17.

2)17

(4.0

)11

(36.

7)11

9 (1

5.7)

65 (1

5.1)

5 (0

.8)

TX. f

rom

Rel

ated

livi

ng d

onor

s (p

mp)

118

(3.3

)21

6 (9

.6)

6 (0

.6)

275

(8.0

)-

--

11 (3

6.7)

90 (1

1.8)

-5

(0.8

)TX

. fro

m U

nrel

ated

livi

ng d

onor

s (p

mp)

6 (0

.2)

39 (1

.7)

015

8 (4

.6)

--

-0

29 (3

.8)

-0

TX. f

rom

DC

D (p

mp)

015

1 (6

.7)

010

8 (3

.1)

0N

A0

--

-N

A

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)6

(0.2

)21

5 (9

.5)

43 (4

.5)

487

(14.

1)12

4 (2

8.2)

450

(5.5

)0

-75

(9.9

)1

(0.2

)0

Pae

diat

ric <

15 y

ears

012

9-

4N

A0

-3

-0

Spl

it TX

. (pm

p)0

30 (1

.3)

016

(0.5

)5

(1.1

)N

A0

-2

(0.3

)-

NA

Dom

ino

TX. (

pmp)

0-

00

0N

A0

--

-N

ATX

. fro

m li

ving

don

ors

(pm

p)6

(0.2

)2

(0.1

)2

(0.2

)64

(1.9

)3

(0.7

)45

0 (5

.5)

0-

6 (0

.8)

-0

TX. f

rom

DC

D (p

mp)

011

(0.5

)0

20 (0

.6)

0N

A0

--

1 (0

.2)

NA

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)0

66 (2

.9)

21 (2

.2)

157

(4.6

)38

(8.6

)N

A0

-23

(3.0

)6

(1.4

)N

AP

aedi

atric

<15

yea

rs0

40

01

NA

0-

3-

NA

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)0

2 (0

.1)

01

(0.0

)-

NA

0-

4 (0

.5)

-N

AP

aedi

atric

<15

yea

rs0

-0

0-

NA

0-

2-

NA

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)0

159

(7.0

)0

181

(5.2

)-

NA

0-

59 (7

.8)

-N

AP

aedi

atric

<15

yea

rs0

50

--

NA

0-

2-

NA

Sin

gle

TX. (

pmp)

012

(0.5

)0

13 (0

.4)

-N

A0

-39

(5.1

)-

NA

Dou

ble

TX. (

hear

t-lu

ng T

X.

incl

uded

) (pm

p)0

147

(6.5

)0

167

(4.8

)-

NA

0-

20 (2

.6)

-N

ATX

. fro

m li

ving

don

ors

(pm

p)0

-0

1 (0

.0)

-N

A0

--

-N

ATX

. fro

m D

CD

(dou

ble

+ si

ngle

)(pm

p)0

33 (1

.5)

024

(0.7

)-

NA

0-

--

NA

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)0

26 (1

.2)

2 (0

.2)

108

(3.1

)12

(2.7

)N

A0

-12

(1.6

)-

NA

Pae

diat

ric <

15 y

ears

01

0-

-N

A0

--

-N

AK

idne

y -

Pan

crea

s TX

. (pm

p)0

26 (1

.2)

2 (0

.2)

56 (1

.6)

10 (2

.3)

NA

0-

12 (1

.6)

-N

AP

ancr

eas

TX. A

lone

(pm

p)0

-0

15 (0

.4)

2 (0

.5)

NA

0-

--

NA

TX. f

rom

DC

D (p

mp)

0-

03

(0.1

)-

NA

0-

--

NA

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

0-

02

(0.1

)-

NA

0-

--

NA

Pae

diat

ric <

15 y

ears

0-

0-

-N

A0

--

-N

ALi

ver

+ S

mal

l bow

el (p

mp)

0-

00

-N

A0

--

-N

AS

mal

l bow

el T

X. A

lone

(pm

p)0

-0

0-

NA

0-

--

NA

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

130

(3.6

)12

66 (5

6.0)

241

(25.

1)-

-18

67 (2

2.6)

17 (4

.0)

11 (3

6.7)

125

(16.

4)87

(20.

2)5

(0.8

)P

aedi

atric

<15

yea

rs12

-30

--

NA

0-

--

0P

atie

nts

tran

spla

nted

fro

m li

ving

don

ors

(pm

p)13

0 (3

.6)

257

(11.

4)8

(0.8

)49

8 (1

4.4)

12 (2

.7)

1867

(22.

6)17

(4.0

)11

(36.

7)12

5 (1

6.4)

65 (1

5.1)

5 (0

.8)

`NA

´: N

ot a

pplic

able

37

Page 40: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

OTH

ER C

OU

NTR

IES

CO

UN

TRIE

SM

ACED

ON

IAM

OLD

OVA

NEW

ZEA

LAN

DN

OR

WAY

PALE

STIN

ER

USS

IASW

ITZE

RLA

ND

SYR

IATU

NIS

IATU

RK

EYU

SAP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/2.

13.

64.

45.

04.

214

2.8

8.0

20.8

10.7

74.7

313.

1

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)0

035

(8.0

)12

7 (2

4.5)

NA

470

(3.3

)10

0 (1

2.5)

06

(0.6

)31

1 (4

.2)

8126

(26.

0)A

ctua

l don

ors

afte

r ci

rcul

ator

y de

ath

–DC

D-

(pm

p)0

02

(0.5

)0

NA

187

(1.3

)3

(0.4

)0

0N

A10

55 (3

.4)

Mul

tiorg

an d

onor

s 0

031

112

NA

188

870

128

363

60 (2

0.3)

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)6

(2.9

)1

(0.3

)11

8 (2

6.8)

302

(60.

4)49

(11.

7)97

5 (6

.8)

282

(35.

3)36

3 (1

7.5)

109

(10.

2)29

42 (3

9.4)

1761

0 (5

6.2)

% (T

X. f

rom

livi

ng d

. / T

X. f

rom

dec

ease

d d.

)10

010

048

.324

.210

018

.435

.810

089

.982

.332

.8P

aedi

atric

<15

yea

rs2

06

5N

A-

725

318

449

1TX

. fro

m d

ecea

sed

dono

rs (p

mp)

00

61 (1

3.9)

229

(45.

8)N

A79

6 (5

.6)

181

(22.

6)0

11 (1

.0)

521

(7.0

)11

838

(37.

8)S

ingl

e TX

. (pm

p)0

057

(13.

0)22

9 (4

5.8)

NA

796

(5.6

)17

5 (2

1.9)

011

(1.0

)N

A11

536

(36.

8)D

oubl

e TX

. (pm

p)0

04

(1.0

)0

NA

06

(0.8

)0

0N

A30

2 (1

.0)

TX. f

rom

livi

ng d

onor

s (p

mp)

6 (2

.9)

1 (0

.3)

57 (1

3.0)

73 (1

4.6)

49 (1

1.7)

179

(1.3

)10

1 (1

2.6)

363

(17.

5)98

(9.2

)24

21 (3

2.4)

5772

(18.

4)TX

. fro

m R

elat

ed li

ving

don

ors

(pm

p)6

(2.9

)1

(0.3

)49

(11.

1)73

(14.

6)49

(11.

7)17

9 (1

.3)

101

(12.

6)14

1 (6

.8)

98 (9

.2)

NA

5029

(16.

1)TX

. fro

m U

nrel

ated

livi

ng d

onor

s (p

mp)

00

8 (1

.8)

00

NA

022

2 (1

0.7)

0N

A74

3 (2

.4)

TX. f

rom

DC

D (p

mp)

00

4 (0

.9)

-N

A-

6 (0

.8)

00

NA

1723

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)1

(0.5

)0

30 (6

.8)

89 (1

7.8)

NA

204

(1.4

)10

9 (1

3.6)

00

904

(12.

1)63

42 (2

0.3)

Pae

diat

ric <

15 y

ears

10

35

NA

-11

00

183

491

Spl

it TX

. (pm

p)0

0-

-N

A1

(0.0

)18

(2.3

)0

0N

A14

3 (0

.5)

Dom

ino

TX. (

pmp)

00

-0

NA

NA

00

0N

A11

(0.0

)TX

. fro

m li

ving

don

ors

(pm

p)0

08

(1.8

)0

NA

81 (0

.6)

9 (1

.1)

00

623

(8.3

)24

7 (0

.8)

TX. f

rom

DC

D (p

mp)

00

2 (0

.5)

-N

A1

(0.0

)1

(0.1

)0

0N

A26

9 (0

.9)

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A12

(2.7

)30

(6.0

)N

A10

7 (0

.7)

36 (4

.5)

01(

0.1)

93 (1

.2)

2349

(7.5

)P

aedi

atric

<15

yea

rsN

AN

A-

2N

A0

30

013

322

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)N

AN

A-

1 (0

.2)

NA

2 (0

.0)

00

0-

27 (0

.1)

Pae

diat

ric <

15 y

ears

NA

NA

-0

NA

00

00

-1

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A13

(3.0

)28

(5.6

)N

A8

(0.1

)54

(6.8

)0

05

(0.1

)18

49 (5

.9)

Pae

diat

ric <

15 y

ears

NA

NA

-0

NA

00

00

-25

Sin

gle

TX. (

pmp)

NA

NA

-0

NA

06

(0.8

)0

05

(0.1

)54

8 (1

.8)

Dou

ble

TX. (

hear

t-lu

ng T

X.

incl

uded

) (pm

p)N

AN

A13

(3.0

)28

(5.6

)N

A8

(0.1

)48

(6.0

)0

0-

1301

(4.2

)TX

. fro

m li

ving

don

ors

(pm

p)N

AN

A-

-N

A0

00

0-

1 (0

.0)

TX. f

rom

DC

D (d

oubl

e +

sing

le)(

pmp)

NA

NA

--

NA

00

00

NA

19 (0

.1)

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A3

(0.7

)20

(4.0

)N

A14

(0.1

)28

(3.5

)0

026

(0.3

)10

82 (3

.5)

Pae

diat

ric <

15 y

ears

NA

NA

--

NA

00

00

-31

Kid

ney

- P

ancr

eas

TX. (

pmp)

NA

NA

3 (0

.7)

10 (2

.0)

NA

13 (0

.1)

14 (1

.8)

00

-79

5 (2

.5)

Pan

crea

s TX

. Alo

ne (p

mp)

NA

NA

-10

(2.0

)N

A1

(0.0

)12

(1.5

)0

0-

287

(0.9

)TX

. fro

m D

CD

(pm

p)N

AN

A-

-N

A1

(0.0

)0

00

NA

32 (0

.1)

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

NA

NA

--

NA

NA

1 (0

.1)

00

1 (0

.0)

129

(0.4

)P

aedi

atric

<15

yea

rsN

AN

A-

-N

AN

A0

00

-51

Live

r +

Sm

all b

owel

(pm

p)N

AN

A-

-N

AN

A0

00

NA

50 (0

.2)

Sm

all b

owel

TX.

Alo

ne (p

mp)

NA

NA

--

NA

NA

00

01

(0.0

)66

(0.2

)

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

6 (2

.9)

1 (0

.3)

115

(26.

1)45

7 (9

1.4)

49 (1

1.7)

1292

(9.0

)49

2 (6

1.5)

363

(17.

5)11

0 (1

0.3)

3928

(52.

6)28

539

(91.

1)P

aedi

atric

<15

yea

rs2

0-

-N

AN

A20

03

557

1406

Pat

ient

s tr

ansp

lant

ed f

rom

livi

ng d

onor

s (p

mp)

6 (2

.9)

1 (0

.3)

65 (1

4.8)

73 (1

4.6)

49 (1

1.7)

260

(1.8

)11

0 (1

3.8)

363

(17.

5)98

(9.2

)30

44 (4

0.7)

6020

(19.

2)

`NA

´: N

ot a

pplic

able

38

Page 41: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

LATI

NA

MER

ICA

N C

OU

NTR

IES

CO

UN

TRIE

SA

RG

ENTI

NA

BO

LIVI

AB

RA

SIL

CH

ILE

CO

LOM

BIA

CO

STA

RIC

AC

UB

AD

OM

INIC

AN

AEC

UA

DO

RP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/40

.610

.119

6.7

17.3

46.9

4.7

11.3

10.1

14.7

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)60

4 (1

4.9)

10 (1

.0)

2207

(11.

2)11

3 (6

.5)

392

(8.4

)24

(5.1

)12

8 (1

1.3)

17 (1

.7)

31 (2

.2)

Act

ual d

onor

s af

ter

circ

ulat

ory

deat

h –D

CD

- (p

mp)

00

2433

(12.

4)0

0N

A-

00

Mul

tiorg

an d

onor

s 33

00

1125

9011

18

229

31

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)10

97 (2

7.0)

75 (7

.4)

4957

(25.

2)23

9 (1

3.8)

798

(17.

0)14

8 (3

1.5)

146

(12.

9)45

(4.5

)82

(5.6

)%

(TX.

fro

m li

ving

d. /

TX.

fro

m d

ecea

sed

d.)

22.7

74.7

33.1

18.4

8.8

80.4

1.4

51.1

36.6

Pae

diat

ric <

15 y

ears

462

83-

5610

60

11TX

. fro

m d

ecea

sed

dono

rs (p

mp)

848

(20.

9)19

(1.9

)33

14 (1

6.8)

195

(11.

3)72

7 (1

5.5)

29 (6

.2)

144

(12.

7)22

(2.2

)52

(3.5

)S

ingl

e TX

. (pm

p)84

7 (2

0.9)

--

-72

4 (1

5.4)

29 (6

.2)

142

(12.

6)22

(2.2

)52

(3.5

)D

oubl

e TX

. (pm

p)1

(0.0

)-

--

3 (0

.1)

02

(0.2

)0

0TX

. fro

m li

ving

don

ors

(pm

p)24

9 (6

.1)

56 (5

.5)

1643

(8.4

)44

(2.5

)71

(1.5

)11

9 (2

5.3)

2 (0

.2)

23 (2

.3)

30 (2

.0)

TX. f

rom

Rel

ated

livi

ng d

onor

s (p

mp)

249

(6.1

)45

(4.5

)13

45 (6

.8)

44 (2

.5)

65 (1

.4)

119

(25.

3)-

19 (1

.9)

30 (2

.0)

TX. f

rom

Unr

elat

ed li

ving

don

ors

(pm

p)0

11 (1

.1)

298

(1.5

)0

6 (0

.1)

0-

4 (0

.4)

0TX

. fro

m D

CD

(pm

p)0

19 (1

.9)

NA

00

24 (5

.1)

00

0

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)36

4 (9

.0)

014

96 (7

.6)

90 (5

.2)

191

(4.1

)14

(3.0

)22

(1.9

)9

(0.9

)15

(1.0

)P

aedi

atric

<15

yea

rs22

018

3 (0

.9)

-27

3 (0

.6)

-0

1S

plit

TX. (

pmp)

25 (0

.6)

00

00

-2

(0.2

)0

0D

omin

o TX

. (pm

p)1(

0.0)

00

00

-0

00

TX. f

rom

livi

ng d

onor

s (p

mp)

32 (0

.8)

010

4 (0

.5)

12 (0

.7)

7 (0

.1)

6 (1

.3)

2 (0

.2)

00

TX. f

rom

DC

D (p

mp)

00

NA

00

7 (1

.5)

00

0

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)10

6 (2

.6)

016

0 (0

.8)

32 (1

.8)

82 (1

.7)

6 (1

.3)

2 (0

.2)

NA

2 (0

.1)

Pae

diat

ric <

15 y

ears

70

29-

5N

A-

NA

0

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)1

(0.0

)0

00

0N

A2

(0.2

)N

A0

Pae

diat

ric <

15 y

ears

00

00

0N

A-

NA

0

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)26

(0.6

)0

48 (0

.2)

27 (1

.6)

4 (0

.1)

NA

0N

A0

Pae

diat

ric <

15 y

ears

30

4-

0N

A0

NA

0S

ingl

e TX

. (pm

p)13

(0.3

)0

0-

2 (0

.0)

NA

0N

A0

Dou

ble

TX. (

hear

t-lu

ng T

X.

incl

uded

) (pm

p)13

(0.3

)0

0-

2 (0

.0)

NA

0N

A0

TX. f

rom

livi

ng d

onor

s (p

mp)

00

1 (0

.0)

00

NA

0N

A0

TX. f

rom

DC

D (d

oubl

e +

sing

le)(

pmp)

00

NA

00

NA

0N

A0

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)75

(1.8

)0

184

(0.9

)1

(0.1

)6

(0.1

)N

A0

NA

0P

aedi

atric

<15

yea

rs0

01

-0

NA

0N

A0

Kid

ney

- P

ancr

eas

TX. (

pmp)

65 (1

.6)

013

0 (0

.7)

1 (0

.1)

4 (0

.1)

NA

0N

A0

Pan

crea

s TX

. Alo

ne (p

mp)

9 (0

.2)

054

(0.3

)0

2 (0

.0)

NA

0N

A0

TX. f

rom

DC

D (p

mp)

00

NA

00

NA

0N

A0

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

5 (0

.1)

0N

A0

3 (0

.1)

NA

0N

A0

Pae

diat

ric <

15 y

ears

30

NA

00

NA

0N

A0

Live

r +

Sm

all b

owel

(pm

p)1

(0.0

)0

NA

01

(0.0

)-

0N

A0

Sm

all b

owel

TX.

Alo

ne (p

mp)

4 (0

.1)

0N

A0

2 (0

.0)

-0

NA

0

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

1377

(33.

9)-

6485

(34.

8)38

9 (2

2.5)

1084

(23.

1)16

8 (3

5.7)

-54

(5.3

)97

(24.

4)P

aedi

atric

<15

yea

rs81

2 30

0-

8813

-0

12P

atie

nts

tran

spla

nted

fro

m li

ving

don

ors

(pm

p)28

1 (6

.9)

56 (5

.5)

1748

(8.9

)56

(3.2

)78

(1.7

)12

5 (2

6.6)

4 (0

.4)

23 (2

.3)

30 (2

4.4)

`NA

´: N

ot a

pplic

able

39

Page 42: Newsletter 2012

DO

NAT

ION

AN

D T

RA

NSP

LAN

TATI

ON

AC

TIVI

TY

LATI

NA

MER

ICA

N C

OU

NTR

IES

CO

UN

TRIE

SEL

SA

LVA

DO

RG

UAT

EMA

LAM

EXIC

ON

ICA

RA

GU

APA

NA

MA

PAR

AG

UAY

PER

UU

RU

GU

AYVE

NEZ

UEL

AP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/6.

214

.811

4.8

5.9

3.4

6.6

29.4

3.4

29.4

DO

NAT

ION

Act

ual d

ecea

sed

orga

n do

nors

-bot

h D

BD

and

DC

D in

clud

ed-

(pm

p)0

8 (0

.5)

356

(3.1

)-

24 (7

.1)

012

7 (4

.3)

68 (2

0.0)

112

(3.8

)A

ctua

l don

ors

afte

r ci

rcul

ator

y de

ath

–DC

D-

(pm

p)0

00

-0

00

NA

0M

ultio

rgan

don

ors

00

356

-6

040

-0

TRA

NSP

LAN

TATI

ON

KID

NE

YTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)44

(7.1

)10

2 (6

.9)

2468

(21.

5)-

64 (1

8.8)

14 (2

.1)

213

(7.2

)13

2 (3

8.8)

298

(10.

1)%

(TX.

fro

m li

ving

d. /

TX.

fro

m d

ecea

sed

d.)

100

84.3

76.5

-25

.010

015

.53.

031

.2P

aedi

atric

<15

yea

rs0

1022

5-

-0

244

14TX

. fro

m d

ecea

sed

dono

rs (p

mp)

016

(1.1

)57

9 (5

.0)

-48

(14.

1)0

180

(6.1

)12

8 (3

7.6)

205

(7.0

)S

ingl

e TX

. (pm

p)0

16 (1

.1)

571

(5.0

)-

-0

176

(6.0

)-

205

(7.0

)D

oubl

e TX

. (pm

p)0

08

(0.1

)-

-0

4 (0

.1)

NA

0TX

. fro

m li

ving

don

ors

(pm

p)44

(7.1

)86

(5.8

)18

89 (1

6.5)

-16

(4.7

)14

(2.1

)33

(1.1

)4

(1.2

)93

(3.2

)TX

. fro

m R

elat

ed li

ving

don

ors

(pm

p)44

(7.1

)80

(5.4

)15

38 (1

3.4)

-13

(3.8

)13

(2.0

)33

(1.1

)4

(1.2

)93

(3.2

)TX

. fro

m U

nrel

ated

livi

ng d

onor

s (p

mp)

06

(0.4

)35

1 (3

.1)

-3

(0.9

)1

(0.1

)0

00

TX. f

rom

DC

D (p

mp)

00

0-

0-

0N

A0

LIVE

RTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A10

0 (0

.9)

-6

(1.8

)0

38 (1

.3)

24 (7

.1)

8 (0

.3)

Pae

diat

ric <

15 y

ears

NA

NA

20-

-0

31

3S

plit

TX. (

pmp)

NA

NA

--

00

0N

A0

Dom

ino

TX. (

pmp)

NA

NA

0-

-0

0N

A0

TX. f

rom

livi

ng d

onor

s (p

mp)

NA

NA

5 (0

.0)

-0

02

(0.1

)N

A8

(0.3

)TX

. fro

m D

CD

(pm

p)N

AN

A0

--

00

NA

0

HE

AR

TTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A19

(0.2

)-

NA

08

(0.3

)8

(2.4

)0

Pae

diat

ric <

15 y

ears

NA

NA

1-

NA

01

10

HE

AR

T-LU

NG

Tota

l TX.

(pm

p)N

AN

A0

-N

A0

00

0P

aedi

atric

<15

yea

rsN

AN

A0

-N

A0

00

0

LUN

GTo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A0

-N

A0

4 (0

.1)

1 (0

.3)

0P

aedi

atric

<15

yea

rsN

AN

A0

-N

A0

00

0S

ingl

e TX

. (pm

p)N

AN

A0

-N

A0

4 (0

.1)

1 (0

.3)

0D

oubl

e TX

. (he

art-

lung

TX.

in

clud

ed) (

pmp)

NA

NA

0-

NA

00

00

TX. f

rom

livi

ng d

onor

s (p

mp)

NA

NA

0-

NA

00

00

TX. f

rom

DC

D (d

oubl

e +

sing

le)(

pmp)

NA

NA

0-

NA

00

NA

0

PAN

CR

EA

STo

tal T

X. -

all c

ombi

natio

ns in

clud

ed-

(pm

p)N

AN

A0

-N

A-

05

(1.5

)0

Pae

diat

ric <

15 y

ears

NA

NA

0-

NA

-0

00

Kid

ney

- P

ancr

eas

TX. (

pmp)

NA

NA

0-

NA

-0

5 (1

.5)

0P

ancr

eas

TX. A

lone

(pm

p)N

AN

A0

-N

A-

0N

A0

TX. f

rom

DC

D (p

mp)

NA

NA

0-

NA

-0

NA

0

SMA

LL B

OW

EL

Tota

l TX.

-al

l com

bina

tions

incl

uded

- (p

mp)

NA

NA

1 (0

.0)

-N

A-

00

0P

aedi

atric

<15

yea

rsN

AN

A0

-N

A-

00

0Li

ver

+ S

mal

l bow

el (p

mp)

NA

NA

0-

NA

-0

00

Sm

all b

owel

TX.

Alo

ne (p

mp)

NA

NA

1 (0

.0)

-N

A-

00

0

RE

CIP

IEN

TSTo

tal n

umbe

r of

pat

ient

s tr

ansp

lant

ed (p

mp)

44 (7

.1)

102

(6.9

)-

-N

A14

(2.1

)26

3 (8

.9)

168

(49.

4)30

6 (1

0.4)

Pae

diat

ric <

15 y

ears

010

24

6 -

NA

-28

617

Pat

ient

s tr

ansp

lant

ed f

rom

livi

ng d

onor

s (p

mp)

44 (7

.1)

86 (5

.8)

1894

(16.

5)-

16 (4

.7)

14 (2

.1)

35 (1

.2)

4 (1

.2)

101

(3.4

)

`NA

´: N

ot a

pplic

able

40

Page 43: Newsletter 2012

WA

ITIN

G L

IST

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

CO

UN

TRIE

SA

UST

RIA

BEL

GIU

MB

ULG

AR

IAC

YP

RU

SC

ZEC

H. R

.D

ENM

AR

KES

TON

IAFI

NLA

ND

FRA

NC

EP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/8.

411

.07.

41.

110

.55.

61.

35.

465

.1

KID

NE

YN

º TX

CEN

TRES

--

62

73

11

44

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

361

500

133

1136

127

939

207

3884

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

969

5310

4261

610

347

412

320

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1174

388

395

041

667

322

4329

289

42

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

4535

2-

2528

413

200

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

--

-37

3-

-32

2-

NA

LIVE

RN

º TX

CEN

TRES

--

2N

A2

11

123

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

162

337

19N

A10

557

1263

1530

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

50N

A16

289

1371

2462

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1111

217

227

NA

4326

611

941

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

3654

4N

A12

41

113

5

HE

AR

TN

º TX

CEN

TRES

--

2N

A2

2-

126

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

5610

69

NA

8436

-29

514

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

40N

A17

153

-49

798

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1167

5928

NA

8416

-22

302

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

923

1N

A11

5-

460

LUN

GN

º TX

CEN

TRES

--

0N

A1

11

113

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

135

142

0N

A29

282

2532

5

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

0N

A67

715

3414

5

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1166

119

NA

3026

28

17

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

208

0N

A18

9-

248

9

PAN

CR

EA

SN

º TX

CEN

TRES

--

0N

A1

0-

116

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

1537

0N

A29

--

492

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

0N

A85

--

424

0

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1117

510

NA

45-

-3

144

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

31

0N

A4

--

05

SMA

LL B

OW

EL

TX C

ENTR

ES-

-0

NA

1-

-1

6

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

--

0N

A0

--

-11

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

0N

A1

--

-23

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

-0

NA

1-

--

12

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

--

0N

A0

--

-1

41

Page 44: Newsletter 2012

WA

ITIN

G L

IST

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

CO

UN

TRIE

SG

ERM

AN

YG

REE

CE

HU

NG

AR

YIR

ELA

ND

ITA

LYLA

TVIA

LITH

UA

NIA

LUX

EMB

OU

RG

MA

LTA

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

81.8

11.4

10.0

4.5

60.8

2.2

3.3

0.5

0.4

KID

NE

YN

º TX

CEN

TRES

41N

A4

143

12

01

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

3241

NA

408

204

2009

2592

025

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-N

A12

1352

886

5218

029

80

65

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1178

7311

1283

346

065

4255

214

090

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-N

A34

1516

25

70

11

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

-98

0562

0417

68N

A50

014

000

243

LIVE

RN

º TX

CEN

TRES

241

11

220

20

0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

1792

9110

863

1101

045

0N

A

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-15

319

283

2272

079

0N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1121

1994

128

2010

000

550

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-17

1910

162

011

0N

A

HE

AR

TN

º TX

CEN

TRES

221

21

191

20

1

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

695

1723

943

25

110

NA

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-44

3816

1143

929

0N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1110

3930

1317

733

318

0N

A

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-3

50

940

70

NA

LUN

GN

º TX

CEN

TRES

14-

01

130

10

0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

435

-11

2521

80

10

NA

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

2038

561

03

0N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1160

6-

736

382

02

0N

A

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

--

010

570

00

NA

PAN

CR

EA

SN

º TX

CEN

TRES

23-

21

130

10

0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

188

-11

966

05

0N

A

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

3118

306

025

0N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1128

2-

21-

236

018

0N

A

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

--

30

30

00

NA

SMA

LL B

OW

EL

TX C

ENTR

ES4

--

NA

30

NA

00

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

15-

-N

A4

0N

A0

NA

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

-N

A29

0N

A0

NA

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1112

--

NA

230

NA

0N

A

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

--

-N

A2

0N

A0

NA

42

Page 45: Newsletter 2012

WA

ITIN

G L

IST

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

CO

UN

TRIE

SN

ETH

ERLA

ND

SP

OLA

ND

PO

RTU

GA

LR

OM

AN

IASL

OVA

KIA

SLO

VEN

IASP

AIN

SWED

ENU

. K.

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

16.7

38.3

10.7

21.4

5.5

2.0

47.2

9.4

62.3

KID

NE

YN

º TX

CEN

TRES

818

83

41

444

26

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

974

1147

366

558

160

56-

610

2485

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-26

4623

01-

548

109

1025

7849

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1188

314

6919

7330

0038

268

4493

426

6721

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

8964

6320

451

-27

308

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

63

7920

000

1152

080

0031

0014

2523

647

-48

000

LIVE

RN

º TX

CEN

TRES

36

31

21

252

7

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

157

335

225

117

4822

1400

6642

7

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-53

033

3-

7830

2172

134

1330

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1112

313

216

938

330

1064

143

523

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

2937

1862

144

127

498

HE

AR

TN

º TX

CEN

TRES

35

42

11

182

7

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

5922

048

1522

2330

947

138

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-44

371

-43

4940

576

298

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1157

252

1711

421

3498

1917

0

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

1153

465

78

181

23

LUN

GN

º TX

CEN

TRES

32

10

01

72

6

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

120

3229

00

030

560

145

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-73

51-

00

478

9345

7

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1123

530

310

00

190

2722

3

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

2012

00

00

225

61

PAN

CR

EA

SN

º TX

CEN

TRES

24

21

11

133

11

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

2535

141

01

9947

171

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-62

61-

01

263

5852

5

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1138

1553

630

013

713

262

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

31

111

00

20

30

SMA

LL B

OW

EL

TX C

ENTR

ES1

10

00

02

14

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

13

00

00

11-

25

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

15

0-

00

23-

45

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

111

30

00

010

-14

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

02

00

00

1-

2

43

Page 46: Newsletter 2012

WA

ITIN

G L

IST

OTH

ER C

OU

NTR

IES

CO

UN

TRIE

SA

LGER

IAA

UST

RA

LIA

BEL

AR

US

CA

NA

DA

CR

OA

CIA

EGY

PT

GEO

RG

IAIC

ELA

ND

ISR

AEL

LEB

AN

ON

LIB

YAP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/36

.022

.69.

634

.54.

482

.54.

30.

37.

64.

36.

4

KID

NE

YN

º TX

CEN

TRES

1020

325

-N

A-

17

81

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

525

281

-18

7N

A-

-25

942

33

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

2121

717

--

--

-99

285

320

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1140

0011

3568

023

6017

2N

A-

-72

985

-

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

810

9511

NA

--

364

-

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

1450

010

710

2075

2557

3-

--

5700

1500

3000

LIVE

RN

º TX

CEN

TRES

28

19

-9

--

41

1

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

267

74-

160

NA

--

457

20

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

437

80-

--

--

204

11-

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1115

016

280

376

78N

A-

-13

511

-

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

1311

9718

NA

--

253

-

HE

AR

TN

º TX

CEN

TRES

05

111

-N

A-

-4

4N

A

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

9711

-64

NA

--

346

NA

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

139

63-

--

--

162

7N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A63

3112

521

NA

--

967

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

7N

A26

12N

A-

-17

5N

A

LUN

GN

º TX

CEN

TRES

05

16

-N

A-

-3

-N

A

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

172

16-

-N

A-

-39

-N

A

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

288

16-

-N

A-

-79

-N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A99

1627

1-

NA

--

70-

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

13N

A68

-N

A-

-27

-N

A

PAN

CR

EA

SN

º TX

CEN

TRES

02

18

-N

A-

-7

-N

A

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

402

--

NA

--

2-

NA

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

7617

--

--

-18

-N

A

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A46

1713

89

NA

--

10-

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

30

161

NA

--

0-

NA

SMA

LL B

OW

EL

TX C

ENTR

ES0

10

3-

NA

--

--

NA

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

10

--

NA

--

--

NA

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

30

--

NA

--

--

NA

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A2

05

-N

A-

--

-N

A

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

10

2-

NA

--

--

NA

44

Page 47: Newsletter 2012

WA

ITIN

G L

IST

OTH

ER C

OU

NTR

IES

COUN

TRIE

SM

ACED

ONI

AM

OLD

OVA

NEW

ZEA

LAND

NORW

AYPA

LEST

INE

RUSS

IASW

ITZE

RLAN

DSY

RIA

TUNI

SIA

TURK

EYUS

AP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/2.

13.

64.

45.

04.

214

2.8

8.0

20.8

10.7

74.7

313.

1

KID

NE

YN

º TX

CEN

TRES

22

31

132

68

662

239

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

52

NA

297

0-

384

NA

192

6267

2977

4

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

52

NA

520

0-

1185

NA

1062

1991

286

565

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

115

245

818

9-

-83

8N

A10

4117

390

5588

3

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

00

NA

6-

-23

NA

995

847

07

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

1450

408

NA

-50

0-

629

5000

8637

5373

3-

LIVE

RN

º TX

CEN

TRES

11

11

012

30

240

133

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

0N

A99

0-

181

NA

NA

-10

757

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

0N

A10

90

-28

9N

AN

A27

3324

160

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A-

2413

0-

125

-N

A14

6013

019

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

-N

A2

0-

24N

AN

A32

915

35

HE

AR

TN

º TX

CEN

TRES

01

11

NA

93

01

1312

9

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

0N

A43

NA

-57

NA

NA

-33

05

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

0N

A54

NA

-88

NA

NA

387

5675

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A-

1316

NA

-36

-N

A21

822

14

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

-N

A3

NA

-9

NA

NA

4433

1

LUN

GN

º TX

CEN

TRES

00

11

NA

32

01

364

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

-N

A30

NA

-54

NA

NA

-23

11

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

-N

A72

NA

-11

3-

NA

1437

73

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A-

1340

NA

-49

NA

NA

413

33

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

-N

A3

NA

-5

NA

NA

324

0

PAN

CR

EA

SN

º TX

CEN

TRES

00

11

NA

33

00

511

2

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

-N

A27

NA

-35

NA

NA

-54

6

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

-N

A31

NA

-84

-N

A19

396

4

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A-

45

NA

-51

NA

NA

6933

6

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

-N

A1

NA

-0

NA

NA

1444

SMA

LL B

OW

EL

TX C

ENTR

ES0

00

-N

A0

20

04

24

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

NA

-N

A-

NA

-2

NA

NA

-17

7

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

NA

-N

A-

NA

-3

-N

A-

379

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11N

A-

0-

NA

-2

NA

NA

-18

4

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

NA

-N

A-

NA

-0

NA

NA

-12

45

Page 48: Newsletter 2012

WA

ITIN

G L

IST

LATI

NA

MER

ICA

N C

OU

NTR

IES

CO

UN

TRIE

SA

RG

ENTI

NA

BO

LIVI

AB

RA

SIL

CH

ILE

CO

LOM

BIA

CO

STA

RIC

AC

UB

AD

OM

INIC

AN

AEC

UA

DO

RP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/40

.610

.119

6.7

17.3

46.9

4.7

11.3

10.1

14.7

KID

NE

YN

º TX

CEN

TRES

536

106

2221

49

811

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

2155

1965

3020

7-

134

593

28-

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

7532

1931

549

1540

--

573

9986

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1158

3919

1948

611

8510

0117

050

0-

34

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

337

125

1-

2523

-4

0

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

2678

620

00-

1700

019

550

170

2714

2009

-

LIVE

RN

º TX

CEN

TRES

240

528

63

31

1

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

681

013

0733

-27

186

-

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

1207

031

6715

5-

4432

1330

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1173

80

1138

155

5026

3-

9

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

116

020

2-

815

51

6

HE

AR

TN

º TX

CEN

TRES

280

447

71

1N

A1

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

151

018

310

-3

4N

A-

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

262

026

59

-8

5N

A7

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1187

020

19

125

4N

A4

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

470

183

-6

32

NA

1

LUN

GN

º TX

CEN

TRES

120

54

10

0N

A0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

930

5412

--

0N

A0

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

193

019

430

--

0N

A0

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1113

20

144

308

-0

NA

0

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

310

54-

1-

0N

A0

PAN

CR

EA

SN

º TX

CEN

TRES

110

162

41

2N

A0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

113

016

1-

20

NA

0

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

111

010

32

-2

0N

A0

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

1110

50

212

42

0N

A0

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

130

0-

01

0N

A0

SMA

LL B

OW

EL

TX C

ENTR

ES4

00

12

00

NA

0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

70

00

--

0N

A0

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

170

00

--

0N

A0

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

118

00

02

-0

NA

0

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

10

00

0-

0N

A0

46

Page 49: Newsletter 2012

WA

ITIN

G L

IST

LATI

NA

MER

ICA

N C

OU

NTR

IES

CO

UN

TRIE

SEL

SA

LVA

DO

RG

UAT

EMA

LAM

EXIC

ON

ICA

RA

GU

APA

NA

MA

PAR

AG

UAY

PER

UU

RU

GU

AYVE

NEZ

UEL

AP

opul

atio

n (m

illio

n in

habi

tant

s)U

NFP

A: h

ttp:

//w

ww

.unf

pa.o

rg/p

ublic

/6.

214

.811

4.8

5.9

3.4

6.6

29.4

3.4

29.4

KID

NE

YN

º TX

CEN

TRES

5-

208

-1

315

310

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

--

3903

-73

-17

414

540

1

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

--

8118

-28

9-

378

558

1068

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

-19

62-

214

-18

344

455

7

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

--

--

18-

-19

38

Pat

ient

s on

dia

lyse

s on

31/

12/2

011

43

00-

3700

0-

1643

--

3079

1258

0

LIVE

RN

º TX

CEN

TRES

-N

A59

-6

-5

11

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

-N

A19

4-

12-

3331

6

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-N

A32

6-

6-

5446

9

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

NA

92-

6-

1627

7

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-N

A-

-0

--

5N

A

HE

AR

TN

º TX

CEN

TRES

-N

A38

--

14

21

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

-N

A48

--

-8

180

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-N

A44

--

-8

400

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

NA

21-

--

024

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-N

A-

--

--

3N

A

LUN

GN

º TX

CEN

TRES

-N

A6

--

-1

00

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

-N

A2

--

-4

30

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-N

A5

--

-4

40

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

NA

2-

--

02

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-N

A-

--

--

1N

A

PAN

CR

EA

SN

º TX

CEN

TRES

-N

A13

--

-0

10

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

-N

A9

--

-0

150

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-N

A17

--

-0

290

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

NA

9-

--

023

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-N

A-

--

-0

0N

A

SMA

LL B

OW

EL

TX C

ENTR

ES-

NA

3-

--

00

0

Pat

ient

s in

clud

ed o

n th

e W

L fo

r th

e fir

st t

ime

in t

he c

ours

e of

201

1

-N

A1

--

-0

00

Tota

l num

ber

of p

atie

nts

ever

act

ive

on t

he W

L du

ring

2011

-N

A0

--

-0

00

Pat

ient

s aw

aitin

g fo

r a

tran

spla

nt (o

nly

activ

e ca

ndid

ates

) on

31/1

2/20

11-

NA

0-

--

00

NA

Pat

ient

s w

ho d

ied

whi

le o

n th

e W

L du

ring

2011

-N

A-

--

-0

0N

A

47

Page 50: Newsletter 2012

FAM

ILY

REF

USA

LS

EUR

OP

EAN

UN

ION

CO

UN

TRIE

SC

OU

NT

RIE

SA

US

TR

IAB

ELG

IUM

BU

LGA

RIA

CY

PR

US

CZ

EC

H.

R.

DE

NM

AR

KE

ST

ON

IAFI

NLA

ND

FRA

NC

EP

op

ulat

ion

(mill

ion

inha

bit

ants

)U

NFP

A:

http

://w

ww

.unf

pa.

org

/pub

lic/

8.4

11.0

7.4

1.1

10.5

5.6

1.3

5.4

65.1

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

--

109

--

40-

-N

umb

er o

f fa

mily

ref

usal

s (%

)-

-3

(30.

0)3

(33.

3)13

-

10 (

25.0

)-

616

CO

UN

TR

IES

GE

RM

AN

YG

RE

EC

EH

UN

GA

RY

IRE

LAN

DIT

ALY

LAT

VIA

LIT

HU

AN

IALU

XE

MB

OU

RG

MA

LTA

Po

pul

atio

n (m

illio

n in

hab

itan

ts)

UN

FPA

: ht

tp:/

/ww

w.u

nfp

a.o

rg/p

ublic

/81

.811

.410

.04.

560

.82.

23.

30.

50.

4

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

--

209

-22

7125

89-

18N

umb

er o

f fa

mily

ref

usal

s (%

)-

-11

(5.

3)19

651

(28.

7)6

(24.

0)34

(38

.2)

-2

(11.

0)

CO

UN

TR

IES

NE

TH

ER

LAN

DS

PO

LAN

DP

OR

TU

GA

LR

OM

AN

IAS

LOVA

KIA

SLO

VE

NIA

SPA

INS

WE

DE

NU

. K

.P

op

ulat

ion

(mill

ion

inha

bit

ants

)U

NFP

A:

http

://w

ww

.unf

pa.

org

/pub

lic/

16.7

38.3

10.7

21.4

5.5

2.0

47.2

9.4

62.3

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

552

732

-15

988

3620

07-

2542

Num

ber

of

fam

ily r

efus

als

(%)

289

(52.

4)68

(9.

3)-

45 (

28.3

)9

(10.

2)5

(13.

9)31

9 (1

5.9)

-11

04 (

43.4

)

OTH

ER C

OU

NTR

IES

CO

UN

TR

IES

ALG

ER

IAA

US

TR

ALI

AB

ELA

RU

SC

AN

AD

AC

RO

AC

IAE

GY

PT

GE

OR

GIA

ICE

LAN

DIS

RA

EL

LEB

AN

ON

LIB

YAP

op

ulat

ion

(mill

ion

inha

bit

ants

)U

NFP

A:

http

://w

ww

.unf

pa.

org

/pub

lic/

36.0

22.6

9.6

34.5

4.4

82.5

4.3

0.3

7.6

4.3

6.4

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

NA

-17

--

NA

NA

-16

232

NA

Num

ber

of

fam

ily r

efus

als

(%)

NA

-11

(64

.7)

--

NA

NA

-73

(45

.1)

22 (

68.8

)N

A

CO

UN

TRIE

SM

ACED

ON

IAM

OLD

OVA

NEW

ZEA

LAN

DN

OR

WAY

PALE

STIN

ER

USS

IASW

ITZE

RLA

ND

SYR

IATU

NIS

IATU

RK

EYU

SAP

op

ulat

ion

(mill

ion

inha

bit

ants

)U

NFP

A:

http

://w

ww

.unf

pa.

org

/pub

lic/

2.1

3.6

4.4

5.0

4.2

142.

88.

020

.810

.774

.731

3.1

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

21

-16

2N

A-

-N

A14

1292

-N

umb

er o

f fa

mily

ref

usal

s (%

)2

(100

)1

(100

)-

35 (

21.6

)N

A-

-N

A8

(57.

1)95

8 (7

4.1)

-

LATI

NA

MER

ICA

N C

OU

NTR

IES

CO

UN

TR

IES

AR

GE

NT

INA

BO

LIV

IAB

RA

SIL

CH

ILE

CO

LOM

BIA

CO

STA

RIC

AC

UB

AD

OM

INIC

AN

AE

CU

AD

OR

Po

pul

atio

n (m

illio

n in

hab

itan

ts)

UN

FPA

: ht

tp:/

/ww

w.u

nfp

a.o

rg/p

ublic

/40

.610

.119

6.7

17.3

46.9

4.7

11.3

10.1

14.7

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

1335

53-

231

690

3014

0-

53N

umb

er o

f fa

mily

ref

usal

s (%

)64

5 (

48.3

)43

(8

1.1)

-11

8 (5

1.1)

197

(28.

6)6

(20.

0)12

(8.

6)-

22 (

41.5

)

CO

UN

TR

IES

EL

SA

LVA

DO

RG

UA

TE

MA

LAM

EX

ICO

NIC

AR

AG

UA

PAN

AM

APA

RA

GU

AY

PE

RU

UR

UG

UA

YV

EN

EZ

UE

LAP

op

ulat

ion

(mill

ion

inha

bit

ants

)U

NFP

A:

http

://w

ww

.unf

pa.

org

/pub

lic/

6.2

14.8

114.

85.

93.

46.

629

.43.

429

.4

Num

ber

of

inte

rvie

ws,

ask

ing

for

cons

ent

to d

onat

ion

--

1353

-24

3924

988

180

Num

ber

of

fam

ily r

efus

als

(%)

--

64 (

4.7)

-8

(33

.3)

9 (2

3.1)

122

(49.

0)16

(18

.2)

68

(37.

8)

48

Page 51: Newsletter 2012

TRA

NSP

LAN

TATI

ON

OF

VASC

ULA

RIS

ED C

OM

PO

SITE

ALL

OG

RA

FTS

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

CO

UN

TRIE

SA

UST

RIA

BEL

GIU

MB

ULG

AR

IAC

YP

RU

SC

ZEC

H. R

.D

ENM

AR

KES

TON

IAFI

NLA

ND

FRA

NC

E

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

8.4

11.0

7.4

1.1

10.5

5.6

1.3

5.4

65.1

Han

d TX

.-

-0

-0

0-

00

Sin

gle

Han

d TX

.-

-0

-0

0-

00

Dou

ble

Han

d TX

.-

-0

-0

0-

00

Face

TX

.-

-0

-0

0-

02

Oth

er T

X.

--

0-

-0

-0

0

CO

UN

TRIE

SG

ERM

AN

YG

REE

CE

HU

NG

AR

YIR

ELA

ND

ITA

LYLA

TVIA

LITH

UA

NIA

LUX

EMB

OU

RG

MA

LTA

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

81.8

11.4

10.0

4.5

60.8

2.2

3.3

0.5

0.4

Han

d TX

.N

A0

-N

A0

-N

A-

0

Sin

gle

Han

d TX

.N

A0

-N

A0

-N

A-

0

Dou

ble

Han

d TX

.N

A0

-N

A0

-N

A-

0

Face

TX

.N

A0

-N

A0

-N

A-

0

Oth

er T

X.

NA

0-

NA

--

NA

-0

CO

UN

TRIE

SN

ETH

ERLA

ND

SP

OLA

ND

PO

RTU

GA

LR

OM

AN

IASL

OVA

KIA

SLO

VEN

IASP

AIN

SWED

ENU

. K.

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

16.7

38.3

10.7

21.4

5.5

2.0

47.2

9.4

62.3

Han

d TX

.-

1N

A0

00

00

0

Sin

gle

Han

d TX

.-

1N

A0

00

00

0

Dou

ble

Han

d TX

.-

0N

A0

00

00

0

Face

TX

.-

0N

A0

00

00

0

Oth

er T

X.

--

NA

00

01

00

49

Page 52: Newsletter 2012

TRA

NSP

LAN

TATI

ON

OF

VASC

ULA

RIS

ED C

OM

PO

SITE

ALL

OG

RA

FTS

OTH

ER C

OU

NTR

IES

CO

UN

TRIE

SA

LGER

IAA

UST

RA

LIA

BEL

AR

US

CA

NA

DA

CR

OA

CIA

EGY

PT

GEO

RG

IAIC

ELA

ND

ISR

AEL

LEB

AN

ON

LIB

YA

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

36.0

22.6

9.6

34.5

4.4

82.5

4.3

0.3

7.6

4.3

6.4

Han

d TX

.0

-0

--

NA

0-

-N

A

Sin

gle

Han

d TX

.0

-0

--

NA

0-

-N

A

Dou

ble

Han

d TX

.0

-0

--

NA

0-

-N

A

Face

TX

.0

-0

--

NA

0-

-N

A

Oth

er T

X.

0-

6-

-N

A0

--

NA

CO

UN

TRIE

SM

ACED

ON

IAM

OLD

OVA

NEW

ZEA

LAN

DN

OR

WAY

PALE

STIN

ER

USS

IASW

ITZE

RLA

ND

SYR

IATU

NIS

IATU

RK

EYU

SA

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

2.1

3.6

4.4

5.0

4.2

142.

88.

020

.810

.774

.731

3.1

Han

d TX

.N

AN

A-

0N

AN

A0

00

13

Sin

gle

Han

d TX

.N

AN

A-

0N

AN

A0

00

02

Dou

ble

Han

d TX

.N

AN

A-

0N

AN

A0

00

11

Face

TX

.N

AN

A-

0N

AN

A0

00

00

Oth

er T

X.

NA

NA

-0

NA

NA

00

00

0

LATI

NA

MER

ICA

N C

OU

NTR

IES

CO

UN

TRIE

SA

RG

ENTI

NA

BO

LIVI

AB

RA

SIL

CH

ILE

CO

LOM

BIA

CO

STA

RIC

AC

UB

AD

OM

INIC

AN

AEC

UA

DO

R

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

40.6

10.1

196.

717

.346

.94.

711

.310

.114

.7

Han

d TX

.-

0-

00

NA

00

-

Sin

gle

Han

d TX

.-

0-

00

NA

00

-

Dou

ble

Han

d TX

.-

0-

00

NA

00

-

Face

TX

.-

0-

00

NA

00

-

Oth

er T

X.

-0

-0

0N

A0

0-

CO

UN

TRIE

SEL

SA

LVA

DO

RG

UAT

EMA

LAM

EXIC

ON

ICA

RA

GU

APA

NA

MA

PAR

AG

UAY

PER

UU

RU

GU

AYVE

NEZ

UEL

A

Pop

ulat

ion

(mill

ion

inha

bita

nts)

UN

FPA

: htt

p://

ww

w.u

nfpa

.org

/pub

lic/

6.2

14.8

114.

85.

93.

46.

629

.43.

429

.4

Han

d TX

.-

-0

--

-0

0-

Sin

gle

Han

d TX

.-

-0

--

-0

0-

Dou

ble

Han

d TX

.-

-0

--

-0

0-

Face

TX

.-

-0

--

-0

0-

Oth

er T

X.

--

0-

--

00

-

50

Page 53: Newsletter 2012

International Data on Tissue andHematopoietic Stem Cell Donation and

Transplantation Activity.Year 2011

Page 54: Newsletter 2012

Data recorded & prepared by: EUROCET - European Network of Competent Authorities for Tissues and Cells -Team (www.eurocet.org)

DATA PROVIDED BY NATIONAL COMPETENT AUTHORITIES:

52

AUSTRIABELGIUMBULGARIAJordan Peev CYPRUSCarolina StylianouCZECH REPUBLICPavel B ezovskýEva K emenováDENMARKJohanna StrobelRalf R. TönjesESTONIAPille HarrisonEliisa LukkFINLANDFRANCEArnaud De GuerraGERMANYJohanna StrobelRalf R. TönjesGREECESofia MaleskouHUNGARYTokar LillaIRELANDITALYFiorenza BarianiLetizia LombardiniLATVIAAnita DaugavvanagaLITHUANIADainora MedeisieneLUXEMBURGMALTANETHERLANDSPOLANDArtur KaminskiAgnieszka A. KrawczykPORTUGALMargarida Amil Diaz Catarina Bolotinha

ROMANIARosana TurcuAndrei NicaSLOVAKIAJan Koller SLOVENIASPAINBibiana RamosMarina AlvarezRosario MarazuelaSWEDENHelena StrömMona HanssonUNITED KINGDOM Liz McAnulty Imogen SwannAmy Gelsthorpe-HillCROATIAVanja NikolacKristina StankoviSandra TomljenoviICELANDMACEDONIAMOLDOVAIgor CodreanuTatiana TimbalariNORWAYVibeke DalenChristine Fjeldstad NulandSWITZERLANDTURKEYHalil Yılmaz SURNuran Erden

ARGENTINACarlos SorattiMartín Alejandro TorresRicardo Rubén IbarBOLIVIAOlker Calla RivadeneiraBRASILHeder Murari BorbaCHILEJose Luis RojasCOLOMBIAJuan Gonzalo López CasasDiana Carolina Plazas SierraCOSTA RICAMarvin Agüero Chinchilla César A. Gamboa PeñarandaCUBAAngela Olga Hidalgo SánchezDOMINICANAFernando Morales BilliniECUADORDiana AlmeidaMEXICOLuis Antonio Meixueiro DazaOmar Sánchez RamírezNICARAGUATulio René Mendieta AlonsoPANAMACesar Cuero ZambranoPARAGUAYHugo A. Espinoza C.PERUJuan A. Almeyda AlcántaraURUGUAYInés AlvarezRaul José MizrajiVENEZUELACarmen Luisa Lattuf de MilanésZoraida Pacheco Graterol

Preliminary European Figures on Tissue & Cell (HPC) Donation andTransplantation Activities, documents produced by the “EUROCET - European

Network of Competent Authorities for Tissues and Cells” (2011)

Page 55: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N T

ISSU

ES -

YEA

R 2

011

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S C

ou

ntr

yA

US

TR

IAB

EL

GIU

MB

UL

GA

RIA

CY

PR

US

CZ

EC

H R

.D

EN

MA

RK

ES

TO

NIA

FIN

LA

ND

FR

AN

CE

Po

pu

lati

on

(F

on

t: e

uro

sta

t)8.4

04.2

52

10.9

51.2

66

7.3

69.4

31

839.7

51

10.4

85.4

89

5.5

52.0

37

1.3

40.1

94

5.3

75.2

76

65.0

48.4

12

TY

PE

OF

TIS

SU

ET

YP

E O

F D

ATA

NO

DATA

NO

DATA

NO

DATA

NO

DATA

CO

RN

EA

N.

of

tiss

ue d

onatio

ns

66

0405

31

5.0

25

Tis

sue d

onatio

n P

MP

8,9

60,0

038,6

223,1

377,2

5N

° o

f t

issu

e r

etr

ieve

d125

0806

34

9.9

98

tiss

ue p

rocess

ed

(units)

125

NO

DATA

658

34

9.9

98

tiss

ue d

istr

ibute

d (

units)

89

NO

DATA

479

34

3.8

46

tiss

ue i

mp

ort

ed

(units)

016

00

0N

° tiss

ue e

xpo

rted

(units)

00

68

0133

of

tiss

ues

transp

lante

d89

16

479

34

3.3

49

of

patients

tra

nsp

lante

dN

O D

ATA

16

479

34

NO

DATA

of

transp

lants

89

16

479

34

3.3

49

SK

INN

. o

f tiss

ue d

onatio

ns

149

050

NO

DATA

189

Tis

sue d

onatio

n P

MP

20,2

20,0

04,7

7N

O D

ATA

2,9

1N

° o

f t

issu

e r

etr

ieve

d (

cm

2)

NO

DATA

0122.1

04

NO

DATA

347.0

41

tiss

ue p

rocess

ed

(units)

NO

DATA

NO

DATA

NO

DATA

NO

DATA

347.0

41

tiss

ue d

istr

ibute

d (

units)

NO

DATA

NO

DATA

NO

DATA

NO

DATA

309.5

55

tiss

ue i

mp

ort

ed

(units)

00

0N

O D

ATA

39.5

00

tiss

ue e

xpo

rted

(units)

00

1.0

20

NO

DATA

0N

° o

f tiss

ues

transp

lante

d64

00

NO

DATA

NO

DATA

of

patients

tra

nsp

lante

dN

O D

ATA

00

NO

DATA

NO

DATA

of

transp

lants

64

00

NO

DATA

NO

DATA

CA

RD

IAC

TIS

SU

EN

. o

f tiss

ue d

onatio

ns

00

61

NO

DATA

165

Tis

sue d

onatio

n P

MP

0,0

00,0

05,8

2N

O D

ATA

2,5

4N

° o

f t

issu

e r

etr

ieve

dN

O D

ATA

0104

NO

DATA

361

tiss

ue p

rocess

ed

(units)

0N

O D

ATA

104

NO

DATA

361

tiss

ue d

istr

ibute

d (

units)

0N

O D

ATA

64

NO

DATA

200

tiss

ue i

mp

ort

ed

(units)

00

0N

O D

ATA

72

tiss

ue e

xpo

rted

(units)

00

8N

O D

ATA

0N

° o

f tiss

ues

transp

lante

d0

064

NO

DATA

NO

DATA

of

patients

tra

nsp

lante

d0

064

NO

DATA

NO

DATA

of

transp

lants

00

64

NO

DATA

NO

DATA

BLO

OD

VE

SS

EL

N.

of

tiss

ue d

onatio

ns

00

13

7276

Tis

sue d

onatio

n P

MP

0,0

00,0

01,2

45,2

24,2

4N

° o

f t

issu

e r

etr

ieve

d0

018

12

4.0

36

tiss

ue p

rocess

ed

(units)

0N

O D

ATA

16

13

4.0

36

tiss

ue d

istr

ibute

d (

units)

0N

O D

ATA

78

1.2

60

tiss

ue i

mp

ort

ed

(units)

00

00

40

tiss

ue e

xpo

rted

(units)

00

00

28

of

tiss

ues

transp

lante

d0

07

10

NO

DATA

of

patients

tra

nsp

lante

d0

07

33

NO

DATA

of

transp

lants

00

734

NO

DATA

MU

SC

ULO

SK

ELE

TAL

N.

of

tiss

ue d

onatio

ns

138

0195

54

86

Tis

sue d

onatio

n P

MP

18,7

30,0

018,6

040,2

91,3

2N

° o

f t

issu

e r

etr

ieve

d2.2

09

01.1

14

62

21.5

18

tiss

ue p

rocess

ed

(units)

00

523

121

21.5

18

tiss

ue d

istr

ibute

d (

units)

00

676

113

27.9

94

tiss

ue i

mp

ort

ed

(units)

00

00

0N

° tiss

ue e

xpo

rted

(units)

00

39

00

of

tiss

ues

transp

lante

d84

0676

113

NO

DATA

of

patients

tra

nsp

lante

dN

O D

ATA

0676

63

NO

DATA

of

transp

lants

84

0676

113

NO

DATA

PLA

CE

NTA

/AM

NIO

TIC

ME

MB

RA

NE

N.

of

tiss

ue d

onatio

ns

19

05

30

NO

DATA

Tis

sue d

onatio

n P

MP

2,5

80,0

00,4

822,3

8N

O D

ATA

of

tis

sue r

etr

ieve

d19

05

30

69

tiss

ue p

rocess

ed

(units)

NO

DATA

NO

DATA

NO

DATA

81

2.2

90

tiss

ue d

istr

ibute

d (

units)

NO

DATA

NO

DATA

54

77

2.2

89

tiss

ue i

mp

ort

ed

(units)

00

00

0N

° tiss

ue e

xpo

rted

(units)

00

10

00

of

tiss

ues

transp

lante

d19

054

30

NO

DATA

of

patients

tra

nsp

lante

dN

O D

ATA

054

77

NO

DATA

of

transp

lants

19

054

77

NO

DATA

OT

HE

RS

N.

of

tiss

ue d

onatio

ns

20

00

NO

DATA

NO

DATA

Tis

sue d

onatio

n P

MP

2,7

10,0

00,0

0N

O D

ATA

NO

DATA

of

tis

sue r

etr

ieve

d20

00

NO

DATA

NO

DATA

tiss

ue p

rocess

ed

(units)

NO

DATA

NO

DATA

NO

DATA

NO

DATA

NO

DATA

tiss

ue d

istr

ibute

d (

units)

NO

DATA

NO

DATA

NO

DATA

NO

DATA

NO

DATA

tiss

ue i

mp

ort

ed

(units)

NO

DATA

10

NO

DATA

NO

DATA

tiss

ue e

xpo

rted

(units)

NO

DATA

00

NO

DATA

NO

DATA

of

tiss

ues

transp

lante

d0

10

NO

DATA

NO

DATA

of

patients

tra

nsp

lante

d0

10

NO

DATA

NO

DATA

of

transp

lants

01

0N

O D

ATA

NO

DATA

53

Page 56: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N T

ISSU

ES -

YEA

R 2

011

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S C

oun

try

GE

RM

AN

YG

RE

EC

EH

UN

GA

RY

IRE

LAN

DIT

ALY

LAT

VIA

LIT

HU

AN

IALU

XE

MB

OU

RG

MA

LTA

Po

pul

atio

n (F

ont

: eu

rost

at)

81.7

51.6

0211

.309

.885

9.98

5.72

24.

480.

858

60.6

26.4

422.

074.

605

3.24

4.60

151

1.84

041

7.61

7

TYP

E O

F TI

SS

UE

TYP

E O

F D

ATA

NO

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

NO

DAT

A

CO

RN

EA

N.

of t

issu

e d

onat

ions

260

7.39

121

29Ti

ssue

don

atio

n P

MP

26,0

412

1,91

10,1

28,

94N

° of

tis

sue

retr

ieve

d75

14.6

0921

57N

° tis

sue

pro

cess

ed (

units

)56

312

.115

2157

tissu

e d

istr

ibut

ed (

units

)49

06.

384

2149

tissu

e im

por

ted

(un

its)

10

00

tissu

e ex

por

ted

(un

its)

035

70

0N

° of

tis

sues

tra

nsp

lant

ed13

85.

935

2149

of p

atie

nts

tran

spla

nted

138

NO

DAT

A21

48N

° of

tra

nsp

lant

s19

947

2021

49

SK

INN

. of

tis

sue

don

atio

ns0

376

00

Tiss

ue d

onat

ion

PM

P0,

006,

200,

000,

00N

° of

tis

sue

retr

ieve

d (

cm2)

01.

060.

002

00

tissu

e p

roce

ssed

(un

its)

NO

DAT

A1.

060.

002

00

tissu

e d

istr

ibut

ed (

units

)N

O D

ATA

945.

790

00

tissu

e im

por

ted

(un

its)

00

00

tissu

e ex

por

ted

(un

its)

00

00

of t

issu

es t

rans

pla

nted

85.

424

00

of p

atie

nts

tran

spla

nted

8N

O D

ATA

00

of t

rans

pla

nts

81.

816

00

CA

RD

IAC

TIS

SU

EN

. of

tis

sue

don

atio

ns10

209

00

Tiss

ue d

onat

ion

PM

P1,

003,

450,

000,

00N

° of

tis

sue

retr

ieve

d9

376

00

tissu

e p

roce

ssed

(un

its)

1033

40

0N

° tis

sue

dis

trib

uted

(un

its)

NO

DAT

A18

00

0N

° tis

sue

imp

orte

d (

units

)0

00

0N

° tis

sue

exp

orte

d (

units

)0

00

0N

° of

tis

sues

tra

nsp

lant

edN

O D

ATA

NO

DAT

A0

0N

° of

pat

ient

s tr

ansp

lant

edN

O D

ATA

NO

DAT

A0

0N

° of

tra

nsp

lant

sN

O D

ATA

205

00

BLO

OD

VE

SS

EL

N.

of t

issu

e d

onat

ions

077

30

0Ti

ssue

don

atio

n P

MP

0,00

12,7

50,

000,

00N

° of

tis

sue

retr

ieve

d0

965

00

tissu

e p

roce

ssed

(un

its)

NO

DAT

A1.

040

00

tissu

e d

istr

ibut

ed (

units

)N

O D

ATA

568

00

tissu

e im

por

ted

(un

its)

00

00

tissu

e ex

por

ted

(un

its)

00

00

of t

issu

es t

rans

pla

nted

NO

DAT

AN

O D

ATA

00

of p

atie

nts

tran

spla

nted

NO

DAT

AN

O D

ATA

00

of t

rans

pla

nts

NO

DAT

A30

90

0

MU

SC

ULO

SK

ELE

TAL

N.

of t

issu

e d

onat

ions

280

3.36

470

128

Tiss

ue d

onat

ion

PM

P28

,04

55,4

933

,74

39,4

5N

° of

tis

sue

retr

ieve

d15

97.

912

218

128

tissu

e p

roce

ssed

(un

its)

154

021

812

8N

° tis

sue

dis

trib

uted

(un

its)

154

9.40

810

911

4N

° tis

sue

imp

orte

d (

units

)0

00

1N

° tis

sue

exp

orte

d (

units

)0

00

0N

° of

tis

sues

tra

nsp

lant

ed22

7N

O D

ATA

109

115

of p

atie

nts

tran

spla

nted

197

NO

DAT

A10

911

3N

° of

tra

nsp

lant

s15

46.

797

218

115

PLA

CE

NTA

/AM

NIO

TIC

ME

MB

RA

NE

N.

of t

issu

e d

onat

ions

117

616

10Ti

ssue

don

atio

n P

MP

0,10

2,90

7,71

3,08

of

tissu

e re

trie

ved

017

616

9N

° tis

sue

pro

cess

ed (

units

)22

081

045

tissu

e d

istr

ibut

ed (

units

)90

13.1

550

73N

° tis

sue

imp

orte

d (

units

)0

00

0N

° tis

sue

exp

orte

d (

units

)0

00

0N

° of

tis

sues

tra

nsp

lant

ed18

NO

DAT

A0

73N

° of

pat

ient

s tr

ansp

lant

ed18

NO

DAT

A0

57N

° of

tra

nsp

lant

s32

1.10

40

73

OTH

ER

SN

. of

tis

sue

don

atio

ns1

00

0Ti

ssue

don

atio

n P

MP

0,10

0,00

0,00

0,00

of

tissu

e re

trie

ved

00

00

tissu

e p

roce

ssed

(un

its)

20N

O D

ATA

00

tissu

e d

istr

ibut

ed (

units

)5

NO

DAT

A0

0N

° tis

sue

imp

orte

d (

units

)0

00

0N

° tis

sue

exp

orte

d (

units

)0

00

0N

° of

tis

sues

tra

nsp

lant

ed32

NO

DAT

A0

0N

° of

pat

ient

s tr

ansp

lant

ed32

NO

DAT

A0

0N

° of

tra

nsp

lant

s32

NO

DAT

A0

0

54

Page 57: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N T

ISSU

ES -

YEA

R 2

011

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S C

oun

try

NE

TH

ER

LAN

DS

PO

LAN

DP

OR

TU

GA

LR

OM

AN

IAS

LOVA

KIA

SLO

VE

NIA

SPA

INS

WE

DE

NU

. K

.P

opul

atio

n (F

ont:

eur

osta

t)16

.655

.799

38.2

00.0

3710

.572

.157

21.4

13.8

155.

392.

446

2.05

0.18

946

.152

.926

9.41

5.57

062

.498

.610

TYP

E O

F TI

SS

UE

TYP

E O

F D

ATA

NO

DAT

AN

O D

ATA

CO

RN

EA

N.

of t

issu

e d

onat

ions

652

506

4412

82.

772

434

NO

DAT

ATi

ssue

don

atio

n P

MP

17,0

747

,86

2,05

23,7

460

,06

46,0

9N

O D

ATA

of

tissu

e re

trie

ved

1.29

498

744

101

4.21

888

210

.556

tissu

e p

roce

ssed

(un

its)

1.17

7N

O D

ATA

444.

218

890

10.2

82N

° tis

sue

dis

trib

uted

(un

its)

905

752

4315

12.

622

630

3.89

4N

° tis

sue

imp

orte

d (

units

)0

162

840

10

159

tissu

e ex

por

ted

(un

its)

00

00

10

159

of t

issu

es t

rans

pla

nted

NO

DAT

A91

612

715

12.

705

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

NO

DAT

AN

O D

ATA

127

151

2.88

7N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

sN

O D

ATA

916

127

0N

O D

ATA

630

NO

DAT

A

SK

INN

. of

tis

sue

don

atio

ns30

113

.675

2120

740

NO

DAT

ATi

ssue

don

atio

n P

MP

13,6

40,

0963

8,61

3,89

4,50

4,28

NO

DAT

AN

° of

tis

sue

retr

ieve

d (

cm2)

86.9

0084

313

.675

109.

378

567.

256

NO

DAT

A1.

364

tissu

e p

roce

ssed

(un

its)

86.5

0084

413

.675

no d

ata

567.

256

461.

247

tissu

e d

istr

ibut

ed (

units

)99

20

12.3

0020

212

cm2

320.

055

93.9

994.

284

tissu

e im

por

ted

(un

its)

01

00

0N

O D

ATA

2.17

4N

° tis

sue

exp

orte

d (

units

)0

00

076

02.

174

of t

issu

es t

rans

pla

nted

NO

DAT

A5.

000

12.3

0020

212

cm2

205.

920

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

NO

DAT

A3

62

45N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

sN

O D

ATA

311

NO

DAT

A19

NO

DAT

A

CA

RD

IAC

TIS

SU

EN

. of

tis

sue

don

atio

ns24

717

020

198

243

NO

DAT

ATi

ssue

don

atio

n P

MP

6,47

1,61

0,00

3,71

4,29

25,8

1N

O D

ATA

of

tissu

e re

trie

ved

494

340

3032

824

31.

048

tissu

e p

roce

ssed

(un

its)

330

180

3032

824

31.

038

tissu

e d

istr

ibut

ed (

units

)21

27

013

134

145

469

tissu

e im

por

ted

(un

its)

00

00

00

23N

° tis

sue

exp

orte

d (

units

)0

00

067

050

of t

issu

es t

rans

pla

nted

NO

DAT

A7

013

142

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

NO

DAT

A7

013

64N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

sN

O D

ATA

70

13N

O D

ATA

148

NO

DAT

A

BLO

OD

VE

SS

EL

N.

of t

issu

e d

onat

ions

121

00

204

94N

O D

ATA

Tiss

ue d

onat

ion

PM

P0,

310,

090,

000,

004,

429,

98N

O D

ATA

of

tissu

e re

trie

ved

151

0N

O D

ATA

391

9428

5N

° tis

sue

pro

cess

ed (

units

)15

00

NO

DAT

A39

111

773

tissu

e d

istr

ibut

ed (

units

)15

00

NO

DAT

A22

015

50N

° tis

sue

imp

orte

d (

units

)0

00

NO

DAT

A0

09

tissu

e ex

por

ted

(un

its)

00

0N

O D

ATA

2120

9N

° of

tis

sues

tra

nsp

lant

edN

O D

ATA

00

NO

DAT

A17

3N

O D

ATA

NO

DAT

AN

° of

pat

ient

s tr

ansp

lant

edN

O D

ATA

00

NO

DAT

A15

615

NO

DAT

AN

° of

tra

nsp

lant

sN

O D

ATA

00

NO

DAT

AN

O D

ATA

15N

O D

ATA

MU

SC

ULO

SK

ELE

TAL

N.

of t

issu

e d

onat

ions

721

5919

771

82.

072

1.73

3N

O D

ATA

Tiss

ue d

onat

ion

PM

P18

,87

5,58

9,20

133,

1544

,89

184,

06N

O D

ATA

of

tissu

e re

trie

ved

3.28

0N

O D

ATA

197

8.97

613

.883

1.73

310

.459

tissu

e p

roce

ssed

(un

its)

2.71

523

536

51.

024

13.8

831.

764

4.40

3N

° tis

sue

dis

trib

uted

(un

its)

10.6

7527

683

550

10.5

351.

321

19.0

41N

° tis

sue

imp

orte

d (

units

)0

118

230

01.

943

339.

851

tissu

e ex

por

ted

(un

its)

00

07.

952

468

09.

890

of t

issu

es t

rans

pla

nted

NO

DAT

AN

O D

ATA

317

550

9.50

6N

O D

ATA

NO

DAT

AN

° of

pat

ient

s tr

ansp

lant

edN

O D

ATA

NO

DAT

A29

127

88.

675

NO

DAT

AN

O D

ATA

of t

rans

pla

nts

NO

DAT

AN

O D

ATA

291

NO

DAT

A1.

321

NO

DAT

A

PLA

CE

NTA

/AM

NIO

TIC

ME

MB

RA

NE

N.

of t

issu

e d

onat

ions

8258

05

506

NO

DAT

ATi

ssue

don

atio

n P

MP

NO

DAT

A5,

490,

000,

931,

080,

64N

O D

ATA

of

tissu

e re

trie

ved

8259

05

1.56

535

149

tissu

e p

roce

ssed

(un

its)

7231

.496

015

31.

565

351

19N

° tis

sue

dis

trib

uted

(un

its)

524

21.7

260

120

1.65

633

254

8N

° tis

sue

imp

orte

d (

units

)0

00

00

010

tissu

e ex

por

ted

(un

its)

00

00

00

10N

° of

tis

sues

tra

nsp

lant

edN

O D

ATA

188

012

01.

080

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

NO

DAT

AN

O D

ATA

011

11.

275

NO

DAT

AN

O D

ATA

of t

rans

pla

nts

NO

DAT

AN

O D

ATA

0N

O D

ATA

332

NO

DAT

A

OTH

ER

SN

. of

tis

sue

don

atio

ns0

1.94

5N

O D

ATA

NO

DAT

A0

NO

DAT

ATi

ssue

don

atio

n P

MP

0,00

90,8

3N

O D

ATA

NO

DAT

A0,

00N

O D

ATA

of

tissu

e re

trie

ved

01.

945

NO

DAT

AN

O D

ATA

02.

878

tissu

e p

roce

ssed

(un

its)

NO

DAT

A1.

945

NO

DAT

AN

O D

ATA

NO

DAT

A1.

924

tissu

e d

istr

ibut

ed (

units

)N

O D

ATA

0N

O D

ATA

NO

DAT

AN

O D

ATA

631

tissu

e im

por

ted

(un

its)

210

NO

DAT

A0

019

7N

° tis

sue

exp

orte

d (

units

)0

0N

O D

ATA

00

197

of t

issu

es t

rans

pla

nted

160

NO

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

NO

DAT

A0

NO

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

of t

rans

pla

nts

NO

DAT

A0

NO

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

55

Page 58: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N T

ISSU

ES -

YEA

R 2

011

OTH

ER C

OU

NTR

IES

Co

untr

yC

RO

AT

IAIC

ELA

ND

MA

CE

DO

NIA

MO

LDO

VAN

OR

WA

Y

SW

ITZ

ER

LAN

DT

UR

KE

Y

Po

pul

atio

n (F

ont

: eu

rost

at)

4.41

2.13

731

8.45

22.

057.

284

4.92

0.30

57.

870.

134

73.7

22.9

88

TYP

E O

F TI

SS

UE

TYP

E O

F D

ATA

NO

DAT

AN

O D

ATA

NO

DAT

A

CO

RN

EA

N.

of t

issu

e d

onat

ions

120

021

68Ti

ssue

don

atio

n P

MP

2,72

0,00

29,4

1N

° of

tis

sue

retr

ieve

d12

00

2168

tissu

e p

roce

ssed

(un

its)

NO

DAT

A0

NO

DAT

A21

68N

° tis

sue

dis

trib

uted

(un

its)

NO

DAT

A0

019

97N

° tis

sue

imp

orte

d (

units

)67

00

NO

DAT

AN

° tis

sue

exp

orte

d (

units

)0

00

NO

DAT

AN

° of

tis

sues

tra

nsp

lant

ed10

0N

O D

ATA

NO

DAT

AN

° of

pat

ient

s tr

ansp

lant

ed77

0N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

s77

0N

O D

ATA

1997

SK

INN

. of

tis

sue

don

atio

ns12

10

2Ti

ssue

don

atio

n P

MP

2,72

0,00

0,03

of

tissu

e re

trie

ved

(cm

2)92

1.00

00

0N

° tis

sue

pro

cess

ed (

units

)16

.416

0N

O D

ATA

NO

DAT

AN

° tis

sue

dis

trib

uted

(un

its)

14.8

960

0N

O D

ATA

tissu

e im

por

ted

(un

its)

00

0N

O D

ATA

tissu

e ex

por

ted

(un

its)

00

0N

O D

ATA

of t

issu

es t

rans

pla

nted

196

1N

O D

ATA

NO

DAT

AN

° of

pat

ient

s tr

ansp

lant

ed4

1N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

s8

1N

O D

ATA

2

CA

RD

IAC

TIS

SU

EN

. of

tis

sue

don

atio

ns10

00

1Ti

ssue

don

atio

n P

MP

2,27

0,00

0,01

of

tissu

e re

trie

ved

140

00

tissu

e p

roce

ssed

(un

its)

140

NO

DAT

AN

O D

ATA

tissu

e d

istr

ibut

ed (

units

)N

O D

ATA

00

NO

DAT

AN

° tis

sue

imp

orte

d (

units

)0

00

NO

DAT

AN

° tis

sue

exp

orte

d (

units

)0

00

NO

DAT

AN

° of

tis

sues

tra

nsp

lant

ed0

0N

O D

ATA

NO

DAT

AN

° of

pat

ient

s tr

ansp

lant

edN

O D

ATA

0N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

sN

O D

ATA

0N

O D

ATA

1

BLO

OD

VE

SS

EL

N.

of t

issu

e d

onat

ions

00

00

Tiss

ue d

onat

ion

PM

P0,

000,

000,

00N

° of

tis

sue

retr

ieve

d0

00

0N

° tis

sue

pro

cess

ed (

units

)N

O D

ATA

0N

O D

ATA

NO

DAT

AN

° tis

sue

dis

trib

uted

(un

its)

NO

DAT

A0

0N

O D

ATA

tissu

e im

por

ted

(un

its)

00

0N

O D

ATA

tissu

e ex

por

ted

(un

its)

00

0N

O D

ATA

of t

issu

es t

rans

pla

nted

NO

DAT

A0

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

NO

DAT

A0

NO

DAT

AN

O D

ATA

of t

rans

pla

nts

NO

DAT

A0

NO

DAT

AN

O D

ATA

MU

SC

ULO

SK

ELE

TAL

N.

of t

issu

e d

onat

ions

230

2637

99

Tiss

ue d

onat

ion

PM

P52

,13

77,0

30,

12N

° of

tis

sue

retr

ieve

d23

026

379

9N

° tis

sue

pro

cess

ed (

units

)15

615

337

9N

O D

ATA

tissu

e d

istr

ibut

ed (

units

)17

018

026

5N

O D

ATA

tissu

e im

por

ted

(un

its)

00

43N

O D

ATA

tissu

e ex

por

ted

(un

its)

00

0N

O D

ATA

of t

issu

es t

rans

pla

nted

126

180

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

167

116

NO

DAT

AN

O D

ATA

of t

rans

pla

nts

166

116

265

9

PLA

CE

NTA

/AM

NIO

TIC

ME

MB

RA

NE

N.

of t

issu

e d

onat

ions

60

00

Tiss

ue d

onat

ion

PM

P1,

360,

000,

00N

° of

tis

sue

retr

ieve

d6

00

0N

° tis

sue

pro

cess

ed (

units

)1.

818

0N

O D

ATA

0N

° tis

sue

dis

trib

uted

(un

its)

510

NO

DAT

A0

tissu

e im

por

ted

(un

its)

00

12N

O D

ATA

tissu

e ex

por

ted

(un

its)

00

0N

O D

ATA

of t

issu

es t

rans

pla

nted

30

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

80

NO

DAT

AN

O D

ATA

of t

rans

pla

nts

120

10N

O D

ATA

OTH

ER

SN

. of

tis

sue

don

atio

ns0

20

1Ti

ssue

don

atio

n P

MP

0,00

0,00

0,01

of

tissu

e re

trie

ved

02

01

tissu

e p

roce

ssed

(un

its)

NO

DAT

A4

NO

DAT

A0

tissu

e d

istr

ibut

ed (

units

)N

O D

ATA

0N

O D

ATA

0N

° tis

sue

imp

orte

d (

units

)0

00

NO

DAT

AN

° tis

sue

exp

orte

d (

units

)0

00

NO

DAT

AN

° of

tis

sues

tra

nsp

lant

edN

O D

ATA

0N

O D

ATA

NO

DAT

AN

° of

pat

ient

s tr

ansp

lant

edN

O D

ATA

0N

O D

ATA

NO

DAT

AN

° of

tra

nsp

lant

sN

O D

ATA

06

1

56

Page 59: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N T

ISSU

ES -

YEA

R 2

011

LATI

NA

MER

ICA

N C

OU

NTR

IES

Co

untr

yA

RG

EN

TIN

AB

OLI

VIA

BR

AS

ILC

HIL

EC

OLO

MB

IAC

OS

TA R

ICA

CU

BA

DO

MIN

ICA

NA

Pop

ulat

ion

(Fon

t: U

NFP

A)

40,6

10,1

196,

717

,346

,94,

711

,310

,1

TYP

E O

F TI

SS

UE

TYP

E O

F D

ATA

CO

RN

EA

N.

of t

issu

e d

onat

ions

772

014

002

441.

181

110

590

17Ti

ssue

don

atio

n P

MP

19,0

00,

0071

,18

2,5

25,1

823

,40

52,2

11,

68N

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)1.

544

024

200

2.00

621

811

46N

° tis

sue

dis

trib

uted

(un

its)

0N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed97

20

1517

52.

013

173

588

of t

rans

pla

nts

SK

INN

. of

tis

sue

don

atio

ns14

027

447

16Ti

ssue

don

atio

n P

MP

0,34

0,00

0,14

0,2

1,00

3,40

of

tissu

e re

trie

ved

(cm

2)N

° tis

sue

pro

cess

ed (

units

)0

38.1

9847

13.2

39N

° tis

sue

dis

trib

uted

(un

its)

11.6

620

tissu

e im

por

ted

(un

its)

tissu

e ex

por

ted

(un

its)

of t

issu

es t

rans

pla

nted

55N

° of

pat

ient

s tr

ansp

lant

ed0

1617

427

of t

rans

pla

nts

CA

RD

IAC

TIS

SU

EN

. of

tis

sue

don

atio

ns25

40

539

13Ti

ssue

don

atio

n P

MP

6,26

0,00

0,3

0,83

2,77

of

tissu

e re

trie

ved

tissu

e p

roce

ssed

(un

its)

344

069

26N

° tis

sue

dis

trib

uted

(un

its)

146

0N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed21

10

887

of t

rans

pla

nts

BLO

OD

VE

SS

EL

N.

of t

issu

e d

onat

ions

10

00

13Ti

ssue

don

atio

n P

MP

0,02

0,00

0,00

2,77

of

tissu

e re

trie

ved

tissu

e p

roce

ssed

(un

its)

40

039

tissu

e d

istr

ibut

ed (

units

)4

00

tissu

e im

por

ted

(un

its)

tissu

e ex

por

ted

(un

its)

of t

issu

es t

rans

pla

nted

of p

atie

nts

tran

spla

nted

40

08

of t

rans

pla

nts

MU

SC

ULO

SK

ELE

TAL

N.

of t

issu

e d

onat

ions

1.44

20

596

724

515

1Ti

ssue

don

atio

n P

MP

35,5

20,

003,

030,

45,

2213

,36

of

tissu

e re

trie

ved

tissu

e p

roce

ssed

(un

its)

1.78

10

999

3.58

81.

005

tissu

e d

istr

ibut

ed (

units

)12

.276

0N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed8.

036

024

.661

17.7

7132

2N

° of

tra

nsp

lant

s

PLA

CE

NTA

/AM

NIO

TIC

ME

MB

RA

NE

N.

of t

issu

e d

onat

ions

Tiss

ue d

onat

ion

PM

PN

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)N

° tis

sue

dis

trib

uted

(un

its)

tissu

e im

por

ted

(un

its)

tissu

e ex

por

ted

(un

its)

of t

issu

es t

rans

pla

nted

of p

atie

nts

tran

spla

nted

of t

rans

pla

nts

OTH

ER

SN

. of

tis

sue

don

atio

nsN

O D

ATA

0Ti

ssue

don

atio

n P

MP

0,00

of

tissu

e re

trie

ved

tissu

e p

roce

ssed

(un

its)

NO

DAT

A0

tissu

e d

istr

ibut

ed (

units

)N

O D

ATA

0N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

edN

O D

ATA

0N

° of

tra

nsp

lant

s

57

Page 60: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N T

ISSU

ES -

YEA

R 2

011

LATI

NA

MER

ICA

N C

OU

NTR

IES

Co

untr

yE

CU

AD

OR

ME

XIC

ON

ICA

RA

GU

APA

NA

MA

PAR

AG

UA

YP

ER

UU

RU

GU

AY

VE

NE

ZU

ELA

Po

pul

atio

n (F

ont

: U

NFP

A)

14,7

114,

85,

93,

46,

629

,43,

429

,4

TYP

E O

F TI

SS

UE

TYP

E O

F D

ATA

NO

DAT

A

CO

RN

EA

N.

of t

issu

e d

onat

ions

181.

118

113

3011

211

074

Tiss

ue d

onat

ion

PM

P1,

229,

7433

,24

4,55

3,81

32,3

52,

52N

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)36

942

226

220

143

tissu

e d

istr

ibut

ed (

units

)N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed1.

753

130

6032

417

113

8N

° of

tra

nsp

lant

s

SK

INN

. of

tis

sue

don

atio

ns5

015

Tiss

ue d

onat

ion

PM

P0,

040,

004,

41N

° of

tis

sue

retr

ieve

d (

cm2)

tissu

e p

roce

ssed

(un

its)

021

.300

tissu

e d

istr

ibut

ed (

units

)0

tissu

e im

por

ted

(un

its)

tissu

e ex

por

ted

(un

its)

of t

issu

es t

rans

pla

nted

of p

atie

nts

tran

spla

nted

011

of t

rans

pla

nts

CA

RD

IAC

TIS

SU

EN

. of

tis

sue

don

atio

ns3

117

Tiss

ue d

onat

ion

PM

P0,

030,

290,

58N

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)0

135

tissu

e d

istr

ibut

ed (

units

)0

3N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed0

36

of t

rans

pla

nts

BLO

OD

VE

SS

EL

N.

of t

issu

e d

onat

ions

016

Tiss

ue d

onat

ion

PM

P0,

004,

71N

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)0

33N

° tis

sue

dis

trib

uted

(un

its)

0N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed0

15N

° of

tra

nsp

lant

s

MU

SC

ULO

SK

ELE

TAL

N.

of t

issu

e d

onat

ions

9121

Tiss

ue d

onat

ion

PM

P0,

796,

18N

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)38

tissu

e d

istr

ibut

ed (

units

)N

° tis

sue

imp

orte

d (

units

)N

° tis

sue

exp

orte

d (

units

)N

° of

tis

sues

tra

nsp

lant

edN

° of

pat

ient

s tr

ansp

lant

ed17

8N

° of

tra

nsp

lant

s

PLA

CE

NTA

/AM

NIO

TIC

ME

MB

RA

NE

N.

of t

issu

e d

onat

ions

Tiss

ue d

onat

ion

PM

PN

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)N

° tis

sue

dis

trib

uted

(un

its)

tissu

e im

por

ted

(un

its)

tissu

e ex

por

ted

(un

its)

of t

issu

es t

rans

pla

nted

of p

atie

nts

tran

spla

nted

of t

rans

pla

nts

OTH

ER

SN

. of

tis

sue

don

atio

ns9

00

Tiss

ue d

onat

ion

PM

P0,

610,

000,

00N

° of

tis

sue

retr

ieve

dN

° tis

sue

pro

cess

ed (

units

)0

0N

° tis

sue

dis

trib

uted

(un

its)

00

tissu

e im

por

ted

(un

its)

tissu

e ex

por

ted

(un

its)

of t

issu

es t

rans

pla

nted

of p

atie

nts

tran

spla

nted

00

of t

rans

pla

nts

58

Page 61: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N H

PC

CEL

LS -

YEA

R 2

011

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

Cou

ntry

AU

STR

IAB

ELG

IUM

BU

LGA

RIA

CY

PR

US

CZE

CH

R.

DEN

MA

RK

ESTO

NIA

FIN

LAN

DFR

AN

CE

Pop

ulat

ion

(Fon

t: eu

rost

at)

8.40

4.25

210

.951

.266

7.36

9.43

183

9.75

110

.485

.489

5.55

2.03

71.

340.

194

5.37

5.27

665

.048

.412

CAT

EGO

RY

OF

DAT

ATY

PE

OF

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

NO

DAT

A

PO

TEN

TIA

L D

ON

ATIO

NA

ND

SEA

RC

HIN

G IN

TH

EN

ATIO

NA

L R

EGIS

TRIE

SN

° of

pot

entia

l don

ors

at 3

1.12

1512

0.54

279

.072

019

6.39

1

of c

oord

blo

od u

nit

at 3

1.12

NO

DAT

A1.

742

3.73

90

16.1

62

of s

earc

hes

requ

este

dN

O D

ATA

2.09

218

.355

019

.490

of u

nrel

ated

don

atio

nN

O D

ATA

2111

50

1.32

5

DO

NAT

ION

of d

onat

ion

- A

utol

ogou

s10

828

035

3.21

8

of d

onat

ion

- A

lloge

nic

737

461

1.66

4

of d

onat

ion

- A

lloge

nic,

rel

ated

715

01

747

of d

onat

ion

- A

lloge

nic,

unr

elat

ed0

2246

091

7

BA

NK

ING

of

CO

RD

BLO

OD

of u

nrel

ated

coo

rd b

lood

uni

ts c

olle

cted

NO

DAT

A1.

289

00

5.44

1

of u

nrel

ated

coo

rd b

lood

uni

ts d

istr

ibut

edN

O D

ATA

00

016

3

of u

nrel

ated

coo

rd b

lood

uni

ts a

t 31

.12

NO

DAT

A1.

712

00

16.1

62

of r

elat

ed c

oord

blo

od u

nits

col

lect

edN

O D

ATA

1.96

10

260

of r

elat

ed c

oord

blo

od u

nits

dis

trib

uted

NO

DAT

A0

0N

A0

of r

elat

ed c

oord

blo

od u

nits

at

31.1

2N

O D

ATA

15.4

990

NA

0

Tota

l N°

of c

oord

blo

od u

nits

col

lect

edN

O D

ATA

3.25

00

NA

5.44

1

Tota

l N°

of c

oord

blo

od u

nits

dis

trib

uted

NO

DAT

A0

0N

A16

3

Tota

l N°

of c

oord

blo

od u

nits

at

31.1

2N

O D

ATA

17.2

110

NA

16.1

62

TRA

NS

PLA

NT

of t

rans

plan

ts -

A

utol

ogou

s79

180

NA

3.00

3

of p

atie

nts

tran

spla

nted

-

Aut

olog

ous

7718

031

0

of t

rans

plan

ts -

A

lloge

nic

110

55N

A1.

769

of p

atie

nts

tran

spla

nted

-

Allo

geni

c11

010

160

of t

rans

plan

ts -

A

lloge

nic,

rel

ated

80

0N

A74

8

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, r

elat

ed8

00

10

of t

rans

plan

ts -

A

lloge

nic,

unr

elat

ed3

055

NA

1.02

1

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, u

nrel

ated

30

1015

0

59

Page 62: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N H

PC

CEL

LS -

YEA

R 2

011

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

Cou

ntry

GER

MA

NY

GR

EEC

EH

UN

GA

RY

IREL

AN

DIT

ALY

LATV

IALI

THU

AN

IALU

XEM

BO

UR

GM

ALT

A

Pop

ulat

ion

(Fon

t: eu

rost

at)

81.7

51.6

0211

.309

.885

9.98

5.72

24.

480.

858

60.6

26.4

422.

074.

605

3.24

4.60

151

1.84

041

7.61

7

CAT

EGO

RY

OF

DAT

ATY

PE

OF

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

NO

DAT

A

PO

TEN

TIA

L D

ON

ATIO

NA

ND

SEA

RC

HIN

G IN

TH

EN

ATIO

NA

L R

EGIS

TRIE

SN

° of

pot

entia

l don

ors

at 3

1.12

NO

DAT

A33

.737

1.24

033

4.77

26.

592

0

of c

oord

blo

od u

nit

at 3

1.12

NO

DAT

A1.

176

1.25

226

.698

765

0

of s

earc

hes

requ

este

dN

O D

ATA

191

03.

594

144

0

of u

nrel

ated

don

atio

nN

O D

ATA

790

735

390

DO

NAT

ION

of d

onat

ion

- A

utol

ogou

s13

.384

NO

DAT

A1.

318

5.08

228

411

7

of d

onat

ion

- A

lloge

nic

10.9

170

01.

219

670

of d

onat

ion

- A

lloge

nic,

rel

ated

1.11

00

093

524

0

of d

onat

ion

- A

lloge

nic,

unr

elat

ed9.

807

00

283

430

BA

NK

ING

of

CO

RD

BLO

OD

of u

nrel

ated

coo

rd b

lood

uni

ts c

olle

cted

2.74

20

021

.820

00

of u

nrel

ated

coo

rd b

lood

uni

ts d

istr

ibut

ed35

00

960

0

of u

nrel

ated

coo

rd b

lood

uni

ts a

t 31

.12

NO

DAT

A1.

176

034

.836

00

of r

elat

ed c

oord

blo

od u

nits

col

lect

ed20

079

7333

921

30

of r

elat

ed c

oord

blo

od u

nits

dis

trib

uted

60

18

00

of r

elat

ed c

oord

blo

od u

nits

at

31.1

2N

O D

ATA

036

722

2.50

371

80

Tota

l N°

of c

oord

blo

od u

nits

col

lect

ed2.

762

079

7322

.159

213

0

Tota

l N°

of c

oord

blo

od u

nits

dis

trib

uted

410

110

40

0

Tota

l N°

of c

oord

blo

od u

nits

at

31.1

2N

O D

ATA

1.17

636

722

37.3

3971

80

TRA

NS

PLA

NT

of t

rans

plan

ts -

A

utol

ogou

s3.

893

NO

DAT

A79

3.00

279

0

of p

atie

nts

tran

spla

nted

-

Aut

olog

ous

3.31

90

792.

377

710

of t

rans

plan

ts -

A

lloge

nic

3.09

897

101.

690

670

of p

atie

nts

tran

spla

nted

-

Allo

geni

c2.

928

010

1.56

464

0

of t

rans

plan

ts -

A

lloge

nic,

rel

ated

962

01

935

240

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, r

elat

ed87

20

184

521

0

of t

rans

plan

ts -

A

lloge

nic,

unr

elat

ed2.

136

979

755

430

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, u

nrel

ated

2.05

60

971

943

0

60

Page 63: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N H

PC

CEL

LS -

YEA

R 2

011

EUR

OP

EAN

UN

ION

CO

UN

TRIE

S

Cou

ntry

NET

HER

LAN

DS

POLA

ND

POR

TUG

ALR

OM

ANIA

SLO

VAK

IASL

OVE

NIA

SPAI

NSW

EDEN

U. K

.

Pop

ulat

ion

(Fon

t: eu

rost

at)

16.6

55.7

9938

.200

.037

10.5

72.1

5721

.413

.815

5.39

2.44

62.

050.

189

46.1

52.9

269.

415.

570

62.4

98.6

10

CAT

EGO

RY

OF

DAT

ATY

PE

OF

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

PO

TEN

TIA

L D

ON

ATIO

NA

ND

SEA

RC

HIN

G IN

TH

EN

ATIO

NA

L R

EGIS

TRIE

SN

° of

pot

entia

l don

ors

at 3

1.12

262.

041

277.

938

NO

DAT

A93

.366

NO

DAT

AN

O D

ATA

of c

oord

blo

od u

nit

at 3

1.12

632

7.25

93.

222

52.3

77N

O D

ATA

NO

DAT

A

of s

earc

hes

requ

este

d90

2*2.

808

02.

349

NO

DAT

AN

O D

ATA

of u

nrel

ated

don

atio

n13

814

70

733

NO

DAT

AN

O D

ATA

DO

NAT

ION

of d

onat

ion

- A

utol

ogou

sN

O D

ATA

395

2.02

91.

675

502

NO

DAT

A

of d

onat

ion

- A

lloge

nic

282

207

1.60

91.

250

98N

O D

ATA

of d

onat

ion

- A

lloge

nic,

rel

ated

144

781.

609

510

NO

DAT

AN

O D

ATA

of d

onat

ion

- A

lloge

nic,

unr

elat

ed13

812

90

740

NO

DAT

AN

O D

ATA

BA

NK

ING

of

CO

RD

BLO

OD

of u

nrel

ated

coo

rd b

lood

uni

ts c

olle

cted

464

10.9

500

5.86

11.

240

7.86

9

of u

nrel

ated

coo

rd b

lood

uni

ts d

istr

ibut

ed0

50

392

6N

O D

ATA

of u

nrel

ated

coo

rd b

lood

uni

ts a

t 31

.12

997

7.26

422

52.7

932.

933

NO

DAT

A

of r

elat

ed c

oord

blo

od u

nits

col

lect

ed5.

823

11.9

7617

.549

30

18.5

01

of r

elat

ed c

oord

blo

od u

nits

dis

trib

uted

42

03

0N

O D

ATA

of r

elat

ed c

oord

blo

od u

nits

at

31.1

236

.527

58.1

7767

.625

00

NO

DAT

A

Tota

l N°

of c

oord

blo

od u

nits

col

lect

ed6.

287

22.9

2617

.549

5.86

41.

240

26.3

70

Tota

l N°

of c

oord

blo

od u

nits

dis

trib

uted

47

039

56

NO

DAT

A

Tota

l N°

of c

oord

blo

od u

nits

at

31.1

237

.524

65.4

4167

.647

52.7

932.

933

NO

DAT

A

TRA

NS

PLA

NT

of t

rans

plan

ts -

A

utol

ogou

sN

O D

ATA

327

01.

675

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

-

Aut

olog

ous

NO

DAT

A31

60

039

7N

O D

ATA

of t

rans

plan

ts -

A

lloge

nic

377

134

099

7N

O D

ATA

NO

DAT

A

of p

atie

nts

tran

spla

nted

-

Allo

geni

c34

912

60

025

9N

O D

ATA

of t

rans

plan

ts -

A

lloge

nic,

rel

ated

144

680

510

NO

DAT

AN

O D

ATA

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, r

elat

ed13

563

00

NO

DAT

AN

O D

ATA

of t

rans

plan

ts -

A

lloge

nic,

unr

elat

ed23

366

048

7N

O D

ATA

NO

DAT

A

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, u

nrel

ated

214

630

0N

O D

ATA

NO

DAT

A

61

Page 64: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N H

PC

CEL

LS -

YEA

R 2

011

OTH

ER C

OU

NTR

IES

Cou

ntry

CR

OAT

IAIC

ELA

ND

MA

CED

ON

IAM

OLD

OVA

NO

RW

AYSW

ITZE

RLA

ND

TUR

KEY

Pop

ulat

ion

(Fon

t: eu

rost

at)

4.41

2.13

731

8.45

22.

057.

284

4.92

0.30

57.

870.

134

73.7

22.9

88

CAT

EGO

RY

OF

DAT

ATY

PE

OF

DAT

AN

O D

ATA

NO

DAT

AN

O D

ATA

PO

TEN

TIA

L D

ON

ATIO

NA

ND

SEA

RC

HIN

G IN

TH

EN

ATIO

NA

L R

EGIS

TRIE

SN

° of

pot

entia

l don

ors

at 3

1.12

26.7

870

33.1

80N

O D

ATA

of c

oord

blo

od u

nit

at 3

1.12

1.56

10

40N

O D

ATA

of s

earc

hes

requ

este

d26

50

6.79

2N

O D

ATA

of u

nrel

ated

don

atio

n21

025

21.

032

DO

NAT

ION

of d

onat

ion

- A

utol

ogou

s99

40

400

NO

DAT

A

of d

onat

ion

- A

lloge

nic

1.93

80

40N

O D

ATA

of d

onat

ion

- A

lloge

nic,

rel

ated

390

0N

O D

ATA

of d

onat

ion

- A

lloge

nic,

unr

elat

ed1.

899

040

NO

DAT

A

BA

NK

ING

of

CO

RD

BLO

OD

of u

nrel

ated

coo

rd b

lood

uni

ts c

olle

cted

1.89

50

0N

O D

ATA

of u

nrel

ated

coo

rd b

lood

uni

ts d

istr

ibut

ed1

00

NO

DAT

A

of u

nrel

ated

coo

rd b

lood

uni

ts a

t 31

.12

1.81

50

0N

O D

ATA

of r

elat

ed c

oord

blo

od u

nits

col

lect

ed15

00

1.80

3

of r

elat

ed c

oord

blo

od u

nits

dis

trib

uted

00

07

of r

elat

ed c

oord

blo

od u

nits

at

31.1

214

00

011

.497

Tota

l N°

of c

oord

blo

od u

nits

col

lect

ed1.

910

00

1.80

3

Tota

l N°

of c

oord

blo

od u

nits

dis

trib

uted

10

07

Tota

l N°

of c

oord

blo

od u

nits

at

31.1

21.

955

00

11.4

97

TRA

NS

PLA

NT

of t

rans

plan

ts -

A

utol

ogou

s16

00

431.

135

of p

atie

nts

tran

spla

nted

-

Aut

olog

ous

132

043

0

of t

rans

plan

ts -

A

lloge

nic

450

086

5

of p

atie

nts

tran

spla

nted

-

Allo

geni

c39

00

0

of t

rans

plan

ts -

A

lloge

nic,

rel

ated

290

NO

DAT

A78

5

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, r

elat

ed23

00

0

of t

rans

plan

ts -

A

lloge

nic,

unr

elat

ed16

00

80

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, u

nrel

ated

160

00

62

Page 65: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N H

PC

CEL

LS -

YEA

R 2

011

LATI

NA

MER

ICA

N C

OU

NTR

IES

Cou

ntry

AR

GEN

TIN

AB

OLI

VIA

BR

ASI

LC

HIL

EC

OLO

MB

IAC

OST

A R

ICA

CU

BA

DO

MIN

ICA

NA

Pop

ulat

ion

(Fon

t: U

NFP

A)

40,6

10,1

196,

717

,346

,94,

711

,310

,1

CAT

EGO

RY

OF

DAT

ATY

PE

OF

DAT

AN

O D

ATA

NO

DAT

A

PO

TEN

TIA

L D

ON

ATIO

NA

ND

SEA

RC

HIN

G IN

TH

EN

ATIO

NA

L R

EGIS

TRIE

SN

° of

pot

entia

l don

ors

at 3

1.12

of c

oord

blo

od u

nit

at 3

1.12

of s

earc

hes

requ

este

d

of u

nrel

ated

don

atio

n

DO

NAT

ION

of d

onat

ion

- A

utol

ogou

s

of d

onat

ion

- A

lloge

nic

of d

onat

ion

- A

lloge

nic,

rel

ated

of d

onat

ion

- A

lloge

nic,

unr

elat

ed

BA

NK

ING

of

CO

RD

BLO

OD

of u

nrel

ated

coo

rd b

lood

uni

ts c

olle

cted

of u

nrel

ated

coo

rd b

lood

uni

ts d

istr

ibut

ed

of u

nrel

ated

coo

rd b

lood

uni

ts a

t 31

.12

of r

elat

ed c

oord

blo

od u

nits

col

lect

ed

of r

elat

ed c

oord

blo

od u

nits

dis

trib

uted

of r

elat

ed c

oord

blo

od u

nits

at

31.1

2

Tota

l N°

of c

oord

blo

od u

nits

col

lect

ed

Tota

l N°

of c

oord

blo

od u

nits

dis

trib

uted

Tota

l N°

of c

oord

blo

od u

nits

at

31.1

2

TRA

NS

PLA

NT

of t

rans

plan

ts -

A

utol

ogou

s0

1018

216

1521

2

of p

atie

nts

tran

spla

nted

-

Aut

olog

ous

of t

rans

plan

ts -

A

lloge

nic

071

410

430

40

of p

atie

nts

tran

spla

nted

-

Allo

geni

c

of t

rans

plan

ts -

A

lloge

nic,

rel

ated

051

780

304

0

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, r

elat

ed

of t

rans

plan

ts -

A

lloge

nic,

unr

elat

ed0

197

240

NO

DAT

A0

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, u

nrel

ated

63

Page 66: Newsletter 2012

PR

ELIM

INA

RY

DAT

A O

N H

PC

CEL

LS -

YEA

R 2

011

LATI

NA

MER

ICA

N C

OU

NTR

IES

Cou

ntry

ECU

AD

OR

MEX

ICO

NIC

AR

AG

UA

PAN

AM

APA

RA

GU

AYP

ERU

UR

UG

UAY

VEN

EZU

ELA

Pop

ulat

ion

(Fon

t: U

NFP

A)

14,7

114,

85,

93,

46,

629

,43,

429

,4

CAT

EGO

RY

OF

DAT

ATY

PE

OF

DAT

AN

O D

ATA

PO

TEN

TIA

L D

ON

ATIO

NA

ND

SEA

RC

HIN

G IN

TH

EN

ATIO

NA

L R

EGIS

TRIE

SN

° of

pot

entia

l don

ors

at 3

1.12

of c

oord

blo

od u

nit

at 3

1.12

of s

earc

hes

requ

este

d

of u

nrel

ated

don

atio

n

DO

NAT

ION

of d

onat

ion

- A

utol

ogou

s

of d

onat

ion

- A

lloge

nic

of d

onat

ion

- A

lloge

nic,

rel

ated

of d

onat

ion

- A

lloge

nic,

unr

elat

ed

BA

NK

ING

of

CO

RD

BLO

OD

of u

nrel

ated

coo

rd b

lood

uni

ts c

olle

cted

of u

nrel

ated

coo

rd b

lood

uni

ts d

istr

ibut

ed

of u

nrel

ated

coo

rd b

lood

uni

ts a

t 31

.12

of r

elat

ed c

oord

blo

od u

nits

col

lect

ed

of r

elat

ed c

oord

blo

od u

nits

dis

trib

uted

of r

elat

ed c

oord

blo

od u

nits

at

31.1

2

Tota

l N°

of c

oord

blo

od u

nits

col

lect

ed

Tota

l N°

of c

oord

blo

od u

nits

dis

trib

uted

Tota

l N°

of c

oord

blo

od u

nits

at

31.1

2

TRA

NS

PLA

NT

of t

rans

plan

ts -

A

utol

ogou

s18

174

185

077

39

of p

atie

nts

tran

spla

nted

-

Aut

olog

ous

of t

rans

plan

ts -

A

lloge

nic

1014

111

00

1914

of p

atie

nts

tran

spla

nted

-

Allo

geni

c

of t

rans

plan

ts -

A

lloge

nic,

rel

ated

911

00

1914

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, r

elat

ed

of t

rans

plan

ts -

A

lloge

nic,

unr

elat

ed1

NO

DAT

A0

00

0

of p

atie

nts

tran

spla

nted

-

Allo

geni

c, u

nrel

ated

64

Page 67: Newsletter 2012

Good Practice Guidelines in the Process of Organ Donation.

Page 68: Newsletter 2012

Good Practice Guidelines in the Processof Organ Donation

That “Spain is the leader in organ donations” has become a national and international slogan. It is quite clear that our system has given ampleproof of effectiveness and soundness and that our donation and transplantation activity has become a reference worldwide and is motive ofpride for our professionals and our society. Furthermore, our system is also characterized by its continuous evaluation and improvement.

Our donation and transplantation activity, although growing in absolute terms, has remained stabilized in relative terms over the last decade.A significant number of patients are faced with long periods on the waiting list and, depending on the organ, 6 to 8% of these patients on thelist die before receiving a transplant.

We are also experiencing times of fortunate epidemiological changes and changes in how society treats and confronts the end of life, changesthat give rise to doubts on the stability over time of our brain death donation potential.

It was within this context that the initiative of the present project was born: Benchmarking applied to organ donation, specifically, to braindeath donation. ‘Benchmarking’ is a modern word used to refer to a practice that is as old as the human being: innately, we establish and tryto learn from those who do it the best. The project has tried to identify those differentiating factors that justify some excellence results in thebrain death donation process by our coordination team.

These factors are summarized in the present document with the single, and we believe commendable purpose, of helping our entire coordinationnetwork to improve their results in the process. These lines serve to acknowledge that this help is supported by the fantastic work carried outby the network and its continuing enthusiasm.

Rafael MatesanzDirector National Transplant Organization

Figure 1: Structure of the donation process inbrain death donation: ICU: Intensive care unit.

1 Camp RC. Benchmarking: The search for industry best practices thatlead to superior performance. Milwukee: Quality Press, American Societyfor Quality Control; 1989.

Management of the possible

donor inside the CU

Detection of the possible donor outside the CU

Obtaining consent to organ donation

11 22 33

Detection outside CU

Detection inside CU Evaluation Brain death

diagnosisObtaining consent

Donation Process after Brain DeathDonation Process after Brain Death

Maintenance

INTRODUCTION

Within the context of the Plan Donación 40 (Donation 40Plan) propelled by the National Transplant Organization(NTO) (in Spanish, Organización Nacional de Trasplantes)to improve the organ donation and transplant activity in ourcountry, one of the strategies proposed is that of identifying,disseminating and implementing better practices applied tothe brain death donation process.

The benchmarking1 methodology has been used in order toachieve this objective. This methodology consists in defininga process and/or subprocesses, construct some indicatorsthat represent the effectiveness in their development, identify

the study units (in this case, hospitals authorized for thedonation of the deceased persons) with the best indicators(references or benchmarks) and to investigate and describethe practices that may justify these excellence results,subsequently favoring their implementation, by adaptingthem to the needs and characteristics of other centers.

In order to put this initiative into practice, a committeeformed by hospital and regional transplant coordinators andby members of the ONT was summoned. This committeedesigned the project and participated in the writing of therecommendations derived from it. The list of the BenchmarkingCommittee members is given in Annex 1.

66

Page 69: Newsletter 2012

For this project, the brain death donation process within thehospital setting was structured into three subprocesses (Figure 1):

1. REFERRAL OF THE POSSIBLE DONOR TOCRITICAL UNITS (CU): Detection of possible donorsoutside of the CU has not been an usual area of workin our setting, at least not in a generalized way. However,early detection and subsequent referral to the CU ofpossible donors may account for important differencesin the potential for brain death donation and therefore,in the final outcome of the process. The possible donorwas defined as a person with serious brain damageand possible evolution to brain death in a shortperiod of time. The indicator used to evaluateeffectiveness in this phase of the donation process wasthe percentage of deaths in the CU out of all the deathsin the hospital with at least one of a series of ICD-9codes among their primary or secondary diagnoses.This series of codes represents the etiology of 95% ofbrain deaths in our country.2

2. MANAGEMENT OF THE POSSIBLE DONOR INTHE CU: This is a subprocess which, in turn, includesa series of phases. Specifically, these are the detectionof the potential intra-hospital CU donor, clinicalevaluation and maintenance of a person with braindeath, as well as its diagnosis. As an indicator of theeffectiveness of this subprocess, the percentage ofappropriate donors for the extraction (pending familialconsent) was calculated out of the total number ofpersons with clinical examination consistent with braindeath within the CU. The data were obtained fromthe Quality Assurance Program in the Donation Process.3

3. OBTAINING CONSENT TO PROCEED TODONATION: Effectivity in this phase was evaluatedusing the percentage of consents to donation obtainedfrom the total number of adequate donors for theextraction, pending consent. Once again, the dataneeded for the construction of the indicator wereobtained from the Quality Assurance Program in theDonation Process.

The study setting included all those hospitals authorized fororgan donation in Spain. In order to participate in the project,the hospitals had to fulfill the requirement of havingparticipated in the Quality Assurance Program in the Donation

Process for at least 3 years out of the 5 included in the studyperiod, this including the years 2003 to and including theyear 2007. A total of 104 hospitals participated in the study,this number accounting for 68% of the hospitals authorizedfor donation in our country, although these hospitals accountedfor approximately 80% of the donors of the period studied.

After having constructed the indicators for each one of theparticipating hospitals, each one of the subprocesses andeach one of the years of study, those centers with excellenceresults in each one of the phases were identified, consideringthose determining hospital factors of the value of eachindicator (homotecia elements). Next, a questionnaire designedfor the description of their practices was sent to the intra-hospital coordination teams of these centers. Each one ofthese hospitals was visited by two members of the benchmarkingCommittee, and the corresponding questionnaire was filledout between them and the hospital coordination of the center.After, the Benchmarking committee analyzed and discussedthese questionnaires in order to extract information on thepractices that could justify these excellence results.

As a consequence of this exercise, the Committee has elaborateda series of recommendations to achieve greater effectivenessin the donation process in brain death and that are expressedin this document. A justification has been provided for eachone of the recommendations, mentioning the description ofthe findings in the hospital selected by their results, whenpertinent. It is important to stress that it was not aimed tooffer detailed step-by-step information of each one of thesubprocesses analyzed but rather of those actionsdifferentiating them from those performed in the rest ofthe hospitals, probably keys for obtaining excellent results.

The recommendations derived from this project are aimedat the entire coordination network, at the hospitaladministrations and at the heads of the hospital units, directlyor indirectly involved in the donation process.4

The purpose is to communicate these practices so that therecipients of these recommendations can evaluate the possibilityof incorporating them as far as possible and with the necessaryadaptations to their work methodology.

RECOMMENDATION ON THE COMPOSITION OFTHE HOSPITAL COORDINATION TEAM

RECOMMENDATION 1: THE NUMBER OF MEMBERSAND THE COMPOSITION OF THE COORDINATIONTEAMS SHOULD BE ADAPTED TO THECOORDINATION NEEDS OF EACH HOSPITAL

Addressed to: Hospital Administration, CU responsible persons,Hospital Transplant Coordination; Regional TransplantCoordination.

There is a variable number of members and composition ofthe coordination team in the hospitals selected based on thecoordination needs of each hospital. The number andcharacteristics of the teams have varied over time, thisresponding to the characteristics of each hospital.

67

2 Cuende, N, Sánchez, J, Cañón, JF, et al. Mortalidad hospitalaria enunidades de críticos y muertes encefálicas según los códigos de laClasificaci n Internacionalla Clasificación Internacional de Enfermedades.Med Intensiva, 2004; 23(1): 1-10.

3 Programa de Garantía de Calidad en el Proceso de la Donación. Webpage of the Organización Nacional de Trasplantes. Available in: Lastaccess: November 2010.

4 Those readers of this guide who are interested in having more detailedinformation on the methodology used, on the actions performed inthe hospitals identified in this study, on the protocols or guidelines usedin them, or any additional information, please do not hesitate to consultat: [email protected]

Page 70: Newsletter 2012

It is very important for the regional coordinator and existingcoordination team to have in-depth knowledge about thepossibilities and needs of the center. Furthermore, a very goodrelationship needs to be established with the hospitaladministration so that it understands the importance of thedonation and transplant and therefore understands and allotsthe necessary human and material requirements to coverthese activities.

In most of the centers selected, the team is formed by medicaland nursing personnel, with a greater percentage of physiciansin the first two subprocesses (referral to CU and intra-CUmanagement). Most of the medical staff are intensivists,although it should be stressed that in the first subprocessthere are only emergency physicians, and that in the secondsubprocess there are only intensivists with somenephrologists and in the third subprocess anesthetists. Theorigin of the nursing staff is more varied, these morefrequently being from surgery in the second indicator andfrom nephrology in the third.

RECOMMENDATION 2: ALL OF THE TEAMMEMBERS SHOULD RECEIVE TRAINING INCOORDINATION AND COMMUNICATION COURSES

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

Almost all of the coordination team members of the centersselected have taken training courses as transplant coordinatorsand communication courses. In many cases, the team membersare even teachers of these courses.

RECOMMENDATION 3: IT IS RECOMMENDED THATTHERE SHOULD BE A STABLE COORDINATIONTEAM OVER TIME

Addressed to: Hospital Administration; Hospital TransplantCoordination; Regional Transplant Coordination

In most of the coordination teams, there is at least oneprofessional with more than 10 years of coordinationexperience, the mean years of sonority of the team beingsuperior in the third subprocess, especially in regards to thenursing staff. Therefore, the existence of certain stability inthe coordination team is important. Experience plays anessential role in all of the project phases and very especiallyin the obtaining of consent for the donation.

RECOMMENDATION 4: IT IS RECOMMENDED THATTHERE BE PERSONS WITH HIERARCHICALRESPONSIBILITY IN THE HOSPITAL IN THECOORDINATION TEAM

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

In several of the hospitals selected as having excellence inthe three subprocesses, section/service chiefs were includedamong the medical staff making up the transplant coordinationteam. This occurred in a lower proportion in subprocess 1,and in half of the hospitals in the subprocesses 2 and 3. Therewere also supervisors among the nursing staff, especially inphases 2 and 3 of the donation process.

The recommendation provided does not imply that havinga position of responsibility in the hospital is a requirementto opt for transplant coordination. However, based on theobservation of the centers, it is deduced that matching thecoordination of the transplant and hierarchy facilitates decisionmaking and therefore, the improvement of the effectivenessin the donation process.

RECOMMENDATION 5: IT IS RECOMMENDABLEFOR THE COORDINATORS TO HAVE PARTIALDEDICATION TO THE COORDINATION TASKS

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

Most of the transplant coordination staff of the centersidentified have partial dedication to the coordination tasks,all of them in the case of subprocess two. In the hospitalsthat have a person with full-time dedication, this is generallybecause of the extra workload related with thetransplantations teams. Therefore, full-time dedication ofsome of the team members is recommended in thosecenters having a large work load associated to the transplantactivity.

In every case, the part time dedication of the professionalsis combined with activities related to their professionalcategory.

RECOMMENDATION 6: DUTIES SHOULD BE BASEDON THE CONCEPT OF AVAILABILITY, ASSUMINGRESPONSIBILITY IF A DONOR APPEARS

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

The number of duties is generally distributed based on thenumber of team members. In general, they are based moreon the availability concept than on that of physical presence,assuming responsibility when any donor appears. On occasions,the coordination duties are shared with care work, althoughthese remain on a second plane if a possible donor appears.

In the second subprocess, the duties are always performedby at least one physician.

RECOMMENDATION 7: THE COORDINATORS MUSTHAVE FULL DECISION CAPACITY

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

To achieve good results in the donation process, it is essentialto have full decision capacity regarding the possible donorin all of the phases of the process. It is desirable for theCoordination Team to be able to participate in the decisionmaking when the patient is admitted to the CU and theautonomy to request the necessary tests, to negotiate theavailability of the operating room, etc.

Depending on the structure of the coordination teams, thework distribution is different. The teams made up of aphysician-nurse share the clinical and logistic work,respectively.

68

Page 71: Newsletter 2012

RECOMMENDATION 8: IT IS ADVISABLE FOR THECOORDINATORS TO CONSIDER THAT THEY ARECORRECTLY PAID AND RECOGNIZEDPROFESSIONALLY

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

In practically all of the centers analyzed, the coordinationteams felt that they were somehow compensated for the largeworkload entailed by the coordination.

It is important for the administrations to recognize that thetransplant coordination work within the hospital is essential.That is why it is important to not only recognize this workeconomically but also as a merit within the professional career.

RECOMMENDATION 9: THE COORDINATION TEAMMUST BUILD AND MAINTAIN A GOODRELATIONSHIP WITH ALL THE HOSPITALPERSONNEL

Addressed to: Hospital Transplant Coordination; HospitalAdministration; Responsible for other units.

It is advisable for the coordination team to attend to all ofthe queries received from the hospital staff with a positiveattitude, helping to resolve any problem. They becomeSOLVERS AND FACILITATORS in all of the subjects relatedwith donation and transplant. The coordination team shouldbe known and be a reference for all the hospital, constitutingthe contact point for any problem or doubt related with thecoordination.

A good relationship must be maintained with the rest of thehospital and to make them aware about the donation andtransplant, facilitating the fluid course of all the process.Participation of several hospital services in the donationprocess is increasingly more frequent. It is considered to beadvisable to go towards collaboration-type models with theseunits, this favoring the sensitivity of the hospital as a whole.

Although it is considered important to act on all the hospital,some centers stress the importance of sharing their statisticswith the management and with other services, presenting themin a session, especially with those who most frequentlycollaborate with the transplant coordination (Laboratories,Pathology, Radiology, Emergency Service, Internal Medicine,Neurology, etc.).

RECOMMENDATIONS ON THE SUITABLE PROFILEOF THE HOSPITAL TRANSPLANT COORDINATION

As a common element to the three process phases in thehospitals selected, it has been seen that the coordinator formsa central axis around which all the donation process structureis constructed. Although some specific characteristics of theaspects analyzed appear in each one of the subprocesses, aseries of common traits and skills that frequently appear inthe individuals making up the coordination team of theselected hospitals are found. These are considered to beimportant in order to achieve excellent results in thecoordination tasks.

It is very difficult to speak about recommendations in thiscase, although these characteristics should be taken intoaccount when selecting a new transplant coordinator or whentraining them to improve these qualities. The fundamentalimportance of the work of the regional transplant coordinatorand the hospital administration in the selection of thehospital coordinators and their capacity to motivate themshould be stressed.

RECOMMENDATION 10: SUITABLE PROFILE OFTHE HOSPITAL TRANSPLANT COORDINATOR

Addressed to: Hospital Administration, Hospital TransplantCoordination; Regional Transplant Coordination.

MOTIVATION, DEDICATION AND WORK CAPACITY,words that are often heard when speaking about the activityof the coordinators interviewed, stand out. The enthusiasmand capacity to transmit this in order to successfully performthe work characteristic of the coordination and to achieve aGOOD RESPONSE IN THE FACE OF THE PRESSURE, sooften present in the donation process, is very positive.

Another highly valued quality is the CAPACITY FORRESPONSE. The components of the team should be personswith problem-solving capacity, this implying KNOWLEDGE,both of the hospital setting as well as the characteristics ofthe donation process, for which extensive training andpedagogic attitudes are required.

VERSATILITY is greatly related to the above, as each processis different. The search for solutions for the diversity ofsituations requires great CREATIVITY and CAPACITY FORIMPROVISATION. The coordinator should be capable ofcoping with any new situation that may arise.

It is very important for the members of the coordinationteam to have LEADERSHIP qualities, with PRESENCE ANDAVAILABILITY for the hospital staff, havingCOMMUNICATION SKILLS, GOOD CAPACITY FORRELATIONSHIPS AND EMPATHY being of great help.

RECOMMENDATIONS TO IMPROVE THEEFFECTIVENESS OF THE REFERRAL OF THEPOSSIBLE DONORS TO THE CRITICAL UNITS

RECOMMENDATION 11: THE EXISTENCE OF APROGRAM SPECIFICALLY ORIENTED TOWARDSTHE TREATMENT OF THE NEUROCRITICALPATIENT IMPROVES THE EFFECTIVENESS OF THEREFERRAL OF POSSIBLE DONORS TO THECRITICAL UNITS (CU)

Addressed to: Hospital Administration; Responsible personoutside the CU Units that attend to patients with severe braindamage; CU responsible persons, Hospital TransplantCoordination; Regional Transplant Coordination

The hospitals with the best results in this phase of the processstand out for having developed a program oriented towardsthe optimization of the treatment of the neurocriticalpatient, and not a specific program for referral to the CUof possible donors.

69

Page 72: Newsletter 2012

In the optimization of the treatment of the neurocriticalpatient, identification of the patient with severe brain damageand its early communication to the CU for the subsequentevaluation of the case and possible admission to said unitsis contemplated as a fundamental step.

In the following, the recommendations oriented towards thedevelopment, implementation and maintenance of saidprogram are specified.

Recommendation 11.1: In the development,implementation and maintenance of said program, allof units outside the CU units attending to patients withserious brain damage must be involved.

Addressed to: Hospital Administration; Responsible personsoutside the CU Units attending to patients with serious braindamage; CU responsible persons

For a program oriented towards the optimization of thetreatment of the neurocritical patient to function adequately,it is important for ALL OF THE UNITS OUTSIDE OF THECU THAT USUALLY ATTEND TO THE PATIENT WITHSERIOUS BRAIN DAMAGE to be involved in its development,implementation and maintenance.

The unit that must be counted on fundamentally is theEMERGENCY SERVICE. However, there are other units thatcan be potentially involved in this program, depending onthe type of hospital, such as the following:

• Neurosurgery Service• Neurology Service (including the emergingStroke

Units).• Internal Medicine Service

The possibility of including other hospitals, both privateand public, in this program, for which a specific hospitalacts as reference, for the care of neurocritical patients, shouldalso be evaluated.

On the other hand, participation of the CommunityEmergency Services should be promoted.

Recommendation 11.2: In the CUs, it is essential togenerate the habit of decisions based on discussion andfor which a consensus has been reached in regards tothe action for each patient, in general, and in regards tothe neurocritical patient and possible donor, specifically.

Addressed to:Responsible persons and personnel of the CUs.

Generating the habit of making decisions after having adiscussion and reaching a consensus can be achieved byholding periodic clinical sessions that include all of the CUpersonnel. However, it is important to favor fluidcommunication within the units as well as outside of thesesessions. Doing so helps to generate common practices andattitudes, including those regarding organ donation.

Recommendation 11.3: The donation should be includedin the CU service portfolio.

Addressed to: Hospital Administration; Regional TransplantCoordination; CU responsible persons

In relationship to the organ donation, in order to favorcommon attitudes in the hospital and within the CUs, it isvery important for the institution to consider it as aCOMPREHENSIVE MEDICAL PROCESS WITHIN THEPORTFOLIO OF THE CU SERVICES.

Recommendation 11.4: It is recommendable toimplement an action protocol oriented towards theidentification of patients with serious brain damageand its early communication to the CUs.

Addressed to: Hospital Administration; Responsible personsoutside the CU Units attending patients with serious braindamage; CU responsible persons. Hospital TransplantCoordination; Regional Transplant Coordination; Care EthicsCommittee.

It is important for the hospital to have an action protocoloriented towards the identification of patients with seriousbrain damage and its immediate communication to the CUs.Such a protocol does not necessarily imply the admission ofthe patient in the CU. However, it does imply the evaluationof the case and therefore of the individual benefit of eachadmission with therapeutic objective or donation, accordingto the patient’s baseline condition and prognosis. Regardingthis action protocol:

• It should be put into practice as a CARE CONCEPT, withthe specific purpose of optimizing the management of theneurocritical patient, and in which this type of patientsare considered to be of PRIORITY.

• All of the units attending to this type of patients shouldparticipate in its elaboration. It must be a protocol that hasbeen reached by CONSENSUS.

• The CLINICAL TRIGGERS that should activate thecommunication of the existence of these patients to the CUby the units outside the CU unit must be clearly defined.Specifically, the protocol should specify what the startingpoint is on the Glasgow Scale (e.g. ≤8) to activate thiscommunication. Furthermore, this communication shouldalways occur, INDEPENDENTLY OF THE PATIENT’SAGE, ASSOCIATED COMORBIDITY AND PROGNOSIS.

• Once the clinical trigger has been specified, the protocolshould detail the action that the physician and/or nurse whoidentifies the corresponding case much carry out and specialemphasis should be placed on the NOTIFICATION SYSTEM(IMMEDIATE CALL), using the mechanism foreseen in thehospital, to the CU.

• The action protocol must also contemplate the IMMEDIATECALL TO THE TRANSPLANT COORDINATION TEAMWHEN THERE ARE POSSIBLE DONORS, if this is notautomatically represented in the previously-mentioned CU.This call can be applied to all patients with SERIOUS BRAINDAMAGE and not be exclusively limited to possible donors.The call to Transplant Coordination can be made either directlyfrom the unit outside of the CU Unit that has identified the

70

Page 73: Newsletter 2012

case or from the CU once alerted. It is recommendable forthe Transplant Coordination to form a part of the decision-making process for the admission of possible donors in theCU, this being especially important in those cases in whichthere are doubts about the presence of absolute or relativecontraindications for the donation. In this way, the TransplantCoordinators can make an early and individualized evaluationof the cases, which facilitates the decision for the rest of theunits involved. In any case, the intervention of the TransplantCoordination must always be understood as by consensuswith all the professionals involved.

• It should be implemented INDEPENDENTLY OFWHETHER THE POSSIBLE DONOR IS either inside andoutside of the hospital (hospitalization units, emergencies,peripheral hospitals, etc.).

• It should be AVAILABLE IN WRITING.

• The protocol should include the POSSIBILITY OF ORGANDONATION as a medical reason for admission of a patientin the CU.

• The INFORMATION TO THE FAMILY on the prognosisand admission of a patient in a CU as a possible donorshould be TRUTHFUL and be provided CLEARLY,ALTHOUGH PROGRESSIVELY, AND SHOULD BEADAPTED TO THE RHYTHM OF ASSIMILATION OFTHE SITUATION. Therefore, it is recommended to makean individualized evaluation of the time and circumstancesin which this information is provided.

• The TRAINING ACTIVITY oriented at its practicalimplementation, an activity that must be aimed at unitsthat attend to patients with serious brain damage (andperipheral hospitals and community emergency services,if appropriate), should be promoted. The distribution ofTRAINING MATERIAL on this action protocol is veryadequate. Training material must include decision algorithmsthat stand out for their SIMPLICITY AND RAPIDUNDERSTANDING.

Recommendation 11.5: It is recommendable to haveprotocols on the limitation of life support treatment(LLST)

Addressed to: CU ad hoc Committee; Care Ethics Committee

These protocols must also be by CONSENSUS with all theCU staff. A MULTIDISCIPLINARY committee should beavailable for its preparation, including the nursing staff andexperts in bioethics.

The protocol should specify the importance of decisionmaking reached by consensus for the application of the LLST,in which all the personnel attending to the correspondingpatient are involved.

The existence of these protocols greatly helps the staffparticipating in the admission of possible donors in the CUin clinical decision making, systematization of the information

to be provided to the relatives of the possible donors andthe action to take if there is no evolution to brain death.

Recommendation 11.6: Performing audits outside theCU units to evaluate and monitor the effectiveness ofreferral to the CU of possible donors and identify areasof improvement is a recommendable activity

Addressed to: Hospital Administration; Responsible CU;Responsible person outside the CU units that attend to patientswith serious brain damage; Hospital Transplant Coordination;Regional Transplant Coordination

The performing of periodic audits consisting in theretrospective evaluation of clinical histories of patientsattended to outside the CU units that attend to neurocriticalpatients is a necessary task to evaluate and monitor theeffectiveness of this phase of the process and to identify areasof possible improvement. In most of the cases, said auditshould be done by consensus with the units involved andwith the sole purpose of continuing improvement.

This work can be extended to the peripheral, public andprivate hospitals (and their critical units) for which a certaincenter is of reference.

Recommendation 11.7: It is recommendable to managethe CU resources in such a way as to facilitate care tothe possible donor.

Addressed to: Responsible persons outside the CU Unitsattending to patients with serious brain damage; CU responsibleperson. Hospital Transplant coordination

BED AVAILABILITY for admission of the possible donor tothe CU is considered one of the main limitations for goodeffectiveness in this donation process phase. The generalizationof the concept of neurocritical patient (including possibledonors) as a priority patient is of special relevance. This mustbe complemented with good management of the CU beds,which is generally sufficient to solve this potential problem,including the authorization of beds belonging to the intermediateunits. In this sense, the support of the Center administrationis fundamental. Under the possibility of lack of beds in a CUand a possible donor identified outside of the unit:

• The development of the donation process outside of theCU must be facilitated with adequate cooperation betweenthe CU-unit outside of the CU-Transplant Coordination.

• When it is impossible to carrying out any of the previousmeasures, it is recommended to negotiate the transfer ofthe possible donor to a nearby hospital with immediatecapacity of admission in the CU.

RECOMMENDATION 12: THE DEVELOPMENT OFTRAINING ACTIONS, PROMOTION, AND EDUCATIONAND DONATION MATERIAL AND TRANSPLANTAIMED AT THE PROFESSIONALS OF THE CU ANDTHE UNITS OUTSIDE OF THE CU THAT ATTEND TONEUROCRITICAL PATIENTS IS RECOM MENDABLE.

Addressed to: Hospital Administration; CU responsible person;Responsible persons outside the CU Units attending to patientswith serious brain damage; Hospital Transplant Coordination

71

Page 74: Newsletter 2012

The CONCEPT OF DONATION must be promoted as:

• A MEDICAL PROCESS THAT FORMS A PART OF THEUSUAL END-OF-LIFE CARE

• MEDICAL CAUSE OF ADMISSION IN A CU

• SHARED PROCESS, not exclusive to the TransplantCoordination.

In the following, specific recommendations are providedaimed at promoting this concept in the hospital setting,in general, and in the outside of the CU setting,specifically.

Recommendation 12.1: The development of trainingsessions oriented at the units outside of the CU thatattend to neurocritical patients on the donation processand transplant is a highly recommendable activity.

Addressed to: Responsible persons outside the CU Unitsattending to patients with serious brain damage; TransplantHospital Coordination; Hospital Administration

The performing of TRAINING SESSIONS oriented at theunits outside of CU that attend to neurocritical patients(including peripheral hospitals and community emergencyservices, if appropriate) on the donation process and transplantis a highly recommendable activity. These training sessionsmust systematically include all the staff, both medical andnonmedical, of these units.

Within the training sessions, the teaching support thatmay be provided to these units in aspects regarding THEDYING PROCESS AND ACCOMPANYING MOURNINGby The Transplant Coordination staff can be important.This is an area in which the Transplant Coordinators haveprivileged training and experience and which, at the sametime, is fundamental in the day-to-day work of theprofessionals in the units outside of the CU that attend tocritical patients.

This training effort can be complemented with the distributionof WRITTEN TRAINING MATERIAL to the units outsideof the CU on donation and transplant. In this sense, thematerial produced periodically by the hospital, regional andnational coordinations, should be proactively distributedamong the personnel of the Units outside of the CU thatattend to patients with serious brain damage.

Recommendation 12.2: The performance of periodicvisits by the Transplant Coordination to the unitsoutside of the CU that attend to patients with seriousbrain damage is fundamental.

Addressed to: Hospital Transplant Coordination

The performance of PERIODIC VISITS to the units outsideof the CU that attend to neurocritical patients by TransplantCoordination is fundamental. In this way, fluid personalrelationships are promoted and a reminder function is madeon the important role played by the personnel of these unitsin the early detection phase and that of referral of the potentialdonors to the CU.

Recommendation 12.3: Performing continuing feedbackwork to the units outside of the CU on the donationand transplant activity is important

Addressed to: Hospital Transplant Coordination; RegionalTransplant Coordination

THE PERIODIC FEEDBACK TO THE UNITS OUTSIDE OFTHE CU on the donation and transplant activity is an activityconsidered to be very important, either carried out withinthe previously-mentioned training sessions or in a moreinformal way. This feedback should consist in providinginformation on:

• The donation and results of the transplant, in general.

• The specific cases of potential donors referred to the CUin the corresponding hospital: if they become donors ornot, the reasons and the patients who have benefited fromthe donation act.

This activity is considered important in order for the personnelfrom the units outside of the CU who attend to neurocriticalpatients to feel that they are fully involved in the process andto generate a “feeling of pride” in said personnel by theiractive participation.

The ways of reinforcing this feedback activity are varied. Forexample, mention can be made of the sending of letters ina short time period by the Transplant Coordination to theunit that has participated in the detection of a potentialdonor and in its referral to the CU, informing them of theresult of the donation, when it exists.

RECOMMENDATIONS TO IMPROVE EFFECTIVENESSIN THE MANAGEMENT OF THE POSSIBLE DONORIN THE CRITICAL CARE UNITS

RECOMMENDATION 13: ALL THE MEDICALPROFESSIONALS FROM THE CRITICAL UNITS MUSTACTIVELY PARTICIPATE IN THE DETECTION OFPOSSIBLE DONORS WITHIN THE CUs

Addressed to: CU medical professionals, CU responsible persons,Hospital Transplant Coordination

In regards to the detection of potential donors, it isrecommended that all of the CU medical professionals shouldbe actively involved in the identification of patients withserious brain damage, in general, and in the identificationof potential donors, specifically. In order to facilitate thisinvolvement:

• Spreading the idea that the DONATION FORMS A PARTOF THE CU FUNCTIONS and of the END-OF-LIFE CARESis essential. To do so, it is important for the hospital torecognize that the donation forms a part of the CU serviceportfolio.

• It would also be useful to hold CLINICAL SESSIONS INTHE CU IN WHICH THE CASES ADMITTED TOHOSPITAL ARE DISCUSSED, including those with possibleevolution to brain death. In these sessions, it is importantto facilitate decision-making reached by consensus on the

72

Page 75: Newsletter 2012

clinical approach, the possibility of donation or the needfor LLST, according to the circumstances of the case.

RECOMMENDATION 14: TO FACILITATEDETECTION OF THE POSSIBLE DONORS, IT ISRECOMMENDABLE FOR THE HOSPITALTRANSPLANT COORDINATOR PER SE TO BEINVOLVED IN THE FOLLOW-UP OF ALL THENEUROCRITICAL PATIENTS

Addressed to: CU medical professionals, CU responsible persons,Hospital Transplant Coordination

Several of the hospitals with better results in this phase ofthe process consider it to be advisable for THE TRANSPLANTCOORDINATOR (WHEN HE/SHE IS AN INTENSIVIST)TO ALSO BE ATTENTIVE TO THE FOLLOW-UP OF EVERYNEUROCRITICAL PATIENT in order to facilitate the detectionof possible donors in the CU.

RECOMMENDATION 15: IT IS ESSENTIAL THAT ALLOF THE MEDICAL PROFESSIONALS OF THE CUsTAKE RESPONSIBILITY FOR THE DIAGNOSIS OFBRAIN DEATH, THE CLINICAL EVALUATION ANDMAINTENANCE OF THE POTENTIAL DONOR, THISALWAYS BEING DONE IN COLLABORATION WITHTHE TRANSPLANT COORDINATOR

Addressed to: CU medical professionals, CU responsible persons,Hospital Transplant CoordinationIt is essential for the medicalprofessionals of the CUs to take responsibility of a potentialdonor in all of the phases of the process, counting on, ofcourse, adequate nursing staff at all times and on the TransplantCoordinator.

The decision to rule out a donor should always be reachedby consensus with the Transplant Coordinator. Although itis important for all the medical professionals of the CUs toparticipate in the evaluation of the potential donors and tobe familiarized with absolute contraindications regardingorgan donation, said evaluation should always be performedin close collaboration with the Transplant Coordinator. Inthis way, losses in the process due to inadequate medicalcontraindications are avoided or minimized.

RECOMMENDATION 16: IT IS IMPORTANT TODEFINE THE PERMANENT AVAILABILITY OFMEDICAL SPECIALISTS IN NEUROLOGY,NEUROSURGERY AND/OR NEUROPHYSIOLOGYFOR THE DIAGNOSIS OF BRAIN DEATH

Addressed to: Hospital Administration; Hospital TransplantCoordination; Regional Transplant Coordination

If this center cannot count on the permanent presence ofthese professionals (24h/365d), specifying the shift of thespecialist available as well as the way to contact them inorder to be able to request their collaboration, if necessary,is recommended. This information should be easily assessablefor all of the CU staff.

RECOMMENDATION 17: IT IS RECOMMENDEDTHAT THE HEALTH CARE CENTER HAVE ATRANSCRANIAL DOPPLER

Addressed to: Hospital Administration; CU responsible person

When providing the diagnosis of brain death, it is essentialto be able to count on the possibility of a flow test. In thissense, it is recommended that the centers authorized for thedonation process should have a transcranial Doppler as wellas professionals trained in the management and interpretationof this diagnostic technique.

RECOMMENDATION 18: IT IS ESSENTIAL TOPERMANENTLY HAVE AVAILABLE AMICROBIOLOGY LABORATORY AND A PATHOLOGYLABORATORY

Addressed to: Hospital Administration; Regional TransplantCoordination; Hospital Transplant Coordination

If the center does not have a permanent microbiologylaboratory or a pathology laboratory (24h/365d), then it isrecommended that this center should have a plan establishedfor the sending of samples to a reference laboratory. In thisway, the need to improvise when faced with complicated orspecial situations when making an adequate clinical evaluationof a possible donor is avoided. This information should beeasily assessable to all of the CU personnel.

RECOMMENDATION 19: IT IS IMPORTANT TO HAVEWRITTEN PROTOCOLS REGARDING THEDETECTION, EVALUATION AND MAINTENANCEOF POSSIBLE DONOR AND THE DIAGNOSIS OFBRAIN DEATH

Addressed to: CU responsible persons; CU Medical Professionals,Hospital Transplant Coordination

Those hospital standing out for their effectiveness in theintra-CU management of possible donors have writtenprotocols regarding the different phases of the donationprocess that take place within the CUs.

It is not only recommendable to have these protocols butalso for the medical personnel or nonmedical personnel ofthe CUs to be familiarized with them, for the protocols tobe easily accessible to all of the professionals involved andthat these protocols be periodically updated.

Training should be carried out for all of the CU personnelthat would make it possible to put these protocols intopractice.

RECOMMENDATION 20: IT IS IMPORTANT TO HAVEA GOOD WORK ENVIRONMENT AND FLUIDCOMMUNICATION WITHIN THE CUs

Addressed to: CU responsible persons; CU Medical Professionals,Hospital Transplant Coordination

It has been seen that the best results are registered in unitswith a good work ambient between all of the professionalsinvolved. This facilitates the active involvement of all theprofessionals in the donation process.

Several aspects have been identified as having been identifiedby the professionals of the center selected as key points:

• Good work environment between the medical professio -nals.

73

Page 76: Newsletter 2012

74

• Good medical-nurse communication/relationship.• Team work.

RECOMMENDATION 21: CONTINUING EDUCATIONOF ALL THE PERSONNEL IN THE CRITICAL UNITSIN THE ORGAN DONATION PROCESS IS ANESSENTIAL ELEMENT

Addressed to: CU responsible persons; CU Medical Professionals,Regional Transplant Coordination; Hospital TransplantCoordination

It is recommended that specific and continuing educationin donation and transplant of all the health care professionalsworking in the CU be promoted.

The training of the resident physicians in the setting shouldbe encouraged.

It is recommended that the origin of this training effortshould begin on all the levels of health care administration:that is, national, regional and hospital.

RECOMMENDATIONS TO IMPROVE EFFECTIVENESSIN OBTAINING CONSENT FOR DONATION

RECOMMENDATION 22: THE INTERVIEW WITHTHE FAMILY MEMBERS OF THE POSSIBLE DONORSHOULD FOLLOW A SPECIFIC METHODOLOGYAND SHOULD BE PLANNED AS MUCH AS POSSIBLE

Addressed to: CU Responsible persons; CU Medical Professionals,Hospital Transplant Coordination

Although each interview is different, a methodology withsequential, clearly defined phases that should not be mixedshould be used.

Recommendation 22.1: The interview should always beprepared. It is important to obtain information on thefamily, plan the site where the interview will be conductedand how the death will be communicated, advise thefamily in good time and organize the necessary humanand material resources.

Addressed to: CU Personnel; Hospital Transplant Coordination

The centers consulted recommend preparing any aspectrelated with the interview that may influence its result,reducing the need to improvise as much as possible.

Those elements that these centers recommend to prepare aheadof time are mentioned in the following:

• It is important to speak with the professionals who haveattended to the possible donor to gather information onthe family (without interpreting or prejudging the result).It is possible to know in advance if it will be necessary tocount on cultural cooperators and/or translators, or whoare the persons who are necessary for the decision ondonation.

• It is recommended to communicate in good time to all ofthe direct family members regarding the importance of

their coming to the center to receive information regardingthe situation and prognosis of the patient. This request toappear makes it possible for all of those who should beincluded in the decision to come. If necessary, it should bestress that it is important that all of the family memberscome with sentences such as “It would be best if they come,”“it is better that I explain it to them.”

• When there are social, cultural or idiomatic type barriersor difficulties, the support of a cooperating person, translatorand friends of the possible donor with a greater level ofintegration or of religious references whose cooperationmay be beneficial for the family can be foreseen. Thesepersons should be previously informed about the donationso that they can support the family and maintain a favorableattitude and not be limited to making a simple translation.

• It is important that the family be gathered together in arelaxed atmosphere, where they can speak in privacy, andnot far from the donor, since they frequently may want tosee him/her.

• The interview should be prepared with the professionalwho is going to communicate the death. This is usuallythe medical professional who has been responsible for thepatient. However, if this is not possible, a medical professionalfrom the same service should be sought, ideally someonetrained in communication techniques. The informationthat will be given to the family and how to communicateit, including the communication of the death, should beprepared.

• If the condition of the donor or the situation of thefamily allows for it, it is preferable to avoid conductingthe interview at night. They are generally more restedand more receptive during daylight. (See recommendation24.2).

Recommendation 22.2: It is considered appropriate tonot limit the number of persons who participate inthe interview. All those persons who are important forthe decision should be present and contact should bemaintained with them.

Addressed to: CU personnel; Transplant Hospital Coordination

All those persons who are important when making thedecision should be present. The exclusion of anyone couldentail the risk of excluding those who are relevant.

It is recommendable to identify all those who, due to theirclose relationship to the donor or their leadership positionor capacity, may have greater influence in the decision ofthe group.

The coordinators should not lose contact with anyone inthe group. During the interview, the group should not beallowed to disintegrate. Therefore, if anyone wants to leavefor a short time, they should not be prevented from doingso (one of the coordinators can accompany this person), butthey should return, since a unanimous decision is desirable,without discrepancies within the group.

Page 77: Newsletter 2012

75

Recommendation 22.3: It is recommended thatprejudging the result of the interview should be avoidedand an attempt should always be made (except in thosecases in which it is known with certainty that thetransplant cannot be performed). Furthermore, nomaximum time for the interview should be pre-established.

Addressed to: CU Personnel; Hospital Transplant Coordination

The hospitals consulted answered unanimously that the interviewshould always be conducted, except when it is known thatthe transplant cannot be done, for example, when there areno appropriate recipients in the case of an infant donor.

The variability in the interview duration is considered to beenormous. Limits regarding the duration of the interviewshould not be established beforehand.

Recommendation 22.4: It is very important to establisha professional relationship of help that facilitates thenecessary trust so that the relatives accept the optionfor donation. To do so, it is essential to know and touse the communication tools

Addressed to: CU Personnel ; Hospital Transplant Coordination

Establishing a good relationship with the family based ontransparency, empathy, emotional support and therelationship of professional help is considered to be veryimportant. The relationship of help should be created withthe relatives from the beginning and maintained duringthe entire interview. It is also recommendable to usecommunication elements, such as open questions, reflectionof emotions, active listening or paraphrasis.

During the interview, it is advisable to allow them to speakwithout interfering while they are speaking and to respecttheir silences. Physical contact is important if the familyshows that they require it.

At the end of the interview, it is important to continuemaintaining the relationship of help to the relatives until theend. This should end with signs of condolence and affect,independently of its outcome.

Recommendation 22.5: The interview is structured intoa series of successive and independent sentences:initiation, communication of death, request for consentto donation, and completion. Different phases of theinterview should not be mixed and it is important tomake sure that the family has understood the fact ofdeath before requesting the consent.

Addressed to: CU Personnel ; Hospital Transplant Coordination

Several teams consulted recommend that the team thatintervenes in the interview should be made up of the medicalprofessional who has been responsible for the patient (oranother from the same service, if this is not possible) whowill be in charge of communicating the death and by twopersons from the transplant coordination team, usually onephysician and one nurse, with training in communication

techniques. Alternatively, if there are only two persons, onewill communicate the death and the other will request theconsent for donation.

It is considered to be very important to establish therelationship of help with the family from the beginning andto maintain it to the end, since according to the experienceof the centers interviewed, in addition to the support thatthis relationship supposes for the family in very difficultmoments, it increases the likelihood that the family willaccept the donation.

The medical professional who is responsible for the patientshould be the one who begins the interview and presentsthe coordinator team by their first and last names. However,that fact that they are transplant coordinators should notbe revealed, except under exceptional situations (for example,the previous request for donation by the family).

Once the interview has been initiated, the communicationof death can be made by the intensivist with the supportof the coordinators (See Recommendation 22.6.)

Once the death has been communicated, the responsibilityof directing the interview should undergo a change, so thatthe coordinators can assume a more important role in thecommunication with the family. The person who hascommunicated the death can leave the room and attend toother work, explaining it to the family.

Before going on to the request for donation, it is veryimportant for the coordinators to assure that the family hasunderstood the fact of the death. If this is not so, they shouldcontinue to give the necessary explanations that will helpthem to accept the situation, maintaining the relationshipof help. The family should set the rhythm. Only after thefamily expresses, through their manifestations of recoveryof emotional control and approach to action, that it hasunderstood and assumed the death of their relative, canthe coordinator continue with the next phase.

Recommendation 22.6: The communication of deathshould be made by the patient’s physician, who willanswer any questions the family may have. There is noclear recommendation on the communication of death,simply, or brain death.

Addressed to: CU Personnel ; Hospital Transplant Coordination

Once the presentations have been made, the communicationof the death should be made by the intensivist with thesupport of the coordinators who, apart from exceptions, willnot identify themselves as such at the beginning of thepresentations (See Recommendation 22.5)

It is recommended that the communication of death beginswith established communication formulae similar to “asyou already know, the situation of your relative was veryserious,” “unfortunately we have bad news,” or “the situation,unfortunately, has worsened,” that give rise to thecommunication and explanation of the death, answeringall of the questions asked by the relatives and encouraging,with open questions, the relatives to clarify their doubts.

Page 78: Newsletter 2012

There is no clear recommendation on the communicationof death, simply, or brain death.

Once the death has been communicated, it is recommendedthat the coordinators take charge of the interview, assuminga greater role in the communication with the family, askingabout any problems and needs they have and offering thenecessary help. As previously mentioned, the person whohas communicated the death can leave the room and attendto other tasks, explaining this to the family.

Recommendation 22.7: The request for consent fordonation should be made clearly, directly and plainlyby the coordinator, as an option, a right, a privilege,or way of helping others. This should always occurafter verifying that the family has understood the factof death.

Addressed to: Hospital Transplant Coordination

Before requesting the donation, it is very important for thecoordinators to ensure that the family has understood thefact of death and that they have no other problem or concernthat may be interfering with it. On the contrary, the problemsshould be discovered through open questions and support,explanations or different ways of approaching the problems(relationship of help) should be offered. As has already beenmentioned, the family should set the rhythm, and only whenthey have expressed, through their manifestations of recoveryof emotional control and action approach, that they haveunderstood and assumed the death of their relative, can thecoordinator continue on to the next phase.

The request for donation should be stated clearly, directlyand in plain language. Exaltation of values is important: itis recommended that an option, right, privilege, or apossibility of helping others be offered. It is very importantto ask what opinion the deceased had (or could have)regarding donation.

Recommendation 22.8: In the case of a negative response,rejection reversal techniques are recommended. Thefamily will establish when the interview ends.

Addressed to: Hospital Transplant Coordination

In the case of a negative response, the centers consulted useddifferent techniques:

• Asking the family to express the reasons for the rejection.Once they are expressed, they can be analyzed andappropriately refuted. Solidarity reasons can be used.

• If lack of empathy is detected, it is advisable to make a changein the person steering the interview and for that person toact in the background.

• Give them time, approaching arguments that seem importantfor the family and maintaining contact, leaving aside thedonation, without insisting on it, for some time.

• Identify the persons involved in the rejection and their rolewithin the family, attempting to communicate separatelywith the negative member, so that this member does nothide and reaffirm in the group and so that the discrepancycan be reduced, everyone assuming the final decision.

The family should set the limit of the interview. The centersconsulted state that they stop trying it when the family showsigns that there is no progression, empathy is lost, and orif it is not providing any benefit to them.

Recommendation 22.9: Regardless of the outcome ofthe interview, it should end with signs of condolencesand affect, maintaining the relationship of help untilthe final moment

Addressed to: CU Personnel ; Hospital Transplant Coordination

The relationship of help is a benefit for the family that shouldbe maintained until the end.

Recommendation 22.10: It is recommended that somedays later the family should be thanked for the donationthrough a letter or telephone call

Addressed to: Hospital Transplant Coordination

This makes it possible to formally close the relationshipestablished with the family and generate a positive opinionon the donation.

Recommendation 22.11: The interviews should bedocumented and then analyzed, especially the rejections

Addressed to: Hospital Transplant Coordination

Recording the activity performed makes it possible to evaluatethe opportunities to improve, since it facilitates the analysisa posteriori of the case and of the possible alternatives to theapproach taken. Furthermore, it makes it possible to provokean educational discussion in the team on ways to respondto the rejection presented.

RECOMMENDATION 23: IT IS IMPORTANT FORTHE TEAM INTERVENING IN THE INTERVIEW TOHAVE SPECIFIC TRAINING

Addressed to: Hospital Administration; CU responsible person;CU Medical Professional; CU Personnel ; Hospital TransplantCoordination; Regional Transplant Coordination

It is very important for the persons who participate in theinterview to have specific training for the roles they assume.These involve elevated difficulty and require specific attitudes.

Recommendation 23.1: It is advisable for the medicalprofessional who communicates the death to havetraining in the techniques of communicating bad news

Addressed to: Hospital Administration; CU responsible person;CU Medical Professional; Hospital Transplant Coordination

The teams interviewed consider that training in communicationof bad news is essential. If, due to exceptional circumstances,the medical professional selected does not have this training,the coordination team should carefully prepare the approachto the family, the information that must be given and onhow to communicate it (See recommendation 22.1.)

It is important for the co-coordinators to promote specifictraining of the professionals in the critical units in thesesubject matters through courses and seminars held withinthe hospital.

76

Page 79: Newsletter 2012

Recommendation 23.2: The transplant coordinationteam should have experience and receive continuingeducation in all of the aspects related with the interview

Addressed to: Hospital Administration; CU responsible person;CU Medical Professional; Hospital Transplant Coordination;Regional Transplant Coordination

The persons who request the consent for donation shouldbe transplant coordinators with specific training in donationand transplant, relationship of help and techniques ofcommunicating bad news. In order to renew and updateconcepts, the personnel of the centers consulted periodicallyreceive training, even if they have previously received thistraining.

At least one of the coordinators should have experience,which is highly considered by the centers.

Equally, in the centers consulted, the active participation ofthe nursing service belonging to the coordination teams inthe request is stated. Their skill to develop complicity andto establish relationship of help in some very difficult momentsis recognized.

It is important for the professionals involved to receive specifictraining in order to avoid the emotional overload that thistype of work may give rise to.

Recommendation 23.3: There is no clearrecommendation on the profile of the cooperatorpersonnel

Addressed to: Hospital Administration; CU responsible person;Hospital Transplant Coordination; Regional TransplantCoordination

Except for one of the hospitals with excellence results in theconsent obtaining phase for the donation, the centers do nothave their own cooperator personnel. The ideal situationwould be for the translator who generally cooperates withthe coordinators to receive specific training in donation andtransplant and in the relationship of help, and not be onlylimited to translating.

RECOMMENDATION 24: IT IS IMPORTANT TO HAVERESOURCES FOR CARRY OUT THE INTERVIEW

Addressed to: Hospital Administration; Responsible personoutside the CU units; Hospital Transplant Coordination

Recommendation 24.1: It is recommended to alwaysmake the interview in a separate place, with privacyand resources that cover the minimum needs

Addressed to: Hospital Administration; CU responsible person;Responsible person outside the CU units; Hospital TransplantCoordination

It is important to have privacy to allow the family to expresstheir emotions and freely communicate among themselvesand with the interviewers.

It is advisable to have resources that cover the minimum needs(telephone, handkerchiefs, water, some food, etc.)

Some centers consider it important to have several rooms

that make it possible to change sites if the coordinator

considers it to be necessary. For such effect, they distinguish

between the room for information to the family and the

mourning room.

It is recommended to conduct the interview in a place where

the family is not far from the donor. They may frequently

request to see the donor.

Recommendation 24.2: It is advised to conduct theinterview in the morning, with daylight

Addressed to: CU Medical Professionals; Hospital Transplant

Coordination

At this time of the day, they are generally more rested and

more receptive. However, it is not uncommon for reasons

to exist, such as emotional condition of the family, distance,

availability of flights, etc., that make it impossible to do so

in the morning. In these cases, the situation of the family

and the relationship of help established with them comes

first and the interviews should be made when necessary.

Recommendation 10:Recommendation 24.3: If thereare incentives for the family, it is recommended to notuse them as an argument to obtain donation or reversea rejection

Addressed to: Hospital Transplant Coordination

The centers consulted that may have incentives for the family,

such as transfer of the cadaver or coverage of some of the

funeral costs, do not use this argument to obtain consent.

This possibility should be commented, when it can be applied,

after having obtained consent for donation.

RECOMMENDATION 25: OTHERRECOMMENDATIONS OR SUGGESTIONS

Recommendation 25.1: It would be desirable to havecounseling available on material of interviews, religion,language, etc.

Addressed to: Hospital Transplant Coordination; Regional

Transplant Coordination; National Transplant Organization

Without detriment to the training received in the capacity

to improvise, the centers consulted consider that it would

be convenient to have specific counseling when there are

cultural, linguistic difficulties or others.

Recommendation 25.2: The relationship of help is a greatbenefit for the family. It should not only be applied todonation.

Some centers consider that the outcome of the relationship

of help is positive, and recommend that using it should not

be limited only to those cases in which the possibility of

donation.

77

Page 80: Newsletter 2012

ANNEX 1: BENCHMARKING COMMITTEE MEMBERS

Arráez Jarque, Vicente Hospital General Universitario de Elche

Bouzas Caamaño, Encarnación Coordinación Autonómica de Galicia (Regional Coordination of Galicia)

Castro de la Nuez, Pablo Coordinación Autonómica de Andalucía (Regional Coordination of Andalusia)

Coll Torres, Elisabeth Organización Nacional de Trasplantes (National Transplant Organization)

de la Concepción Ibáñez, Manuel Coordinación Autonómica de la Comunidad Valenciana (Regional Coordination ofthe Valencian Community)

de la Rosa Rodríguez, Gloria Organización Nacional de Trasplantes (National Transplant Organization)

Domínguez-Gil González, Beatriz Organización Nacional de Trasplantes (National Transplant Organization)

Elorrieta Goitia, Pilar Hospital de Cruces

Fernández García, Antón Hospital Universitario La Coruña

Fernández Renedo, Carlos Coordinación Autonómica de Castilla y León (Regional Coordination of Castilla y Leon)

Galán Torres, Juan Hospital Universitario La Fe

Getino Melián, María Adela Hospital Nuestra Señora de la Candelaria

Gómez Marinero, Purificación Hospital General de Alicante

Marazuela Bermejo, Rosario Organización Nacional de Trasplantes (National Transplant Organization)

Martín Delagebasala, Carmen Organización Nacional de Trasplantes (National Transplant Organization)

Martín Jiménez, Silvia Organización Nacional de Trasplantes (National Transplant Organization)

Martínez Soba, Fernando Coordinación Autonómica de La Rioja (Regional Coordination of La Rioja)

Masnou Burallo, Núria Hospital de Vall d’Hebrón

Rodríguez Hernández, Aurelio Coordinación Autonómica de Canarias

Salamero Baró, Pedro Hospital de Vall d´Hebrón

Sánchez Ibáñez, Jacinto Coordinación Autonómica de Galicia (Regional Coordination of Galicia)

Serna Martínez, Emilio Organización Nacional de Trasplantes

(National Transplant Organization) Special thanks is given to Adela Moñino Martínez, a psychologist from the DiputaciónProvincial (Regional Council) of Alicante, for her contribution to the design and writing of the questionnaire for the study onthe effectiveness in obtaining the consent to donation and the contents of the recommendations in the mentioned subprocess.

78

Page 81: Newsletter 2012

Co-operation between countries of the Black SeaArea (BSA Project): Development of the activities

related to donation and transplantation

Page 82: Newsletter 2012

Co-operation between countries of the Black Sea Area(BSA Project): Development of the activities related to

donation and transplantation

PROJECT BACKGROUND

The Council of Europe, based in Strasbourg (France), is aninter-governmental organisation that covers, by virtue of its47 member states, the entire European continent. Foundedin 1949, the Council of Europe promotes human rights,democracy and the rule of law. The work of the Council ofEurope in the area of organ transplantation started in the1980s. In particular, blood transfusion and organtransplantation activities are managed from the EuropeanDirectorate for the Quality of Medicines & HealthCare(EDQM), a Directorate of the Council of Europe. The EDQMis a leading organisation that protects public health bysupporting the development, implementation and applicationof quality standards for medicines and healthcare.

The European Committee on Organ Transplantation (CD-P-TO) is the steering committee in charge of organtransplantation activities at the EDQM. It actively promotesthe non-commercialisation of organ donation, the fightagainst organ trafficking and the development of ethical,quality and safety standards in the field of organ, tissue andcell transplantation. Its activities include the collection ofinternational data and monitoring of practices in Europe,the transfer of knowledge and expertise between organisationsand experts through training and networking and theelaboration of reports, surveys and recommendations.

The development of organ transplantation activities in thecountries of the Black Sea Area (BSA) date back from thelate 1970s but, from the early 1990s, they began to declineand, in some countries, even ceased. Therefore, it has becomeextremely crucial to identify and share experience with themfrom countries with well-developed and establishedtransplantation programmes and from other local initiatives,which could provide models for the implementation of safedonation and transplantation programmes in the BSAcountries, according to their developmental and culturalbackgrounds.

In this context, in 2011, the Council of Europe launched athree-year collaborative project that aims to battle organshortages and to improve access to transplant health servicesin the Council of Europe BSA member states (Armenia,Azerbaijan, Bulgaria, Georgia, Moldova, Romania, RussianFederation, Turkey and Ukraine) through the developmentof safe and ethical donation and transplantation programmes.Efforts are mainly being directed towards the developmentof effective legislative frameworks and the establishment ofnational transplant authorities and national transplantprogrammes and infrastructures. Specialists in the field oftransplantation from countries with established transplant

systems, such as France, Italy, Czech Republic, Portugal andSpain, are participating and supporting experts from theBSA countries. The intention is to create a permanent networkof national experts that will allow the participating countriesto co-ordinate their efforts and pool resources.

PROJECT STRUCTURE AND ACTION PLAN

The BSA Project has been organised into several WorkPackages that focus on different aspects of the various donationand transplantation processes, which are based on the levelof development of the already existing transplantation activitiesin each BSA member state.

WP1: Project Management

The Council of Europe is in charge of the overall managementof the project. A Steering Committee, consisting of expertsfrom national transplant authorities and organisations fromcountries with well-developed transplant programs, has beenconstituted to guide and ensure the successful developmentof the project.

WP2: Development and implementation of an effectivelegislative and financial framework

Participating member states: Armenia, Azerbaijan andGeorgia. Work package leaders: Agence de la Biomédecine(France) and Czech Transplantations Co-ordinating Centre(Czech Republic).

This Work Package focuses on the development andimplementation of effective legislative and financial frameworksfor transplantation activities. The countries participating inthis Work Package have legislation on organ transplantation,but no established national transplant organisations. Thereis some existing organ transplantation activity from livingdonations, but no deceased donation programmes. This WorkPackage focusses on the assessment of existing transplantlegislation, the financial provisions in each country relativeto health programmes and transplantation activities, theinstitutional and structural obstacles for the development oftransplantation and the political will to develop suchprogrammes.

Between December 2011 and March 2012, information aboutthe countries was collected using a number of questionnairesand subsequently analysed. On April 2012, a delegation ofexperts visited the three countries to complete data collection.Based on the country reports elaborated, a number ofindividual recommendations were produced for each country.These recommendations will be submitted to the threecountries and discussed further.

80

Page 83: Newsletter 2012

WP3: Establishment of National Transplant Authorities

Participating member states: Bulgaria, Moldova and Ukraine.Work package leaders: Centro Nazionale Trapianti (Italy)and the Autoridade para os Serviços de Sangue e daTransplantaçao (Portugal).

This Work Package focuses on the establishment of NationalTransplant Authorities. The countries participating in thisWork Package have already established National TransplantOrganisations and, some of them, minimal deceased donationactivity. This Work Package focuses on the evaluation ofthese existing organisational systems and their functionalityin order to identify areas for intervention and improvement.

Between December 2011 and March 2012, information aboutthe countries was collected using a number of questionnairesand subsequently analysed. The planned site visits will beessential to complete the country evaluations and for theelaboration of individual recommendations and nationalaction plans.

WP4: Clinical Practices

Participating member states: Romania, Russian Federationand Turkey. Work package leaders: DTI Foundation andOrganización Nacional de Trasplantes (Spain).

This Work Package focuses on analysis of the clinical practicesfor the donation-transplantation process inside hospitals.The countries participating in this Work Package haveestablished National Transplant Organisations and have fullyfunctional living and deceased donation programmes.

Between December 2011 and January 2012, informationabout the countries was collected using a number ofquestionnaires and analysed. A delegation of experts visitedTurkey in March 2012 to assess existing clinical practices andto speak to representatives from the Ministry of Health. Sitevisits to Romania and Russian Federation will be scheduledshortly and will allow completion of the country evaluations.Individual recommendations and national action plans willbe elaborated thereafter.

NEXT ACTIONS

Two courses of action will be established for each of theparticipating countries:

• Governmental level -> working with the governmentsand Ministries of Health to engage political involvementthrough site visits and direct meetings.

• Technical level -> working directly with the nationaltechnical experts at a practical level. Specific tasks and goalswill be defined for each country and appropriate trainingwill be provided to accomplish them. There will be continuousfollow-up of progress and the results will be evaluated afterthe first year.

CONTACT

Marta López Fraga PhD, Scientific Officer, EDQM, Councilof Europe: [email protected]

Tel. +33 (0)3 90 21 45 30; Fax +33 (0)3 88 41 27 71

Web Pages: http://www.edqm.eu http://www.coe.int

81

Page 84: Newsletter 2012
Page 85: Newsletter 2012

Transplantation of Non-Nationals andNon-Residents in the Countries of the Council of

Europe: Results of a Survey Conducted in theContext of the Initiatives of the European

Committee on Organ Transplantation (CD-P-TO)

Page 86: Newsletter 2012

84

This study on transplantation for non-nationals/non-residentsin the member states of the Council of Europe commencedin 2008 as an initiative of the European Committee (PartialAgreement) on Organ Transplantation (CD-P-TO) of theCouncil of Europe and was co-ordinated by the ItalianNational Transplant Centre (CNT).

The CNT circulated a questionnaire to the health authoritiesof the 35 member states of the Council of Europe, to membersof the CD-P-TO and to two trans-national transplantorganisations.

The main objective of the survey was to investigate various

aspects related to transplantation in non-nationals/non-

residents, especially with regard to access to waiting lists,

transplantation (including from living donors), allocation and

health and social assistance provided to non-nationals/non-

resident patients.

Twenty-nine of the 37 agencies contacted returned the

questionnaire (Table 1) and the results of the survey are

presented in this report.

Transplantation of Non-Nationals and Non-Residentsin the Countries of the Council of Europe: Results of aSurvey Conducted in the Context of the Initiatives ofthe European Committee on Organ Transplantation

(CD-P-TO)Carella C, Cozzi E, Di Ciaccio P, Nanni Costa A.

Italian National Transplant Centre (CNT), Rome, Italy

Austria Medical University Wien

Belgium Ministère de Santé Publique

Bulgaria Executive Agency of Transplantation

Cyprus Paraskevaidion surgical and transplant center of Cyprus

Czech Republic National Transplantations Coordinating Center

Denmark Rigshospitalet

Estonia Tartu University Hospital

Eurotransplant

Finland Division of Transplantation, Helsinki University

France Agence de la Biomédecine

Georgia Georgian Association of Transplantologists

Germany Deutsche Stiftung Organtransplantation

Greece Hellenic Transplant Organization

Hungary Department Of Transplantation and Surgery, Semmelweis University

Iceland Ministry of Health

Ireland Department of Public Health

Italy Italian National Transplant Centre

Luxembourg Luxembourg Transplant

Moldova Republican Clinical Hospital

Netherlands National Board of Health and Welfare

Norway Oslo University Hospital

Poland Poltransplant

Portugal Autoridade Dos Serviços De Sangue E Transplantação

Romania National Transplant Agency

Slovenia Institute for Transplantation of Organs and Tissues of the Republic of Slovenia

Spain Organización Nacional de Trasplantes

Sweden National Board of Health and Welfare

Switzerland Swisstransplant

United Kingdom National Health Service

Table 1. List of countries/authorities participating in the survey.

Page 87: Newsletter 2012

Countries withrestrictinglaws/regulations

85

Definitions:

For the purpose of this survey, the status of non-residentsand non-nationals was defined according to the currentdefinitions in the Italian legislation and these definitionswere made available to the participating countries when thequestionnaire was distributed.

In particular, residency is defined as the act of establishingor maintaining a residence in a given place, regardless ofnationality and race. Residency can be either legal (throughnationality, permanent or temporary residency card or asylumseeker or refugee status) or illegal. In case of legal residency,citizens are obliged to be registered by national authoritiesand pay insurance or social security fees, health care coverageand/or taxes, depending on the national laws. A resident caneither be a national or an alien with legal temporary orpermanent residency status. In the case of asylum seekersand refugees, the resident status is automatically granted.

Non-residents are individuals who are not residing whereofficial duties require them to reside. A non-resident couldbe a national citizen living abroad or an alien withouttemporary or permanent residency status. Tourists and peopleresiding illegally in a country are considered non-residents.

ACCESS TO WAITING LISTS AND TOTRANSPLANTATION

With regard to access to waiting lists and to transplantation,all but seven of the national health authorities that returnedthe questionnaire declared that there was a restrictinglaw/regulation in force in the country regarding non-resident/non-national individuals (Table 2).

Different restricting criteria, however, are used in the 21remaining countries and, in some cases, more than one setof restricting criteria are applied (Table 3). In 77.3% of thecountries answering the questionnaire, residency is used as arestricting criterion, and in 3 countries, nationality or citizenshipis an additional restricting element. Fifty per cent of respondentshad other restricting criteria, including having health insurancecoverage or coverage by a social security system or privatefunding. Evidence of financial coverage (health insurance,social security system or private funding) was the uniquerestricting element in just one country. Finally, the presenceof a bilateral health co-operation agreement was reported asan additional restricting criterion by 22.7% of respondents.It is noteworthy that none of the countries replying to thesurvey reported patients’ ethnic origin as a restricting criterion.

The national parliament was reported as the institutionissuing the regulations in place for non-resident/non-nationalindividuals in 61.5% of countries whilst, in 23% of countries,a specific ministry was the primary promoter of the legalframework through decrees, guidelines, by-laws or otherinstruments. In the remaining countries, a central role for aNational Organ Transplant/Procurement Organisation or arole for regional/administrative/local authorities was reported.

The regulations in place are legally-binding in 86.9% of thosecountries that responded, of which 90% have a mechanismto ensure compliance.

Interestingly, the countries within Eurotransplant (ET) areexpected to adhere to the “5% non-resident rule”, whichrequires that the number of non-resident listings per centrefor liver, heart and lung transplantation should not exceed5% per year of the total number of patients transplantedwith an organ from a deceased donor in the previous calendaryear. All transplantations from deceased donors are used forthe determination of compliance with the “5% non-residentrule”, with the exception of:

Paediatric patients who are successfully transplanted with aleft lateral liver split, in the event that the (extended) rightlobe of the same donor organ is also transplanted;

Patients from a non-ET twinned country or centre who arelisted on the waiting list or the ET twinning centre, in caseof an approved twinning agreement.

Non-compliance with the “5% non-resident rule” iscommunicated by ET to the centre concerned and to the Boardof ET on a regular basis (at least annually). The “5% non-

Countries without arestrictinglaws/regulations

Table 2. Countries with or without a restricting law/regulation in forcefor transplantation of non-resident/non-national patients.

Table 3. Restricting criteria that impact on access to transplantationwaiting lists for non-resident/non-national patients.

Austria Cyprus

Belgium Estonia

Bulgaria Georgia

Czech Republic Ireland

Denmark Moldova

Finland Portugal

France Romania

Germany

Greece

Hungary

Iceland

Italy

Luxembourg

Netherlands

Norway

Poland

Slovenia

Spain

Sweden

Switzerland

United Kingdom

Residency 77.3%Nationality 14%Ethnic origin NoneHealth insurance, socialsecurity system or privatefunding 50%

Bilateral health agreement 22.7%

PERCENTAGERESTRICTINGCRITERION

Page 88: Newsletter 2012

86

resident rule” does not apply to kidney and pancreas recipients,on the understanding that these patients are not allowed tobe registered on the ET waiting list.

In the ET countries (where the “5% non-resident rule” isapplied), and in Cyprus and Romania due to the absence ofa regulatory framework or specific restrictions, virtually anyperson (including non-nationals and non-residents) in thecountry can have access to transplantation.

The existence of special provisions at a national or local levelfor asylum seekers, refugees and non-residents in a countryfor humanitarian reasons were reported in 58.3% of therespondents.

In order to fully comprehend the situation in terms of accessto the deceased waiting list in the various Council of Europemember states according to citizenship and residency status,the questionnaire included specific questions, summarisedin Figure 1.

ALLOCATION

In 91.6% of cases, non-nationals and non-residents are notdisadvantaged compared to residents in terms of organ allocation.However, in Poland, non-residents can only receive an organif a suitable Polish recipient does not exist. Similarly, in theUnited Kingdom, non-EU residents can receive a graft from adeceased donor only if there is no suitable national recipient.

It is encouraging, however, that in 85.7% of countries withrestrictions on access to transplantation for non-nationalsand non-residents, this does not apply to paediatric cases.Similarly, 66.6% of countries with restrictions on access totransplantation for non-nationals and non-resident individualswould consider enabling access to transplantation for suchindividuals in the case of a medical emergency associatedwith life-threatening conditions. In most of these cases,however, access to transplantation for such individuals isonly allowed if the life-threatening condition arose suddenlywhilst in the country.

TRANSPLANTATION FROM LIVING DONORS

With regard to organ transplantation from living donors, 80.7%of the respondent countries indicated that they would considerit even in cases where the living donor, the recipient or bothwere non-resident/non-national individuals (Figure 2).

It should be clarified, however, that in the vast majority ofcases, a thorough assessment of both the donor and recipientprofiles, including technical and non-technical aspects, wouldbe undertaken in advance. In addition, the financial aspectsof the procedures would also be closely analysed prior toproceeding with the transplant.

A familial relationship is required in all cases to perform livingdonor organ transplantation if the living donor, the recipientor both are non-resident/non-national, where this is allowed(Figure 3). However, 71.4% of these countries would alsoconsider living donor organ transplantation involving non-residents/non-nationals if a close emotional relationshipbetween donor and recipient existed.Figure 1. Access to cadaveric waiting lists for different patient categories

in European countries.

Figure 2. Countries that would consider organ transplantation usinga living donor even in the cases where the living donor, the recipientor both were non-resident/non-nationals.

European citizens,non-resident in a country,

having access to thecadaveric waiting list

Non-European citizens,non-resident in a country,

having access to thecadaveric waiting list

National residing abroad(who have lost their

resident status) havingaccess to the cadaveric

waiting list

Non-national, non residentindividuals paying for

their own medicaltreatments and havingaccess to the cadaveric

waiting list

Yes38.5%No

61.5%

Yes33.3%

No66.7%

Yes50%

No50%

Yes80.7%

No19.3%

Yes27%

No73%

Page 89: Newsletter 2012

87

The questionnaire also explored the provisions in place ineach country in case of acute graft failure following livingdonor organ transplantation and where the living donor, therecipient or both are non-resident/non-national. In 50% ofthe countries, recipients of an acutely failed graft from a livingdonor are legally entitled to have access to the national waitinglist; in another 10%, this would be possible only for a failedliver transplant, whilst in 5% access to the national waitinglist would be possible only if the recipient was otherwisequalified. In 35% of the countries, however, recipients of anacutely failed living donor graft, where the living donor, therecipient or both are non-resident/non-national, are notentitled to have access to the national waiting list.

Finally, the survey also explored whether, in a given country,non-nationals and non-resident patients could undergotransplantation from a living donor at his/her own expense.More than one third of the respondent countries stated that,even at their own expense, non-resident patients were notauthorised to undergo transplantation from a living donor.

HEALTH & SOCIAL ASSISTANCE

The questionnaire also looked into the financial coverage ofthe transplantation amongst the various categories ofindividuals in need of a transplant. As far as residents areconcerned, whilst cost coverage is guaranteed for all nationalsundergoing transplantation in their own country, this wasextended to residing aliens in only one third of the countries.As far as residing aliens, national non-residents, illegal aliensand asylum seekers the situation is summarised in Figure 4.

Interestingly, financial coverage is also provided to non-resident/non-nationals in 2 countries, a benefit that is alsoextended to non-EU citizen in one of these. Healthcareassistance rules for non-resident/non-nationals asking foradmission to deceased waiting lists do not differ in publicversus private hospitals in 77% of countries, whereas only23% of countries declared that transplantation takes placeexclusively in public institutions. The financial scheme reportedabove is independent of whether the transplant takes placein a private or public hospital.

CONCLUSIONS

This brief report highlights the significant degree of diversitywith regard to access to transplantation for non-resident/non-national patients in member states of the Council of Europe.Indeed, the spectrum of transplantation opportunities providedto non-resident/non-national citizens by European countriesgoes from granting rights similar to those reserved fornationals to denying access to transplantation.

However, it is encouraging to note that in many, but not allcountries, very specific circumstances, such as paediatrictransplantation, life-threatening emergencies and immediatefailure of a transplanted organ, may allow to by-pass the existingregulatory frameworks and grant access to transplantation topatients with special needs. It is anticipated that activities suchas those conducted and promoted by the CD-P-TO will beinstrumental to better appreciate the heterogeneity of theEuropean landscape with regard to transplantation, to identifypossible areas of intervention and to facilitate the transfer ofknow-how across Europe. Together, such efforts are expectedto contribute to the harmonisation of transplantation accessand practices across the member states of the Council of Europe.

Figure 3. Relationship required between donor and recipient in thecountries that perform living donor organ transplantations where theliving donor, the recipient or both are non-resident/non-nationals.

Figure 4. Financial coverage of the transplantation procedures fordifferent patient categories.

Relative oremotionally related

71.4%

Relativeonly

28.6%

Residingaliens

Yes30%No

70%

Yes47.8%No

52.2%

Nationalnon-residents

Illegalaliens

Yes30.4%No

69.6%

Yes65.2%

No34.8% Asylum

seekers

Page 90: Newsletter 2012

Page 91: Newsletter 2012

European Committee (Partial Agreement)on Organ Transplantation (CD-P-TO)

ChairmanPFEFFER Per

MembersAUSTRIA

MUEHLBACHER FerdinandBELGIUM

COLENBIE LucMUYLLE Ludo (secondment)

BULGARIAGICHEVA Maria

CROATIABUSIC MirelaRALEY Lydia

CYPRUSHADJIANASTASSIOU Vassilis

CZECH REPUBLICBREZOVSKY Pavel

DENMARKCARLSEN Jorn

ESTONIADMITRIEV Peeter

FINLANDSALMELA Kaija

FRANCELAOUABDIA-SELLAMI KarimTHUONG Marie (secondment)LIFFRAN Geneviève (secondment)

GERMANYKIRSTE Günter (vice chair)TONJES Ralf Reinhard (secondment)

GREECEHATZIS AnastasiosGAKIS Dimitrios (secondment)

HUNGARYLANGER Robert

ICELANDMAGNUSSON Sveinn

IRELANDEGAN Jim

ITALYNANNI COSTA AlessandroCOZZI Emanuele (secondment)CHATZIXIROS Efstratios(secondment)

LATVIATRUSHKOV Sergey

LUXEMBURGJOME Laurent

MALTAZARB ADAMI Joseph

NETHERLANDSHAASE-KROMWIJK Bernadette

NORWAYOYEN Ole

POLANDDANIELEWICZ Roman

PORTUGALAMIL MargaridaBOLOTINHA Catarina

ROMANIAZOTA Victor

SLOVAK REPUBLICDANNINGER Filip

SLOVENIAAVSEC Danica

SPAINMATESANZ RafaelDOMINGUEZ-GIL Beatriz(secondment)MARAZUELA Rosario (secondment)

SWEDENMÖLLER CharlotteERICZON Bo-Göran (secondment)

SWITZERLANDMOREL Philippe

TURKEYKEMALOGLU BahriSEYHAN Türkay

UNITED KINGDOMNEUBERGER James

Observers

ARMENIASARKISSIAN Ashot

AZERBAIJANKADIROV Aydin Vali

BELARUSRUMO Aleh

CANADAAGBANYO Francisca

CDBI (BIOETHICS COMMITTEE,COUNCIL OF EUROPE)

GEFENAS Eugenijus HAËRTEL Ingo (secondment)

ESOT (EUROPEAN SOCIETY FORORGAN TRANSPLANTATION)

PLOEG RutgerEUROPEAN COMMISSION

LE-BORGNE HélèneSISKA Ioana-Raluca

EUROTRANSPLANT INTERNATIONALFOUNDATION

RAHMEL AxelOOSTERLEE Arie

GEORGIATOMADZE Gia

HOLY SEEMgr RALLO Vito

ISRAEL ASHKENAZI Tamar

MOLDOVACODREANU Igor

SCANDIATRANSPLANTHOCKERSTEDT Krister

TTS (THE TRANSPLANTATION SOCIETY)DELMONICO FrancisEKBERG Henrik

RUSSIAN FEDERATIONGABBASOVA LyalyaNIKOLAEV German

UKRAINENYKONENCO OleksandrSOBOKAR Vitaliy

UNOS (UNITED NETWORK FOR ORGANSHARING)

MYER KevinPRUETT Timothy

USAWITTEN Celia

WHO (WORLD HEALTH ORGANISATION)NOEL Luc

Page 92: Newsletter 2012

4

DU

BR

OVN

IK

CR

OAT

IA

5-7

OC

TOB

ER

2ND A

NN

OU

NC

EMEN

T &

CA

LL F

OR

AB

STR

ACTS

Und

er th

e au

spic

es o

f the

M

inis

try

of H

ealt

h an

d So

cial

W

elfa

re o

f the

Rep

ublic

of C

roat

ia

ww

w.e

sot.

org

2012

EU

RO

PEA

N O

RG

AN

DON

ATIO

N C

ONGR

ESS:

Nex

t >B

ack

24TH

ETC

O-E

DC

A SE

CTI

ON

OF